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Carbohydrates are ubiquitous in Nature where they play important roles as materials. 
The structural diversity of carbohydrates results in materials with extremely different 
properties, from gels to extremely rigid materials. Still, structure-property correlations 
are hardly established due to the difficulty in obtaining pure molecules and the lack of 
analytical methods. This lack of knowledge drastically hinders the application of 
carbohydrate materials in nanotechnology, where, in contrast, DNA and peptide have 
found great success. In this thesis, automated glycan assembly (AGA) is used as a 
platform to produce well-defined carbohydrate materials and establish structure-
properties correlations. 
In Chapter 2, the optimization of AGA is discussed. The insertion of a new capping 
method into the AGA cycle granted access to oligo- and polysaccharides in high yield, 
minimizing the accumulation of deletion sequences. The use of methanesulfonic acid 
and acetic anhydride allowed for the fast and quantitative capping of hydroxyl groups 
that failed to be glycosylated. Commonly used protecting groups in AGA are stable 
under these capping conditions. Drastically improved overall yields are a consequence 
of decreased side‐products and simplified purifications. Moreover, the building block 
consumption is reduced. To illustrate the method, the biologically important 
tetrasaccharide Lc4, as well as a 50‐mer polymannoside were prepared.  
These optimized AGA conditions provide reliable access to a collection of oligo- and 
polysaccharides with defined structure, which are ideal for establishing structure-
property correlations of natural polysaccharides. Chapter 3 focuses on cellulose, the 
most abundant polysaccharide in Nature. Well‐defined unnatural oligosaccharides 
including methylated, deoxygenated, deoxyfluorinated, as well as carboxymethylated 
cellulose and chitin analogues with full control over the degree and pattern of 
substitution were prepared. Molecular dynamics simulations and crystallographic 
analysis show how distinct hydrogen‐bond modifications drastically affect the solubility, 
aggregation behavior, and crystallinity of carbohydrate materials.  
After proving that oligosaccharides exhibit similar conformational features as their 
polysaccharide counterparts, the formation of well-defined supramolecular 
architectures based on simple oligosaccharides was targeted. In Chapter 4, six 
synthetic oligosaccharides, ranging from dimers to hexamers, are shown to self-
assemble into nanostructures of varying morphologies and emit within the visible 
spectrum in an excitation-dependent manner. Well-defined differences in chain length, 
monomer modification, and aggregation methods yield glycomaterials with distinct 
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shapes and properties. The excitation-dependent fluorescence in a broad range within 
the visible spectrum illustrates their potential for use in optical devices and imaging 
applications.  
The systematic approach presented in this thesis, based on well-defined synthetic 
oligosaccharides, will create the foundation of our understanding of carbohydrate 





Kohlenhydrate sind in der Natur allgegenwärtig, wo sie als Materialien eine wichtige 
Rolle spielen. Die strukturelle Vielfalt von Kohlenhydraten führt zu Materialien mit 
extrem unterschiedlichen Eigenschaften - von Gelen bis hin zu extrem starren 
Materialien. Struktur-Eigenschafts-Korrelationen sind immer noch kaum etabliert 
aufgrund von Schwierigkeiten reine Moleküle zu erhalten und mangels analytischer 
Methoden. Diese Wissenslücke behindert die Anwendung von 
Kohlenhydratmaterialien in der Nanotechnologie drastisch, wohingegen DNA und 
Peptide große Erfolge erzielt haben. In dieser Arbeit wird die automatisierte 
Festphasensynthese von Glykanen (Automated Glycan Assembly, AGA) als Plattform 
verwendet, um definierte Kohlenhydratmaterialien herzustellen und Korrelationen 
zwischen Struktur und Eigenschaften herzustellen. 
In Kapitel 2 wird die AGA-Optimierung besprochen. Die Einführung einer neuen 
Capping-Methode in den AGA-Zyklus ermöglichte den Zugang zu Oligo- und 
Polysacchariden in hoher Ausbeute, durch die Minimierung der Anhäufung von 
Deletionssequenzen. Die Verwendung von Methansulfonsäure und 
Essigsäureanhydrid ermöglichte das schnelle und quantitative Capping von Hydroxy-
Gruppen, die nicht glykosyliert werden konnten. Häufig in AGA verwendete 
Schutzgruppen sind stabil unter diesen Bedingungen. Die drastisch verbesserten 
Gesamtausbeuten sind auf weniger Nebenprodukte und vereinfachte Aufreinigungen 
zurückzuführen. Darüber hinaus wird der Verbrauch von Monosaccharid-Bausteinen 
reduziert. Zur Veranschaulichung der Methode wurden das biologisch relevante 
Tetrasaccharid Lc4 und ein 50-mer-Polymannosid hergestellt.   
Diese optimierten AGA-Bedingungen bieten zuverlässigen Zugang zu einer 
Sammlung von Oligo- und Polysacchariden mit definierter Struktur, die sich ideal für 
die Herstellung von Struktur-Eigenschafts-Korrelationen von natürlichen 
Polysacchariden eignen. Kapitel 3 befasst sich mit Cellulose - dem am häufigsten 
vorkommenden Polysaccharid in der Natur. Es wurden genau definierte unnatürliche 
Oligosaccharide mit vollständiger Kontrolle über den Substitutionsgrad und das 
Substitutionsmuster hergestellt, darunter methylierte, desoxygenierte, desoxyfluorierte 
sowie carboxymethylierte Cellulose- und Chitinanaloga. Molekulardynamik-
Simulationen und kristallographische Analysen zeigen, wie drastisch unterschiedliche 
Wasserstoffbrücken-Modifikationen die Löslichkeit, das Aggregationsverhalten und 
die Kristallinität von Kohlenhydratmaterialien beeinflussen.   
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Nachdem bewiesen wurde, dass Oligosaccharide ähnliche Konformationsmerkmale 
aufweisen, wie ihre Polysaccharid-Gegenstücke, wurde die Bildung wohldefinierter 
supramolekularer Architekturen basierend auf einfachen Oligosacchariden angestrebt. 
In Kapitel 4 wird gezeigt, dass sich sechs synthetische Oligosaccharide, die von 
Dimeren bis hin zu Hexameren reichen, zu Nanostrukturen unterschiedlicher 
Morphologie zusammenlagern und anregungsabhängig im sichtbaren Spektrum 
emittieren. Ausschlaggebende Unterschiede in der Kettenlänge, der Monomer-
Modifikation und den Aggregationsmethoden ergeben Kohlenhydratmaterialien mit 
unterschiedlichen Formen und Eigenschaften. Die anregungsabhängige Fluoreszenz 
in einem breiten Bereich innerhalb des sichtbaren Spektrums zeigt ihr Potenzial für 
den Einsatz in optischen Geräten und bildgebenden Anwendungen.  
Der in dieser Arbeit vorgestellte systematische Ansatz, der auf genau definierten 
synthetischen Oligosacchariden basiert, wird die Basis für unser Verständnis der 
Wechselwirkungen von Kohlenhydraten in der Natur bilden. 
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1.1. Carbohydrates 
Carbohydrates are the most abundant organic compounds in Nature, with 
comprehensive existence in all the living things. Even though composed mainly of only 
four elements: carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), they are the 
most diversified class of molecules in Nature. Carbohydrates are involved in a wide 
variety of physiological and pathological processes,1-2 including cell-cell recognition,3 
blood-group classification,4 and oncogenic transformation5. In addition, the large 
abundance of carbohydrates in Nature makes them important candidates in materials 
science. 
 Polysaccharides as materials 
Carbohydrates are also referred to as saccharides. As a rule of thumb, saccharides 
can be divided into monosaccharides (one unit), disaccharides (two units), 
oligosaccharides (three to ten units), and polysaccharides (more than ten units). 
Polysaccharides serve as important biomaterials in Nature. The striking abundance 
makes carbohydrates an attractive resource of raw material for textile, food, paper, 
and pharmaceutical industries. 
Polysaccharides consisting of one or multiple kinds of monosaccharide units are 
classified as homopolysaccharides and heteropolysaccharides, respectively. 
Homopolysaccharides account for the majority of polysaccharides in terms of mass. 
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Based on the type of monosaccharide and the linkage between these units, different 
homopolysaccharides are defined, with cellulose, chitin, and amylose among the most 
abundant (Figure 1-1).  
 
Figure 1-1. Chemical structure of cellulose, chitin, and amylose. 
As a polymer, each polysaccharide can be then differentiated by the degree of 
polymerization (DP). The DP of polysaccharides from different sources varies 
drastically. Polysaccharides can be also classified as linear or branched, charged or 
non-charged. 
1.1.1.1. Cellulose 
Cellulose is the most abundant biomass in Nature, with a wide distribution in the 
biosphere.6 It is one of the major components of the plant cell wall and provides 
structural support and strength. Cellulose plays also a crucial role in the protective 
biofilm of some bacteria.7 
In human society, cellulose has been used since the beginning of civilization in making 
paper products, clothes, and building materials. Although cellulose cannot be digested 
by human due to the lack of cellulase, recent discovery in nutriology suggests that 
taking in cellulose fiber (known as dietary fiber) in diet is beneficial for digestive 
system.8 In addition, cellulose finds broad application in manufacturing scientific 
devices, such as quantitative filter paper, dialysis membrane, and thin-layer 
chromatography. 
Cellulose is a biopolymer that consists of repeating glucose units, connected through 
β-1,4-glycosidic bonds (Figure 1-1). The β configuration allows for a compact sheet-
like secondary structure.9 The hydroxyl groups arrange themselves to give a dense H-
bonding network (Figure 1-2A), which is majorly responsible for the high crystallinity 
and stiffness of cellulose. While most carbohydrates can hardly be crystallized, the 
high crystallinity of cellulose allows for substantial structural study with X-ray 
diffraction.10 Till now, four types of cellulose crystalline forms based on different H-
bonging patterns have been characterized. Cellulose I is the natural form of cellulose. 
The treatment on cellulose I with alkali irreversibly yields cellulose II, which is lower in 
free energy than cellulose I. Cellulose III and cellulose IV are less common and can 
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be also obtained by chemical treatments, but will not be included within the framework 
of this thesis. 
 
 
Figure 1-2. Schematic representation of crystalline structure of cellulose (A) and 
intermittent occurrence of crystalline and amorphous region in cellulose (B). 
In the hierarchical structure of cellulose,11 highly ordered crystalline regions are 
separated by disordered amorphous regions (Figure 1-2B).12 By acid hydrolysis, the 
crystalline part of cellulose (cellulose nanocrystals, CNCs) can be obtained. Due to 
their renewable nature, biocompatibility, high stiffness, and low cost, CNCs are gaining 
popularity in materials engineering.13 Important examples of applications of CNCs in 
material science include the formation of cross-linked hydrogels14 and hierarchical 
architectures with interesting optical behavior15. 
Chemical modifications drastically change the properties of cellulose and chemically 
modified cellulose has found broad application in industry. 
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Methylation is one of the most common methods for cellulose modification.16 
Methylcellulose (MC) (Figure 1-3) is broadly applied as bulk forming laxative 
pharmaceutical, thickener in food, and additive in construction materials. In addition, 
methylation gives cellulose a temperature-dependent gelation property17-18 which has 
aroused a lot of interests in material sciences. 
The introduction of polar carboxymethyl group into cellulose increases the water 
solubility. Carboxymethyl cellulose (CMC, Figure 1-3) is used, in its sodium salt form, 
as tackifier, lubricant, and thickening agent.19-20 Its properties are largely affected by 
the degree of substitution. 
 
Figure 1-3. Chemical structure of methylcellulose, carboxymethyl cellulose, and 
phosphoethanolamine cellulose. 
In 2018, Thongsomboon et al. reported the first discovery of naturally modified 
cellulose.21 Solid-state NMR analysis confirmed that some bacteria produce modified 
cellulose which contains a phosphoethanolamine modification at the 6-OH of every 
second glucose unit (Figure 1-3). This modification was then proved to play a crucial 
role in adjusting the macroscopic morphology of biofilm to better protect the bacteria 
against harsh conditions. 
1.1.1.2. Chitin and amylose 
Next to cellulose, chitin is the second most abundant polysaccharide found as the 
major component of the exoskeletons of crustaceans and insects.22 The chemical 
structure of chitin is closely related to cellulose. The two polysaccharides share the 
same structural scaffold and only differs in the substitution at 2-C (Figure 1-1). The 
acetyl amino group of chitin allows for stronger H-bonding compared with the hydroxyl 
group of cellulose, thus gives chitin higher mechanical strength. 
Amylose is one of the major components of starch and an important energy resource 
for humans.23-24 Amylose shares the same monomeric unit of cellulose but with α-1,4- 
instead of β-1,4-glycosidic linkage (Figure 1-1). This relatively small difference results 
in an entirely different enzymatic reactivity, which makes starch easily digested by the 
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enzymes in the mouth, stomach and small intestine of human, while cellulose remains 
stable during the digestion process. Additionally, the difference in the configuration of 
the glycosidic bonds drastically affects the secondary structure, with amylose chain 
adopting an amorphous or helical conformation, with much lower crystallinity than the 
linear cellulose. 
 Challenges in polysaccharide materials 
Although it is well-known that the properties of polysaccharides are strongly affected 
by their chemical structure,25 a detailed structure-property correlation is missing, 
largely due to the lack of pure molecules and effective analytic methods. 
To achieve solid characterization and establish structure-property correlations, pure 
compounds are necessary. However, polysaccharides extracted from natural sources 
are generally heterogeneous. Due to the structural complexity, large molecular size, 
and low solubility of natural polysaccharides, purification is often inapplicable. In most 
cases, chemical synthesis remains the only access to pure samples.26 However, 
synthesis of carbohydrate is challenging and laborious due to the intrinsic complexity 
of glycans and the lack of a universal synthetic approach. 
The lack of reliable characterizing methods also limits the understanding of 
carbohydrate materials. Most carbohydrates only consist of four basic elements (C, H, 
O, N) and do not contain a chromophore. Therefore, very few analytical methods are 
available for the structural characterization of carbohydrates at the molecular level.27-
28 In addition, such methods are generally challenging and require expertise. Molecular 
dynamics simulations have also been applied to assist the structural study of 
polysaccharides,29-30 but remain limited by the lack of validating standards. 
1.2. Synthetic polysaccharides 
In comparison with DNA and peptide synthesis, the synthesis of polysaccharides is 
more challenging due to the structural diversity. Polysaccharides can form branched 
structures, requiring multiple temporary protecting groups (tPGs) for synthesis. In 





Figure 1-4. Comparison of DNA, peptide, and carbohydrate synthesis. 
 Chemical glycosylation 
A glycosylation reaction forms a glycosidic bond between the glycosyl donor and a 
hydroxyl group on the glycosyl acceptor. Glycosylation can be catalyzed enzymatically 
or chemically. In this thesis, only chemical glycosylation is discussed. 
The first step of a chemical glycosylation involves the activation of the glycosyl donor 
with a suitable activator. This results in the departure of the leaving group (LG) with 
consequent formation of an oxocarbenium ion. Nucleophilic attack by the hydroxyl 
group on the glycosyl acceptor yields the product (Figure 1-5A). The instability and 
water sensitivity of the intermediates are the major reasons why low temperature and 
anhydrous condition (usually achieved by molecular sieve) are necessary during the 
glycosylation process. 
When the glycosyl acceptor is itself a sugar, several hydroxyl groups can potentially 
react (Figure 1-5B). Regioselectivity is therefore necessary to obtain the desired 
product. Protecting groups (PGs) are employed to block the undesired reactive sites 
and leave only the desired hydroxyl available for coupling (Figure 1-5B). The formation 
of the glycosidic bond generates a new stereogenic center. The glycosyl acceptor can 
attack from both sides of the oxocarbenium intermediate, resulting in a mixture of 
products (α and β anomers). Therefore, stereoselectivity should be ensured so that 
only one anomer is obtained as major product (Figure 1-5C). The use of particular 
PGs is often exploited to control the stereoselectivity by neighboring group 
participation. This is generally an ester group that, upon activation of the glycosyl donor, 
can stabilized the oxocarbenium ion and form an acetoxonium ion, which blocks the α 




No stereocontrol StereocontrolNo stereocontrol




Figure 1-5. General mechanism of glycosylation and regio- and stereochemistry 
control by protecting groups and neighboring group participation. 
The installation and removal of protecting groups result in extra synthetic workload. In 
addition, some glycosidic bonds are still difficult to construct, such as the 1,2-cis 
linkage and the ketosidic bond of sialic acid. Many special glycosylation strategies 
have been developed, such as remote participation,31-32 or conformational constraint.33 




 Synthesis of polysaccharides 
In the last decades, many elegant works have been reported that allowed for the 
access to defined and complex oligosaccharides. Nevertheless, such protocols are still 
considerably challenging when applied to big polysaccharides, often requiring huge 
chemical efforts and synthetic steps. Depending on the target molecules, different 
strategies were employed to minimize the manual work (Figure 1-6). 
 
Figure 1-6. General scheme of well-defined polysaccharide synthesis. 
 Most natural polysaccharides are based on repetitive structures with a repeating 
unit consisting of one or multiple (linear or branched) glycosidic residues. To 
synthesize repetitive polysaccharides, a building block representing the repeating unit 
needs to be obtained and used iteratively (Figure 1-6A). A careful protecting group 
strategy is always employed to assure the desired regio- and stereochemistry.  
When the repeating unit consists of a branched structure, the retro-synthesis becomes 
more complex. As common strategy, a linear multi-ol acceptor is firstly synthesized 
and the ensuing multi-glycosylation inserts all the branches in one single step.  
The synthetic strategy for non-repetitive polysaccharides highly depends on the 
structures of the target molecule (Figure 1-6B). In 2017, an impressive total synthesis 
of mycobacterial arabinogalactan with 92 monosaccharide units was reported (Figure 
1-7, m = 13, n = 9), resulting in the biggest well-defined polysaccharide ever 
synthesized in solution phase.34 The key glycosylation step was a [31+31+30] coupling, 
promoted by benzenesulfinyl morpholine/triflic anhydride. A preactivation-based 
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glycosylation strategy was adopted during the assembly to decrease the need of 
protecting group manipulation. 
 
Figure 1-7. Structure of mycobacterial arabinogalactan with highlighted β-
arabinofuran linkages (red). 
 Automated glycan assembly of polysaccharides 
Several automated synthetic platforms have been developed to reduce the manual 
work required by classical solution phase synthesis and to improve the process 
efficiency. Youshida et al. reported the automated synthesis of hexa-N-
acetylglucosamine based on electrochemical oxidation.35 Using fluorous tag-assisted 
automated synthesis, Pohl et al. synthesized trimannoside in solution phase.36 
Demchenko et al. reported the automated oligosaccharide synthesis in adapted 
HPLC.37 Nevertheless, none of the automated synthetic platforms reaches the length 
beyond hexasaccharide, except for automated glycan assembly. 
1.2.3.1. Automated glycan assembly (AGA) 
In 1971, Schuerch et al. reported the first solid phase glycan synthesis.38 Since then, 
much advancement has been made to optimize this method. In parallel, automated 
synthesis of peptides and oligonucleotides found great success in 
commercialization.39-41 Automated solid phase glycan synthesis was not achieved until 
10 
 
2001, when Seeberger et al. reported the first fully automated glycan synthesis.42 In 
the ensuing two decades, different linkers and building blocks have been tested and 
applied in order to enrich the synthesis ability.43-45 
 
Figure 1-8. Photo and schematic diagram of automated glycan assembly with 
essential components in colored boxes.  
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The resin is manually added to the chilled reaction vessel (red box). Reagents (green 
box) and building blocks (orange box) are delivered from inert-gas-compressed stock 
glassware to the reaction vessel via syringe pumps (yellow box). Solvents (light blue 
box) are driven to the reaction vessel by compressed argon. A filter pad is fitted at the 
bottom of the vial to enable a rapid removal of excessive reagents and solvents after 
each reaction or washing step. The reaction temperature is controlled by a 
temperature-controlling device (purple box). The operation of the synthesizer is highly 
programmable and controlled by computer (dark blue box). 
All AGA reactions are conducted on solid support. A cleavable linker, containing a free 
hydroxyl group, is bound to the resin and used as first anchoring point (Figure 1-9A). 
The cleavable part between resin and hydroxyl group enables the release of the 
synthetic oligosaccharides from the solid support upon completion of AGA. Depending 
on the cleaving condition, different linkers have been developed, such as metathesis-
labile linker, base-labile linker, and photocleavable linker. In this thesis, unless stated 
otherwise, only the photocleavable linkers are used. 
Two types of photocleavable linkers are currently employed. Resin 1 releases the 
glycan equipped with an aminoalkyl spacer at the reducing end (Figure 1-9B), 
enabling the subsequent attachment of the glycan to a protein or microarray. The 
recently developed photocleavable linker 2 offers the option of releasing the free 
reducing end after photocleavage (Figure 1-9C).45 
 
Figure 1-9. Examples of photocleavable linkers currently employed in AGA. 
AGA is based on the iterative addition of protected monosaccharides to a growing 
oligosaccharide chain bound to a solid support (Figure 1-10). A sugar building block, 
equipped with a reactive leaving group, is chemically activated and coupled to the 
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hydroxyl group of the linker. After glycosylation, the excess building block and 
reactants are removed by filtration. The BB is equipped with one or multiple temporary 
protecting groups (generally levulinyl group (Lev) or fluorenylmethyloxycarbonyl group 
(Fmoc)) that permit to release the desired hydroxyl group to be used in the next 
glycosylation step. All the other BB positions are protected as benzyl ethers or benzoyl 
esters (permanent protecting groups). The iterative glycosylation and deprotection 
cycles are programmed and controlled by a computer.  
 
Figure 1-10. Synthetic cycle of automated glycan assembly. 
Upon completion of the assembly, the UV light sensitive linker is cleaved from the solid 
support under the irradiation of a mercury lamp, liberating the desired fully protected 
polysaccharides. To improve the efficiency of this UV-cleavage, a flow device is 




Removal of all the protecting groups through methanolysis of the ester-type PGs 
followed by hydrogenation of the ether PGs affords the target glycan. 
1.2.3.2. Polysaccharide synthesis with AGA 
To date, a wide range of glycans have been successfully synthesized with AGA. Still, 
the synthesis of long polysaccharides remains quite challenging. Here some important 
achievements are reviewed. In 2012, the 12-mer β-mannuronic acid alginate 3 was 
synthesized by AGA (Scheme 1-1).32 This synthetic route employs Lev as temporary 
group and trifluoroacetimidate as leaving group. The 12-mer was obtained in a 40% 
yield, indicating a 90% average coupling efficiency. Similarly, the synthesis of a 
pentadecasaccharide fragment of hyaluronic acid 4 was reported (Scheme 1-1), with 
92% average coupling yield. The use of the disaccharide building block BB-3 permitted 
to obtain the desired alternated polysaccharides structure. The entire process of eight 
cycles of automated coupling and deprotection took only 28 hours. 
 
Scheme 1-1. Synthesis of β-mannuronic acid alginate 3 and hyaluronic acid 4. 
In 2013, a 30-mer polymannoside (5) was synthesized using a monosaccharide 
phosphate building block BB-3 (Scheme 1-2).47 A “catch-release” strategy was 





Scheme 1-2. Automated glycan assembly of linear polymannosides 5 and 6. 
To push the limit of automated glycan assembly, the 50-mer polymannoside 6 was 
targeted and synthesized in a 5% yield (Scheme 1-2).48 This is the longest synthetic 
oligosaccharide reported directly assembled from monosaccharide building blocks. 
Notably, an exploratory capping procedure was introduced to reduce the deletion 
sequences. However, this capping procedure requires 90 minutes and was therefore 
never implemented in the standard AGA sequence. 
Based on the results on polymannosides, AGA was employed for the synthesis of 
polysaccharides based on different repeating units (Figure 1-11). A collection of 
polysaccharides (homo- and heteropolymers) based on mannose, glucose and 
glucosamine was synthesized and used for structural studies.49 The iterative addition 
of monomeric BBs permits the introduction of modifications (e.g. a different BB or a 
labelled unit) in specific positions of the chain. Single site modifications drastically 
affected the geometry and properties of the final compound, suggesting the potential 
of AGA for a detailed structure-property study of polysaccharides. Moreover, the 
insertion of a terminal BB bearing a carboxylic acid introduced a linkage point that was 




Figure 1-11. Synthetic homo- and hetero-polysaccharides for structural studies 
and schematic representation of block coupling. 
 Synthetic carbohydrate materials for structural studies 
Large access to well-defined structures allows for detailed structural characterization. 
Recent years have seen a substantial advancement in the conformational study of 
carbohydrates based on defined molecules obtained with chemical synthesis. 
Carbohydrates had been generally regarded as flexible in aqueous solution, while DNA 
and peptide have been proved to exhibit well-defined conformations. However, recent 
research indicates that certain oligosaccharides possess varying degrees of 
conformational preference in solution state. 
In 2018, our group suggested the use of defined oligo- and polysaccharides for 
structural studies.49 Different classes of oligo- and polysaccharides were synthesized 
and studied with molecular dynamics (MD) simulations and NMR analysis, indicating 
that each oligomer presents a different geometry and flexibility. For example, in water, 
a 1,6-oligomannoside 12 adopts a flexible linear structure, while the analogue 1,6-





Figure 1-12. Chemical structure and MD simulations of 1,6-mannoside and 1,6-
glucoside. 
To support the MD model, NMR analysis was employed. NMR is a powerful tool for 
the structural study of polysaccharides in solution.50 However, detailed structural 
information at monosaccharide level is difficult to obtain, largely due to the chemical 
shift degeneracy which results in signal overlap and ambiguity in assignment. To 
simplify the analysis, a 13C6-labeled glucose unit was inserted at specific position of 
the hexasaccharide chain. The labelling broke the chemical shift degeneracy and 
provided reliable NMR information that confirmed the MD results. 
In 2013, Ernst et al. discovered a non-conventional H-bond in Lewis X,51 which 
stabilizes the conformation of Gal[Fucα(1–3)]β(1–4)GlcNAc trisaccharide motif. NMR 
studies and quantum mechanical calculation were employed. In 2015, Freedberg et al. 
further confirmed the existence of this non-conventional H-bond by a temperature-
dependent NMR study and molecular dynamics simulations.52 
In 2019, Codée et al. synthesized a series of zwitterionic Streptococcus pneumoniae 
serotype 1 polysaccharides (Sp1),53 ranging from tri- to dodecasaccharides. MD 
simulation and NMR studies unraveled a helical structure for the Sp1 chain. To 
complete one single helical turn, nine glycosidic units are needed. ELISA and STD-
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NMR experiments were then performed, which revealed a minimal antibody binding 
epitope of 7-8 residues of Sp1. The coincidence of the minimal length for one helical 
turn and antibody binding affinity might indicate the role of carbohydrate conformation 
in biological events.  
1.3. Nanotechnology based on biomolecules 
DNA and peptide have found great success in nanotechnology, based on the following 
two facts: 
 Well established synthetic platform enables quick access to pure material 
 Their conformation is well studied by reliable analyzing methods 
Taking advantage of the well-established synthetic platform and stable double helical 
structure of DNA, DNA origami has shown that the design of complex nanostructures 
can be highly rational and programmable. In 2006, Rothemund reported the 
sophisticated computer-assisted bottom-up design of DNA sequences,54 which can 
self-organize into a bewildering array of defined supramolecular structures. Since then, 
a variety of DNA nanostructures were created, offering nanometer control on the 
supramolecular architectures and found applications in nanorobot construction, drug 
delivery, and biosensing.55 
The bottom-up construction of supramolecular structure has also been achieved with 
peptide-based material. A representative example is the three-block structure, peptide 
amphiphile (PA) designed by Stupp et al.56 The scaffold of PA contains an H-bonding 
peptide sequence, with has the tendency to assembly in a β-sheet manner. The N-
terminus is linked to a hydrophobic C16 alkyl chain, which guides the assembly into 
one-dimensional supramolecular structure. Charged amino acid residues are 
connected at the C-terminus, which further stabilize the assembled structure by 
improving the water solubility. This peptide based self-assembling system is 
biocompatible, stimuli responsive, self-healable, and biodegradable and has found 
broad biomedical applications, such as bone regeneration,57 smooth muscle 
preservation,58 burn would healing,59 cancer therapy,60 and plaque burden reduction in 
atherosclerosis.61 Nature has also inspired several synthetic supramolecular 
architectures. For example, amyloid fibrils in Alzheimer's disease exhibit a defined β-
sheet structure, which is responsible for the stability and low solubility of amyloid fibrils 
and makes it difficult to be removed from human brain.62-63 Inspired by the structure of 
amyloid fibrils, Gazit et al. designed short peptide fragments64-65 (e.g. diphenylalanine66) 
and their analogues (e.g. cyclo-dipeptide,67 di-peptide nucleic acid (PNA)68), which 
were shown to exhibit a self-assembly behavior comparable to the natural amyloid 
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protein. These artificial self-assembled materials exhibit intrinsic fluorescence and 
unique semiconducting properties. 
Carbohydrates are often applied in nanotechnology as adjunct component. In 2017, 
Stupp et al. introduced sulfated monosaccharide into the PA-based nanostructure to 
mimic the biological function of natural heparin.69 The filamentous glycopeptide was 
found to exhibit stronger influence on biological signals than its natural counterpart. In 
2019, Meijer et al. attached a series of carbohydrate to their renowned benzene-1,3,5-
tricarboxamide (BTA) based supramolecular system to mimic the structure and 
function of the glycocalyx (carbohydrate-enriched coating of many cells).70 Still, 
carbohydrates are rarely used for the creation of the supramolecular architecture, but 
rather to improve water solubility or as decorating appendances. This is surprisingly 
considering their ability to engage in hydrogen bonding networks.  
As discussed, defined aggregation of carbohydrate is commonly observed in Nature, 
as with cellulose and chitin, indicating the possibility for carbohydrate-based material 
to form ordered supramolecular structure. Therefore, carbohydrate-based 
nanotechnology holds great promise, owing to the biocompatibility, renewability, and 
high abundance of carbohydrates. 
1.4. Aims of this thesis 
The general aim of this thesis was the development of an efficient synthetic strategy 
to produce well-defined oligo- and polysaccharides, as probes to study carbohydrate 
materials. 
The first aim was to improve AGA yields, through the implementation of a capping step 
into the AGA cycle. The capping method needs to: 
i) be compatible with other AGA reagents and commonly used protecting 
groups; 
ii) ensure a fast synthesis; 
iii) avoid expensive and toxic materials; 
iv) be able to improve the yield in real synthesis of biologically important 
oligosaccharides and long polysaccharides; 
v) simplify the purification of long polysaccharides. 
The second aim of the thesis was to use AGA to produce a collection of well-defined 
probes to establish structure-property correlation of oligo- and polysaccharides. This 
task can be separated into following steps: 
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i) A collection of building blocks bearing unnatural modifications (e.g. a 
methyl group) needs to be synthesized.  
ii) A collection of cellulose analogues with specific modification patterns 
should be prepared. 
iii) This collection needs to be the analyzed in terms of solubility and 
crystallinity (XRD), with particular attention to the difference between 
cellulose analogues with and without modifications.  
iv) MD simulations were planned to study the conformation and aggregation of 
cellulose analogues. 
The third aim of this thesis was the study of the self-assembly of oligosaccharides. To 
this end: 
i) A collection of oligosaccharides has to be designed. 
ii) Suitable self-assembly conditions for carbohydrates needs to be probed. 
iii) Microscopic observations needs to be performed to study the morphology 
of self-assembled samples. 





 A Capping step during automated glycan 
assembly enables access to complex glycans 
in high yield 
This chapter has been modified in part from the following article: 
Y. Yu, A. Kononov, M. Delbianco, P. H. Seeberger, A Capping Step During Automated 
Glycan Assembly Enables Access to Complex Glycans in High Yield. Chem. Eur. J. 
2018, 24, 6075. https://doi.org/10.1002/chem.201801023 
2.1. Introduction 
AGA provides rapid access to different classes of structurally defined glycans. Due to 
the nature of solid-phase synthesis, excess reagents and building blocks, used to 
ensure high coupling yields, can be simply removed by washing and filtration from the 
solid support to accelerate oligosaccharide synthesis. Crucial for a successful AGA is 
the completion of each glycosylation reaction. In ideal conditions, all hydroxyl groups 
exposed on molecules attached to the solid support should be glycosylated such that, 
after removal of the temporary protecting groups (Fmoc and Lev etc.), the next 
glycosylation cycle can take place only on the freshly released hydroxyl groups. Even 
in automated peptide and oligonucleotide assembly, where coupling yields commonly 
exceed 99.9%, a capping step is inserted to minimize the accumulation of n-1 deletion 
sequences and to maximize the overall yield.71 Because of the intrinsic structural 
complexity of carbohydrates, the yields of the glycosylation reaction vary significantly. 
Incomplete glycosylations can result in deletion sequences that render the final 
purification challenging. Therefore, excess building block, typically ten equivalents, is 
added to drive the glycosylation to completion. 
Taking an AGA of a trisaccharide as an example (Figure 2-1), ideally only the desired 
trimer should be obtained. In reality, the glycosylation reactions sometimes do not 
reach completion. This results in free not-glycosylated OH groups on the n-1 glycan 
sequence. This uncoupled OH group can further participate in the ensuing 
glycosylation reactions and a mixture of side products is eventually generated, making 
final purification more difficult. For a trimer synthesis, theoretically, seven different 
deletion sequences can be generated (Figure 2-1A). Additionally, the side reactions 
consume building block, decreasing the amount of building block available for the 




Figure 2-1. Conceived synthesis of a trisaccharide with possible side products 
without (A) and with capping (B). 
Incorporation of a capping step to block the unreacted hydroxyl groups after each 
glycosylation prevents any undesired chains from growing (Figure 2-1B). Efficient 
capping would help expand the use of AGA to create more complex oligosaccharides 
in higher yields. 
A procedure based on the standard capping conditions used in automated 
oligonucleotide synthesis using a pyridine-acetic anhydride (Ac2O) mixture was 
sometimes implemented in AGA. However, several issues had limited the 
implementation of this capping step in the standard AGA cycle. Unlike oligonucleotide 
synthesis, where very limited kinds of building blocks are used, AGA employs a large 
pool of building blocks and thus the reactivity of hydroxyl group varies much more 
dramatically. In addition, acetylation with the pyridine-Ac2O method proved to be quite 
slow, requiring at least 90 min to reach completion.48 No strong nucleophiles (e.g. 
DMAP) could be utilized to improve the capping rate, as the base-labile 9-
fluorenylmethoxycarbonyl (Fmoc) temporary protecting group, commonly used in 
AGA, is not compatible with strong bases. Herein, an acid-catalyzed capping method 
to improve the efficiency of AGA is described (Figure 2-2) as illustrated in the context 





Figure 2-2. Schematic overview of the capping principle used for AGA. 
2.2. Results 
 Pilot synthesizer for capping optimization 
For the development of new capping conditions, different solvents and reagents need 
to be screened. Some of them have never been used in AGA and may potentially 
contaminate the delivery system of AGA (tubings, syringe pumps, and valves etc.). 
Therefore, a pilot synthesizer (Figure 2-3) was designed and used for capping 
optimization.  
     
Figure 2-3. Photo and schematic diagram of the pilot synthesizer for capping 
optimization. 
This device consists of a reaction vessel, two valves, and tubings. The reaction vessel 
is 5 mL in volume and equipped with a filter pad at the bottom. The reaction 




Valve 1 assures a way out for gas (b → c) or the delivery of fresh DCM from syringe 1 
(b → a). Valve 2 enables the connection to compressed N2 for bubbling (c → a) or to 
syringe 2 for the injection of capping reagent (b → a) or the removal of waste (a → b). 
By manual valve-syringe operations, basic functions of the real synthesizer can be 
replicated with different modules (See in 6.4.1.2). 
 Optimization of capping condition 
Reaction conditions for capping were explored using glycosylated resin 13 (See in 
6.4.1.1). Inglis et al. reported a solution-phase acetylation method for alcohols 
catalyzed by Lewis acid, which only requires 30 seconds for completion.72  
Table 2-1. Optimization of the capping conditions. 
 
Entry Capping conditionsa Time (min) Completionb Formation of 15c 
1 0.1% Ac2O, 0.01% TMSOTf 5 Y N 
2 0.1% Ac2O, 0.01% TMSOTf 5 x 6 Y Y 
3 0.1% Ac2O, 0.01% TfOH 5 Y N 
4 0.1% Ac2O, 0.01% TfOH 5 x 6 Y Y 
5 10% Bz2O, 1% TfOH 20 N N 
6 10% Bz2O, 0.1% TfOH 20 N N 
7 10% BzCl in Py 20 N N 
8 10% Ac2O, 1% TFA 20 N N 
9 1% Ac2O, 0.1% MsOH 20 N N 
10 10% Ac2O, 2% MsOH 20 Yd N 
11 10% Ac2O, 2% MsOH 20 x 6 Y Nd 
aAll reactions were conducted in anhydrous DCM unless otherwise mentioned. 
bMonitored by LC-MS, Y: Capping complete; N: Capping incomplete. cMonitored by 
LC-MS, Y: 6-OBn unstable; N: 6-OBn stable. dConfirmed by HPLC (Method A0). 
24 
 
Therefore, acid catalyzed acetylation was selected as capping strategy. After 
treatment of glycosylated resin 13 with a solution of Ac2O and different acids in 
dichloromethane (DCM), the products were cleaved from the solid support and 
analyzed by LC-MC and/or HPLC (Table 2-1). 
With a solution of 0.01% TMSOTf and 0.1% Ac2O in DCM, the acetylation went to 
completion within five min, but the C6 benzyl ether protecting group was partially 
cleaved and the resulting hydroxyl group was acetylated to give side-product 15 (Table 
2-1, entry 1 and 2). This undesired C6-OBn replacement was again observed when 
trifluoromethanesulfonic acid (TfOH) was used as catalyst (Table 2-1, entry 3 and 4). 
Unsatisfying results were obtained when Ac2O was replaced by Bz2O or BzCl. The 
reaction proved to be much slower, so this option was abandoned. (Table 2-1, entry 
5, 6, and 7). Milder acids such as trifluoroacetic acid (TFA) failed to give any acetylated 
product 14 after 20 min (Table 2-1, entry 8). Treatment of the resin with a solution of 
methanesulfonic acid (MsOH) and Ac2O in DCM, resulted in a partial acetylation of the 
hydroxyl group (Table 2-1, entry 9). A more concentrated solution of methanesulfonic 
acid (2%) and Ac2O (10%) resulted in complete acetylation and no cleavage of the C6 
benzyl even after six capping cycles (Table 2-1, entries 10 and 11). 
 Stability test of common protecting groups under capping condition 
The compatibility of the capping procedure with commonly-used protecting groups was 
tested. The Fmoc and the levulinoyl (Lev) groups are important temporary protecting 
groups in AGA, and the trichloroacetyl (TCA) group is often employed to protect amino 
groups in the synthesis of oligosaccharides containing amino-sugars. 
 
Figure 2-4. Stability test of Lev, TCA, and Fmoc groups. 
Glycosylated resins containing these protecting groups (Figure 2-4, also see in 6.4.2) 
were subjected to six capping cycles and subsequent photocleavage for analysis. No 
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cleavage or substitution of Lev or TCA group was observed (Figure 2-4A). This direct 
method is not applicable for the Fmoc group that can be partially cleaved during 
photocleavage. Therefore, an indirect method was adopted, where glycosylated resin 
containing an Fmoc group was treated with six capping cycles and then subjected to 
Fmoc deprotection before photocleavage. In the event of Fmoc cleavage during 
capping, acetylated substrate should be observed. Since no acetylated substrate was 
observed, Fmoc was proved stable after six capping cycles (Figure 2-4B). 
 Application of capping in oligo- and polysaccharide synthesis 
2.2.4.1. Comparative synthesis of 1,6- and 1,4- hexaglucose 
The capping procedure was tested for the assembly of various oligosaccharides. AGA 
syntheses with and without capping were compared to assess the value of a capping 
step. In order to mimic a particularly bad scenario, the amount of building block used 
for each coupling was drastically reduced. Since typically ten equivalents of building 
block are used for AGA, 2.5 equiv./cycle of 1,6-glucose building block BB-6a resulted 
in a moderate yield of the desired hexasaccharide 16a (14%). The amount of deletion 
sequences decreased notably when a capping cycle was included (Figure 2-5), 
resulting in a much higher yield for the desired product (30%). The effect of the capping 
cycle was even more pronounced when 2.5 equiv./cycle of the more sterically hindered 
1,4-glucose building block BB-6b was used (Figure 2-5). Without capping, only trace 
amounts of the desired hexamer 16b were observed (1%), while 16b was obtained as 
the main product with capping (15%). These comparisons illustrate that capping can 
render AGA effective even when poor-yielding glycosylations are involved. 
Capping blocks the unreacted free hydroxyl groups stopping the deletion sequences 
from growing. Therefore, less deletion sequences are obtained, leading to easy 
purification. Secondly, as only the desired sequence participates in the glycosylation 
without competing hydroxyl groups, no building block donor is “wasted” for the 
glycosylation of unwanted compounds. These two reasons ensure a better final yield 




Figure 2-5. Synthesis of 1,6- and 1,4-hexaglucoside 16 with and without capping. 
a) Glycosylation conditions: 2.5 equiv. of building block BB-6, NIS, TfOH, 
DCM/dioxane, -20 °C (5 min) → 0 °C (20 min). b) Capping conditions: MsOH (2%) and 
10% Ac2O (10%) in anhydrous DCM, 25 °C for 20 min. c) Fmoc deprotection 
conditions: piperidine in DMF (20%), 25 °C for 5 min. d) Photocleavage conditions: UV 
(305 nm, 20 °C). HPLC analysis of the crude products (Method A0). ELSD trace is 
shown in the figure, while the 280 nm channel was used for yield determination (See 




2.2.4.2. Implementation of capping for the synthesis of Lc4 and 50mer 
Encouraged by the success of the hexasaccharide, AGA including a capping step was 
tested for the synthesis of the biologically important lactotetraosyl (Lc4) (Figure 2-6A). 
Lc4 is the backbone of the lacto subfamily of glycosphingolipids, which serves various 
roles in the control of physiological processes including cell growth, motility, and signal 
transduction.73-75 Previously, a 41% yield for the AGA of tetrasaccharide 17 using 
building blocks BB-7, BB-8, and BB-9 was reported without capping.76 To enhance 
yields, two cycles of glycosylation were needed for each synthetic step, thus using a 
total of ten equivalents of building block for each elongation. Using the newly-
developed capping cycle, tetrasaccharide Lc4 was obtained in 67% yield even though 
only one cycle of 6.5 equiv. of building block was used for each glycosylation step. The 
HPLC of the crude product (Figure 2-6A) showed high purity which permitted easy 
purification. 
The novel AGA procedure was tested for the synthesis of a 50-mer oligomannoside 
(Figure 2-6B). Our recent synthesis of this oligosaccharide yielded 50-mer 
polymannoside 6 in just 5% yield, using a basic capping method.48 This synthesis of 
the longest synthetic oligosaccharide directly assembled from monosaccharide 
building blocks required ten days for completion (without capping: 2 hours/cycle; with 
capping: 4 hours/cycle). Using the new capping method and optimized synthesis 
parameters, the coupling cycle for the incorporation of each building block was 
shortened to 90 minutes, such that the 50-mer was obtained within four days and in 
drastically improved yield (22%) using building block BB-5. In addition to the 50-mer, 
the 49-mer in both uncapped (18) and capped (19) form were synthesized to serve as 
controls in assessing the resolution power of the HPLC in the separation of longer 
polysaccharides. Uncapped 50-mer 6, that represents the desired final product of 
AGA, and the potential deletion sequence, the uncapped 49-mer 18, are eluted with 
virtually the same retention time. In contrast, capped 49-mer 19 is eluted more than 
one minute earlier that the desire compound and can be readily separated from the 
final product. This finding demonstrates that capping not only improves the yield, but 






Figure 2-6. Implementation of capping to the synthesis of tetrasaccharide Lc4 
(A) and a 50-mer (B) oligomannose. a) Glycosylation conditions: building block (2.5 
equiv), NIS, TfOH, DCM/dioxane, -20 °C (5 min) → 0 °C (20 min). b) Capping 
conditions: MsOH (2%) and Ac2O (10%) in anhydrous DCM, 25 °C for 20 min. c) Fmoc 
deprotection conditions: piperidine in DMF (20%), 25 °C for 5 min. d) Photocleavage 
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conditions: UV (305 nm, 20 °C). HPLC analysis of the crude products is shown (Lc4: 
280 nm, Method A0; 6: ELSD trace, Method A50). 
2.3. Conclusion 
In conclusion, the incorporation of a 20 minute capping step into the coupling cycle 
mildly and efficiently blocks the unreacted hydroxyl groups after each glycosylation. 
The efficiency of AGA was significantly improved as illustrated by the comparison of 
syntheses with and without capping. Overall yields improved by decreasing the 
formation of side-products while lowering the amount of building block used by 33%. 
The purification of the desired product was greatly facilitated as demonstrated in the 
synthesis of a 50-mer. The capping procedure described here is now incorporated in 
all AGA syntheses since it improves yields and decrease building block consumption 




 Systematic hydrogen bond manipulations to 
establish polysaccharide structure-property 
correlations 
This chapter has been modified in part from the following article: 
Y. Yu,* T. Tyrikos-Ergas,* Y. Zhu, G. Fittolani, V. Bordoni, A. Singhal, R. J. Fair, A. 
Grafmüller, P. H. Seeberger, M. Delbianco, Systematic Hydrogen Bond Manipulations 
to Establish Polysaccharide Structure-Property Correlations. Angew. Chem. Int. Ed.  
2019, 131, 13261. https://doi.org/10.1002/anie.201906577 
* equal contribution. 
3.1. Introduction 
The new capping method described in Chapter 2 improves the efficiency of AGA, 
allowing for quick access to pure and well-defined polysaccharides for the study of 
polysaccharides structure and property. Cellulose is the most abundant 
polysaccharide on earth and, because of its well-studied supramolecular organization, 
was selected as model system. The stability, crystallinity, and poor water solubility of 
cellulose are the result of a dense network of inter- and intramolecular hydrogen bonds 
that create allomorphs with different properties (See in 1.1.1.1).77-78 In particular, the 
hydrogen bond between the OH(3) and the O(5) of the ring stabilizes the cellobiose 
repeating unit, with additional stabilization gained from intra- and intermolecular 





Figure 3-1. Cellulose hydrogen bond network with cellobiose repeating unit 
highlighted. Chemical modification (symbolized by scissors) can be used to 
manipulate the hydrogen bond network. 
Chemical modifications are commonly used to block cellulose H-bonds and alter the 
organization of cellulose, creating new materials with enhanced water solubility or ionic 
character (See in 1.1.1.1).21, 81-83 Non-regioselective derivatization results in 
polydisperse materials with respect to length and modification patterns that do not 
allow for proper structure-function correlations. The lack of standards and experimental 
data also hampered in silico modelling. Molecular dynamics (MD) simulations capture 
some structural changes,84-87 but a detailed structural description is often lacking due 




Figure 3-2. Systematic approach to study structure-property correlations in 
carbohydrate materials. 
This project was a cooperative effort of several scientists (Table 3-1), in this chapter 
the major focus will be given to my contribution. Tailor-made cellulose derivatives were 
designed to selectively disrupt H-bond networks and/or alter the electronic properties 
in order to establish structure-property correlations (Figure 3-2). Methylated, 
carboxymethylated, deoxygenated, and deoxyfluorinated cellulose, as well as chitin 
analogues, are prepared with full control over the length, pattern and degree of 
substitution. MD simulations guided the synthesis, by correlating the disruption of the 
H-bond network with the increased flexibility of the modified oligosaccharides. 
 
Table 3-1. Contribution table. 
Contribution Name 
Synthesis of methylated cellulose, solubility test, XRD 
measurements  
Yang Yu 
MD simulations Theodore Tyrikos‐Ergas 
Synthesis of deoxygenated and carboxymethyl cellulose Dr. Yuntao Zhu 
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Synthesis of deoxyfluorinated cellulose Giulio Fittolani 
Synthesis of chitin analogues Dr. Vittorio Bordoni 
3.2. Results 
 Synthesis of modified cellulose 
3.2.1.1. Synthesis of linker-free oligosaccharides 
To mimic natural cellulose, glycans with the free reducing end are required. The 
standard functionalized solid support for AGA 1 (Figure 3-3) liberates the glycan 
bearing an alkylamino linker for further conjugation to proteins or surfaces. For this 
particular project, this unnatural “tail” is undesirable since it could interfere with the 
structural analysis (Figure 3-3A). Therefore, the UV-labile linker 2 (Figure 3-3) was 
designed to release the free reducing end upon photocleavage.88 To our surprise, the 
ensuing methanolysis of the ester protecting groups in strong basic condition (NaOMe) 
results in glycan decomposition (peeling) and a mixture of shorter oligosaccharides 
(penta-, tetra-, and trisaccharides) was obtained (Figure 3-3B). This peeling reaction 
is not observed when the reducing end is protected with a linker (Figure 3-3A), 






Figure 3-3. Linkers and deprotection process. (A) AGA with resin 1 affords the 
pentylamino linker functionalized glycan. (B) Peeling of hexasaccharide with free 
reducing end is observed in basic condition. 
To avoid glycan decomposition, one option is to perform methanolysis on solid support 
(resin 21, Figure 3-4) so that the hydroxyl group at the reducing end is protected with 
the linker. Upon complete hydrolysis of ester protecting groups, glycan 23 can be 
released from the solid support (resin 22). 
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Standard solution-phase methanolysis conditions (1:10 mixture of NaOMe solution 
(0.5 M in MeOH) and DCM for 24 hours49) were not applicable due to the extremely 
low reaction rate of solid-phase methanolysis (Figure 3-4). Increasing the 
concentration of the NaOMe solution did not accelerate the reaction, presumably due 
to the low swelling volume of polystyrene in MeOH (1.6 mL/g). The high swelling 
volume of polystyrene resin in THF (7.5 mL/g) suggested the use of such a solvent. 
Treatment of the glycosylated resin with a 1:10 mixture of NaOMe solution (0.5 M in 
MeOH) and THF resulted in complete ester hydrolysis, within four hours. After 
photocleavage, the partially deprotected oligosaccharide 23 with free reducing end is 
subjected to hydrogenolysis to afford the linker-free oligosaccharides. Due to the solid 
phase nature of this approach, the base catalyst is easily removed by filtration and also 
resulted in faster hydrogenolysis. This solid phase methanolysis (Module F, see in 
6.2.3) was adopted for the synthesis of most cellulose analogues in this thesis. This 
procedure is also applicable to other types of solid supports (i.e. resin 1). 
 
Solvent DCM MeOH THF 
Swelling volume of polystyrene89 (mL/g) 7.5 1.6 7.5 
Figure 3-4. Optimization of methanolysis conditions and swelling volume of 
polystyrene in DCM, MeOH, and THF. 
Alternatively, linker 20 (Figure 3-3, developed by Dr. Yuntao Zhu88) liberates the 
desired glycan protected with a 4-hydroxymethyl-benzyl group at the reducing end, 
allowing for solution-phase methanolysis, and subsequent cleavage, during 
hydrogenolysis. 
To monitor the methanolysis on solid phase, a micro-cleavage method was developed 
(Figure 3-5A, see in 6.2.3). Approximately 20 beads of resin are taken from the 
reaction and irradiated by UV light (366 nm) for ten minutes. The cleaved compounds 
are analyzed by MALDI, which proved to give identical signals with UV-cleavage with 
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full batch (Figure 3-5B). This method is now a common strategy to monitor the reaction 
status not only during methanolysis, but also during AGA. 
 
Figure 3-5. Micro-cleavage for monitoring solid phase reaction. (A) Experimental 
set-ups of micro-cleavage. (B) Comparison of MALDI signals from the same batch of 
AGA synthesis by full batch UV-cleavage (up) and micro-cleavage (down). 
3.2.1.2. Synthesis of modified cellulose 
A collection of well-defined cellulose derivatives was prepared using AGA (Figure 3-6, 
Table 3-1). Two natural cellulose oligomers (hexamer A6 and dodecamer A12) and one 
chitin analogue (N6) served as standards for the structural analysis. Unnatural 
analogues with defined substitution patterns were prepared to tune the conformation 
and properties of the material. Regioselective functionalization was achieved with five 
“unnatural” monosaccharide building blocks BB-11 - BB-15 (Figure 3-6). Global 
deprotection afforded oligosaccharide derivatives with complete control over the 
length, pattern, and degree of functionalization. This thesis emphasizes the synthesis 
of methylated analogues. 
Methylation effectively alters the solubility and gelation properties of cellulose by 
influencing intra- and intermolecular hydrogen bonding. The resulting methylcellulose 
is widely used in the food and pharmaceutical industries (See in 1.1.1.). Six hexa- and 
four dodecamers, with different methylation patterns, were synthesized using BB-11 
and BB-12, that contain 3-methyl and 3,6-dimethyl motifs (Figure 3-6). The position of 
the substituents was chosen to selectively disrupt H-bonds that play a fundamental 
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role in cellulose rigidity. Methylation of OH(3) impedes the H-bond between O(5) and 
OH(3), while 6-methylation hinders the inter- and intra-chain stabilization offered by 
OH(6). Structures with a regular methylation pattern (e.g. (AB)3), di-block analogues 
(e.g. A3B3), as well as irregularly functionalized structures (e.g. (ABA)2) were 
assembled to assess the effect of methylation patterns on the overall cellulose 
conformation. Similar considerations were followed for the synthesis of 3-
deoxyfluorinated and 3-deoxygenated cellulose analogues (Figure 3-6, Table 3-1). 
Such modifications, in addition to selectively disrupting H-bonds, are expected to 
modulate the steric hindrance and dipole orientation within the sugar unit. Additionally, 
carboxymethylation is introduced to assess the effect of charges on the overall 
structure. 
 
Figure 3-6. AGA synthesis and nomenclature of tailor-made cellulose 
oligosaccharides. 
The synthesis of A6 was low yielding (18%) due to the low solubility of the 
oligosaccharide product. Methylation drastically improved product solubility, that is 
reflected in much better yields for the unnatural hexasaccharide analogues (24%-72% 
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overall yield). Similar results were observed for the 12-mer syntheses (Figure 3-6), 
that benefitted from the insertion of BB-11, BB-12 and BB-14 with drastically better 
yields than for A12 (2% overall yield). 
 Conformations of cellulose analogues  
The perturbation of the 3D-shape of oligosaccharides as a result of single-site 
substitutions was modelled using MD simulations, employing a modified version of the 
GLYCAM06 carbohydrate force field (performed by Theodore Tyrikos‐Ergas).90-91 
 
Hexamer AAAAAA-OH ABABAB-OH AAABBB-OH ACACAC-OH 
Average distance (nm) 2.76 2.71 2.65 2.80 
Standard deviation 0.17 0.25 0.26 0.17 
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Figure 3-7. End-to-end distances as a function of MD time, representative 
conformations as obtained by MD simulations, and average end-to-end distance 
(displayed as a table). 
Cellulose A6 revealed a fairly rigid backbone core with low conformational variability 
(average end-to-end distance 2.76 ± 0.17 nm for A6) (Figure 3-7). The structure tends 
to adopt an extended helical conformation. Large fluctuations are observed for 
methylated analogues, indicating that these molecules are more flexible. 
Deoxyfluorination, carboxymethylation and deoxygenation also result in more flexible 
systems (See in 6.6.3 and publication92). 
To examine how specific modifications affect such organized structures, two 
methylated analogues were studied. A regular alternated substitution pattern, as in the 
case of (AB)3, revealed an increased distance between OMe(3) and O(5) due to the 
decreased tendency to form hydrogen bonds and the increased steric bulk. The same 
degree of methylation but with a di-block distribution, as in the case of A3B3, resulted 
in dramatic changes. A significantly more flexible bent shape (Figure 3-7) with an end-
to-end distance of 2.65 ± 0.26 nm was observed for most of the simulation time. 
Surprisingly, the OH(3)∙∙∙O(5) hydrogen bond between the first two glucose monomers 
was detected for most of the simulation time, suggesting the coexistence of a rigid rod 
block (A3, marked in gray in Figure 3-7) and a very flexible counterpart (B3, marked in 
red in Figure 3-7). Methylation at the 3 and 6 positions (C), disrupts the “standard” 
dihedral values, resulting in a completely new geometry. A similar trend was observed 
for the dodecamers, with more regular modification patterns exhibiting a higher 
cellulose character as compared to randomly methylated structures (See in 6.6.3 and 
publication92). 
 Aggregation, solubility, and crystallinity study of modified cellulose 
Oligosaccharide behavior in a crowded environment was studied and correlated to the 
material crystallinity and solubility. Long MD simulations (1μs production run, by 
Theodore Tyrikos‐Ergas) of concentrated experiments (Figure 3-8A) aimed to 
elucidate molecular interactions. Radial distribution functions (RDFs) (Figure 3-8B) 
were used to characterize the spatial correlations in the systems. The RDF for A6 
shows three sharp signals at small distances and remains large for distances up to 1.5 
nm, indicating high aggregation tendencies of such oligosaccharides. The more 
soluble methylated analogue (AB)3 shows some tendency to aggregate at high 
concentrations. However, a significantly decreased signal at 0.5 nm indicates the lower 
probability to find two chains in very close proximity, as compared to cellulose 
oligomers. RDF peaks are only found at shorter distances, revealing a lower tendency 
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for cluster formation and a less organized structure, with a homogeneous distribution 
of molecules beyond the nearest neighbors. No aggregation was detected for A3B3, as 
expected from the high flexibility of such compound that should prevent chain-stacking. 
 
Figure 3-8. Representative snapshots of MD simulations of concentrated 
solutions (A), RDFs (B), XRD (C), and solubility test (inset). 
X-ray diffraction (Figure 3-8C, Figure 3-9 and 6.6.2) and solubility data (See in 6.6.1) 
support the calculations. As anticipated, A6 and A12 are very poorly soluble in water 
(less than 1 mg/mL), due to the formation of cellulose-like aggregates. Powder XRD 
measurements of both A6 and A12 gave sharp peaks (Figure 3-8C and Figure 3-9), 
that are distinctive for cellulose II, indicating that short oligomers adopt the same 
aggregation pattern and the same H-bonding arrangement of cellulose. The flat XRD 
profile of the di-block analogue A3B3 indicates the absence of any ordered structural 
organization, as predicted by the theoretical model (Figure 3-8). The alternating 
methylation pattern of (AB)3, renders the material more sensitive to the X-ray beam 
angle and, while the XRD peaks are still broad, they resemble the cellulose II structure, 
as predicted by MD simulations (Figure 3-8). This trend is confirmed by the longer 
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oligomers, where more intense, yet broad, XRD profiles are observed for the regularly 
substituted analogues (Figure 3-9). No cellulose-like character is detected for 
randomly functionalized structures. Similarly to cellulose, the XRD profile of chitin 
analogue N6 is identical to that of natural chitin (Figure 3-9), as it is poorly soluble (13-
17 mg/mL) and tends to form gels at higher concentrations. Surprisingly, the hybrid 
cellulose-chitin (ANA)2, is much better soluble (> 50 mg/mL) with no ordered 
supramolecular structure (Figure 3-9). All functionalized cellulose analogues are, in 
contrast to the natural derivatives, highly water soluble (> 50 mg/mL) and form 
amorphous solids (Figure 3-9). Interestingly, while remaining highly water soluble, the 
deoxy series (E) adopts a cellulose-like character in the solid state with two broad, yet 
noticeable, peaks in the XRD profile (Figure 3-9). 
 
Figure 3-9. Powder XRD analysis of natural oligosaccharides (A6, A12, and N6) 
and selected modified analogues. 
3.3. Conclusion 
Tailor-made cellulose oligosaccharide analogues, prepared by sequential addition of 
monomeric BBs using AGA, allow for control over the length and substitution patterns. 
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Seven BBs bearing unnatural modifications were used to disrupt specific H-bonds and 
tune the three dimensional shape and properties of the material. Methylation blocked 
the hydrogen bond between OH(3) and O(5), resulting in an increased flexibility of the 
chain, as observed by the fluctuation of the end-to-end distance during MD simulations 
time. Compounds with the same degree of methylation, but different substitution 
patterns, behave drastically different. Regular substitution patterns result in quasi-
linear structures, whereas more bent geometries are observed with a block 
arrangement. These structural features control the aggregation process that is 
expressed in high crystallinity for the natural compound and amorphous organization 
for irregular or block substituted analogues. A more significant disruption of the 
“standard” dihedral values was observed with methylation at the OH(3) and OH(6) 
positions. All unnatural analogues are drastically more soluble, due to the more flexible 
backbone. Novel bio-materials with tuned properties that could be engineered 
depending on nature and pattern of the substituents can be envisioned. The collection 






 Oligosaccharides self-assemble and show 
intrinsic optical properties 
This chapter has been modified in part from the following article: 
Y. Yu,* S. Gim,* D. Kim, Z. A. Arnon, E. Gazit, P. H. Seeberger, M. Delbianco, 
Oligosaccharides Self-Assemble and Show Intrinsic Optical Properties. J. Am. Chem. 
Soc. 2019, 141, 4833. https://doi.org/10.1021/jacs.8b11882 
* equal contribution. 
4.1. Introduction 
Simple peptides57, 93-95 and DNA96-98 can spontaneously self-assemble to form defined 
supramolecular patterns. These supramolecular architectures are the essence of 
modern bionanotechnology, with implications in the medical99-101 and energy67, 95, 102 
fields. The main limitation to the use of these systems is often associated with the 
modest quantities that can be produced. Polysaccharides are much more abundant, 
biocompatible, and cheap, but have found much less applications in nanotechnology. 
This is surprisingly if we consider that some polysaccharides (e.g. cellulose and chitin) 
can generate highly ordered hierarchical structures, tunable by chemical modifications 
(see in Chapter 3). To date, natural polysaccharides have found applications in drug 
delivery103 and tissue engineering104. Still, the use of polysaccharide materials is 
limited. The extraction, purification and analysis of natural polysaccharides is hindered 
by the low solubility. Besides, the polydispersity of chain length and modifications 
results in poor quality control and reproducibility of polysaccharide-based materials. 
Chemical synthesis provides an attractive alternative to the modification of natural 
polysaccharides. Collections of related compounds can be created to study the 
aggregation tendency of carbohydrate materials. In addition, it was recently shown 
that, like peptides and DNA, some oligosaccharides can adopt defined conformations 
in solution.49 As peptide and DNA nanotechnologies are heavily based on defined 
secondary structures, we hypothesized that such conformations could be used for the 
formation of supramolecular assemblies. 
The inspiration came from the problematic deprotection of hexasaccharide 28 (Figure 
4-1A).49 This semi-protected hexasaccharide proved so poorly soluble in most solvents 
that further chemical manipulations are impossible. A similar compound that carries 
fewer benzyl ethers (i.e. hexamer 29, Figure 4-2) showed fewer solubility and reactivity 
issues. These differences likely are a consequence of the formation of supramolecular 
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structures due to strong intermolecular interactions, such as hydrogen bonding, 
together with π-π interactions of the benzyl ether modifications. 
 
Figure 4-1. Insoluble compound 28 leads to synthetic difficulty (A) and forms 
nanoparticles upon sonication in water (B, scale bar: 1 µm). A suspension of 
compound 28 in water was sonicated for 30 minutes. TEM sample was stained with 




Figure 4-2. Synthetic carbohydrates for self-assembly study. 
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In this chapter, the systematic study of the self-assembly of synthetic carbohydrates is 
presented. Three hexasaccharides (28-30) as well as three disaccharides (25-27) 
(Figure 4-2) were prepared to probe the influence of chain length, linkage, and 
modification on morphology and property of self-assembled carbohydrate materials. 
This project was carried out in collaboration with Soeun Gim. 
4.2. Results 
In preliminary test, we suspended compound 28 in water followed by sufficient 
sonication. TEM observations (Figure 4-1B) suggested the formation of spherical 
aggregates in water, which motivated us to systematically study the self-assembly 
behavior of carbohydrates. Due to the lack of literature on oligosaccharides self-
assembly, we followed self-assembly methods reported for other biomolecules (i.e. 
peptides, DNAs, PNAs). Based on the solubility of oligosaccharides 25-30, we 
explored dialysis (D), solvent-switch (S) and film forming (F) methods (Figure 4-2). 
Within each method, several parameters can be modulated (e.g. solvent, 
concentration) to trigger different self-assembling behavior. Beside microscopic 
observations, photophysical characterization was also conducted to study the property 
of the self-assembled samples. 
 Self-assembly 
4.2.1.1. Nomenclature for the self-assembled samples 
The names of the self-assembled samples indicate the sugar oligomer (e.g. 26) and 
the assembly method (D, S, or F). In solvent-switch and film forming methods, different 
solvents (i.e. hexafluoroisopropanol (HFIP), dimethylacetamide (DMAc), acetone 
(Ace), and isopropanol (iPrOH)) were screened. Therefore, the solvent name is 
appended for those samples. For example, 26-S-HFIP means compound 26 prepared 
by solvent-switch method with HFIP as good solvent. Detailed conditions for the 
formation of each sample are given in 6.7.1. 
4.2.1.2. Dialysis method 
The oligosaccharide was dissolved in a dimethylacetamide (DMAc)/water mixture and 
dialyzed against water. TEM measurements revealed nanoparticles with diameters of 
40-60 nm for all the samples (Figure 4-3). These particles exist in solution as 
confirmed by dynamic light scattering (DLS) measurements (Figure 4-3) and cryo-




Figure 4-3. TEM images (left, scale bar: 100 nm) and DLS analysis (right) of 
samples prepared by dialysis method (0.1 mg mL−1). (a) 25-D, (b) 26-D, (c) 27-D, 
(d) 28-D*, (e) 29-D, and (f) 30-D*. *0.01 mg mL−1 due to poor solubility of the starting 
material. The cryo-SEM image of 26-D (inset, scale bar: 1 µm) confirmed the presence 
of the particles in solution. 
4.2.1.3. Solvent-switch 
Direct injection of water into a glycan solution in HFIP (solvent-switch) results in faster 
mixing, higher oligosaccharide concentration and altered self-assembly behavior 
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(Figure 4-4). Needle-like structures were found for 26-S-HFIP (5-10 µm length, 10-50 
nm height and 100-500 nm width, Figure 4-4-b) and a spheroidal architecture (1-2 µm 
diameter) for the hexamer 29-S-HFIP analogue (Figure 4-4-e). These supramolecular 
structures were stable for one month at ambient conditions and resisted dilution and 
sonication (See in 6.7.2). 25-S-HFIP assembled into a mixture of rods and toroid 
structures (Figure 4-4-a), while 28-S-DMAc formed clusters of nanoparticles (Figure 
4-4-d). Differences in oligosaccharide structure such as linkage and modification 
patterns fundamentally affect the material morphology as 27-S-HFIP (Figure 4-4-c) 
and 30-S-DMAc (Figure 4-4-f) aggregated randomly and did not form any ordered 
supramolecular structure. Compounds 27 and 30 are based on a fairly rigid 1,4 
glycosidic linkage (secondary alcohol) and therefore can adopt a limited number of 
conformations in solution. The flexibility of the 1,6 linkage allows for higher 
conformational diversity, permitting the formation of fundamentally different 
nanostructures. 
 
Figure 4-4. SEM images (scale bar: 2 µm) of samples prepared by the solvent-
switch method. (a) 25-S-HFIP-low (0.1 mg mL−1), (b) 26-S-HFIP, (c) 27-S-HFIP, (d) 
28-S-DMAc, (e) 29-S-HFIP, and (f) 30-S-DMAc. If not mentioned, the standard 
concentration is 2 mg mL−1 and the content of organic solvent is 2%. 
4.2.1.4. Screening of conditions for the self-assembly of disaccharide 26 
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Motivated by the well-defined, disperse, and stable needle-like structures obtained 
from disaccharide 26 (Figure 4-4), more conditions for the assembly of this compound 
were screened. Dialysis using a higher concentration of 26 (2 mg mL−1) led to the 
formation of nanofibers (Figure 4-5-a), likely due to the further association of the 
spherical particles existing in the diluted solution. The solvent exchange method 
generated longer needles when a lower concentration of compound 26 was employed 
(0.1 mg mL−1) (Figure 4-5-b). A higher HFIP content (20%) did not change the shape 
or length of the supramolecular structures (Figure 4-5-c). In this case, the selective 
solvation properties of HFIP, in a HFIP–H2O system, result in a similar local HFIP 
concentration, limiting aggregation diversity. A similar elongated morphology was 
obtained when isopropyl alcohol was used instead of HFIP (Figure 4-5-d). When 
DMAc was used, short and flat bar-like structures were observed. A gel-like microwire 
material was obtained in acetone (Figure 4-5-f, see in 6.7.2). The diversity observed 
is ascribed to the different conformations adopted by compound 26, when solvated by 
different solvents. In particular, the well-known ability of HFIP to cluster the 
hydrophobic regions of peptides and affect their folding (HFIP-induced enhancement 
of the hydrophobic effect)105-106 is responsible for the dramatic differences of the 
generated nanostructures. 
 
Figure 4-5. Screening of assembly conditions for compound 26. (a) TEM image 
(scale bar: 500 nm) for 26-D-high (2 mg mL−1). (b-f) SEM images (scale bar: 2 µm) 
for (b) 26-S-HFIP-low (0.1 mg mL−1), (c) 26-S-HFIP-20%, (d) 26-S-iPrOH-20%, (e) 
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26-S-DMAc, and (f) 26-S-Ace-20%. If not mentioned, the standard concentration for 
the solvent-switch method (S) is 2 mg mL−1 and the content of organic solvent is 2%. 
 Real-time measurements 
The self-assembly of 26-S-HFIP was captured in real-time using bright-field 
microscopy (Figure 4-6) by injecting a freshly-prepared solution into a cell counting 
slide. Needle-like structures diffuse from the HFIP droplets containing the 
oligosaccharide into the surrounding water. The contact between the needles and a 
second HFIP droplet (Figure 4-6, time 06:52) disrupt the droplet to release the 
oligosaccharide and results in further needle growth. Surprisingly, glycan-containing 
HFIP droplets are intensely fluorescent. We believe that this phenomenon is the result 
of the formation of supramolecular chromophores within the material, as previously 
observed for self-assembled peptides, nucleic acids, and amino acids.107-111 An 
extended π-conjugation system and/or charge delocalization through a dense 
hydrogen-bonding network are generally responsible for this behavior. 
 
Figure 4-6. Real-time merged bright-field (scale of gray) and fluorescence 
(magenta) images illustrate the self-assembly process for 26-S-HFIP. Excitation 
wavelength at 405 nm and detection range 410-676 nm (scale bar: 20 µm).  
 Photophysical characterization 
4.2.3.1. Polarized optical mircoscope characterization of 2-S-HFIP 
The needle-like structure of 26-S-HFIP is an indication of highly ordered 
supramolecular arrangement. Therefore, this sample was visualized with a polarized 
optical microscope (Figure 4-7A), which showed intense birefringence, indicating that 
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26-S-HFIP exhibits anisotropic property. Moreover, staining with Congo red, a 
commonly-used dye to detect highly-ordered amyloid fibrils, gave intense gold-green 
birefringence (Figure 4-7B). 
 
Figure 4-7. Polarized microscopy images of 26-S-HFIP with parallel (left) and 
perpendicular (right) polarizer, without (A) and with (B) Congo red staining (scale 
bar: 20 µm). Congo red staining was performed following reported literature.  
4.2.3.2. Confocal microscopy and XRD analysis 
Confocal microscopy analysis of different morphologies revealed that thin films 
prepared by direct evaporation of a glycan solution in HFIP on a slide glass (26-F-
HFIP) emit strongly in four different channels (Figure 4-8A) upon visible light 
irradiation. Films prepared in other organic solvents showed a similar fluorescence 
behavior (See in 6.7.2). Aggregates obtained via the solvent-switch method are only 
weakly emissive (Figure 4-8A). This observation agrees with the supramolecular 
chromophore hypothesis, since emission intensity is strong in organic solvents, where 
a dense H-bonding network is favored and quenching occurs when the H-bonding 
pattern is disrupted by water. The morphology of these materials was further probed 
with X-ray powder diffraction (XRD) (Figure 4-8B). 26-S-HFIP exhibited sharp peaks, 
as typical for crystalline structures; in contrast, 26-F-HFIP shows broad peaks. This 
confirms the drastic change in morphology upon interaction with water (26-S-HFIP). 





Figure 4-8. (A) Confocal microscopy images of 26 prepared by HFIP film-forming 
F (scale bar: 100 µm), solvent-switch S (scale bar: 10 µm), and compounds 31-
35 prepared by film-forming method (scale bar: 100 µm) in four different 
channels (blue(ex/em): 405/451 nm, green: 488/529 nm, yellow: 561/597 nm, and 
red: 633/709 nm). (B) XRD profiles of 26-F-HFIP (red) and 26-S-HFIP (black) and 
compounds 31-35. 
To probe the importance of aromatic groups for the emissive behavior, compound 31 
was synthesized. This amphiphilic, partially methylated analogue allows for the 
formation of a dense hydrogen bonding network, in the absence of aromatic groups. 
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Upon film formation (31-F-HFIP), compound 31 showed a similar optical behavior, 
confirming that the optical properties are not merely a result of π-π stacking. 
Disaccharides 32-34 are fully functionalized, blocking the formation of a dense 
hydrogen bonding network within the material. Different substituents (Bn vs Me vs Ac) 
were tested. Surprisingly, confocal microscopy analysis showed emissive behavior for 
compound 32-F-HFIP and 33-F-HFIP. We suspect that such compounds, even in the 
absence of a strong hydrogen bonding network, maintain a self-organization tendency. 
On the other hand, the per-acetylated analogue 34, as well as the fully deprotected 
compound 35, showed no emission. XRD analysis of all the materials suggested a 
correlation between the broad XRD profile and the emissive behavior. Similarly, the 
appearance of sharp peaks in the XRD profiles, indicating high crystallinity, is 
associated with emission quenching.  
4.2.3.3. Absorption and emission spectroscopy 
Further photophysical characterization showed a broad absorption band for compound 
26-F-HFIP, associated with the formation of new self-assembled entities upon film 
formation. The broadening of the absorption spectrum is not observed for compound 
26 in solution, nor for the low emissive, crystalline sample 26-S-HFIP (Figure 4-9A). 
Excitation spectra (See in 6.7.2) confirmed that the emissive species are linked to this 
spectral region (350 – 500 nm). Emission quantum yield was calculated for 26-F-HFIP 
(Ф(λex = 360 nm) = 0.85 ± 0.01%). Moreover, unlike commonly-used dyes, where the 
emission peak position is independent of the excitation wavelength, the emission 
spectrum of 26-F-HFIP is drastically affected by the excitation wavelength (Figure 
4-9B). A broad fluorescence emission profile was observed with maxima shifting from 
410 to 490 nm as the excitation is changed from 340 to 410 nm. This red edge 
excitation shift (REES) is a common phenomenon observed in graphene oxide,110 ionic 
liquids,111 and highly ordered assemblies.108 A very similar behavior was reported by 
Gazit et al. for self-assembling PNA dimers (Figure 4-9C).  
 
Figure 4-9. Absorption and emission spectroscopy. (A) Absorption spectra of 26-
F-HFIP, 26-S-HFIP (recorded for the solid samples), and compound 26 in HFIP 
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solution. (B) Normalized emission spectra of 26-F-HFIP at excitation wavelengths of 
340, 350, 360, 370, 380, 390, 400, 410, 420, and 430 nm, showing the red shifting of 
the emission maxima. Spectra acquired at r.t. (C) Normalized emission spectra of di-
PNA from literature by Gazit et al.108 
4.3. Conclusion 
In conclusion, I successfully generated supramolecular structures from fully synthetic 
well-defined oligosaccharides, and demonstrated that the fine-tuning of the 
oligosaccharide structure has a tremendous effect on the material morphology. The 
three dimer and hexamer analogues with different glycosidic linkages and protecting 
group patterns form similar nanospheres when generated by the slow dialysis method, 
whereas distinctive microstructures are obtained with the fast solvent-switch method. 
These compounds show unique optical properties such as broad emission profiles and 
red edge excitation shift. Further studies to modulate the fluorescent properties of such 
materials are currently underway, with potential applications for optical devices and 
nanotechnology. These findings suggest that synthetic oligosaccharides are viable 
substrates for the fundamental study of the forces that guide the polysaccharide 
aggregation in Nature. For example, tuning glycomaterial properties through the 
synthesis of well-defined structures will be relevant for drug delivery systems, where 




 Conclusion and outlook 
This thesis highlights the use of synthetic tailor-made oligo- and polysaccharides to 
study carbohydrate materials at different levels: chemical structure, conformation, 
aggregation tendency, and properties. The ultimate goal of my work is to understand 
the fundamental principles that guide carbohydrate interactions and provide important 
information for the rational design and application of carbohydrate materials. Here, the 
remaining challenges are highlighted. Several aspects of future work can be 
envisioned: 
1) Even though the biological roles of carbohydrates have long been appreciated,1-2 
the correlation between structure and function has not been clarified. Specific chemical 
modifications permitted a deeper understanding of cellulose structure and properties 
as shown in Chapter 3. This methodology can be applied to other glycans for studying 
their conformational preference, physical property, and functions. Such studies will 
boost a better understanding and utilizing of carbohydrates.112 
2) Natural cellulose aggregates into nanocrystals, that is used for applications in 
nanotechnology and materials science.13-15 Short cellulose fragments (i.e. A6) 
aggregate with the same packing of natural cellulose as shown in XRD measurement 
in chapter 3 and are promising candidates for self-assembly studies. Preliminary data 
showed that A6 can self-assemble into nanorods (Figure 5-1, left) with similar size of 
natural cellulose nanocrystals (Figure 5-1, right). Further study are needed to 
elucidate the crystallinity of the nanorods. This artificially self-assembled cellulose 
nanorods are valuable materials for studying the structure and properties of natural 
CNCs owing to their chemical homogeneity. 
 
Figure 5-1. TEM images of self-assembling A6 (left) and extracted cellulose 
nanocrystals (right)113 (Scale bar: 500 nm). 
3) The knowledge gained from my thesis work can guide the bottom-up design of 
cellulose analogues for the construction of supramolecular structures. A cellulose-like 
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domain (An) provides tendency for well-defined aggregation, limiting water solubility. A 
modified counterpart (Xn) disrupts the regular aggregation of cellulose, improving water 
solubility. A di-block structure (Figure 5-2) is a promising candidate for the construction 
of ordered supramolecular structures with high stability in water. A similar multi-block 
approach (i.e. BTA and peptide amphiphiles, Figure 5-2, also see in 1.3) has found 
great success for the construction of ordered 2D supramolecular architectures, with 
implications in catalysis,114-115 regenerative medicine,58 and cancer therapy116. 
 
Figure 5-2. Schematic illustration of cellulose derivatives with block structure 
(top left: A: non-modified cellulose; X: modified cellulose), BTA (top right)70, and 




 Experimental section 
In this section, only my contributions to each project will be included unless otherwise 
specified. More experimental data can be found in the publication mentioned at the 
beginning of each chapter. 
6.1. General materials and methods 
All chemicals used were reagent grade and used as supplied unless otherwise noted. 
The automated syntheses were performed on a home-built synthesizer developed at 
the Max Planck Institute of Colloids and Interfaces. Merrifield resin LL (100-200 mesh, 
novabiochemTM) was modified and used as solid support. Analytical thin-layer 
chromatography (TLC) was performed on Merck silica gel 60 F254 plates (0.25 mm). 
Compounds were visualized by UV irradiation or dipping the plate in a p-anisaldehyde 
(PAA) solution. Flash column chromatography was carried out by using forced flow of 
the indicated solvent on Fluka Kieselgel 60 M (0.04 – 0.063 mm). Analysis and 
purification by normal and reverse phase HPLC was performed by using an Agilent 
1200 series. Products were lyophilized using a Christ Alpha 2-4 LD plus freeze dryer. 
1H, 13C and HSQC NMR spectra were recorded on a Varian 400-MR (400 MHz), Varian 
600-MR (600 MHz), or Bruker Biospin AVANCE700 (700 MHz) spectrometer. Spectra 
were recorded in CDCl3 by using the solvent residual peak chemical shift as the 
internal standard (CDCl3: 7.26 ppm 1H, 77.0 ppm 13C) or in D2O using the solvent as 
the internal standard in 1H NMR (D2O: 4.79 ppm 1H). High resolution mass spectra 
were obtained using a 6210 ESI-TOF mass spectrometer (Agilent) and a MALDI-TOF 
autoflexTM (Bruker). MALDI and ESI mass spectra were run on IonSpec Ultima 
instruments. IR spectra were recorded on a Perkin-Elmer 1600 FTIR spectrometer. 
Optical rotations were measured by using a Perkin-Elmer 241 and Unipol L1000 
polarimeter. For XRD measurements, a Bruker D8 Advanced X-ray diffractometer with 
Cu Kα radiation was used. 
6.2. General procedure for automated glycan assembly 
Solvents used for dissolving building block and making activator, TMSOTf and capping 
solutions were taken from an anhydrous solvent system (jcmeyer-solvent systems). 
Other solvents were HPLC grade. The building blocks were co-evaporated three times 
with chloroform and dried for 1 h on high vacuum before use. Activator, deprotection, 
acidic wash, capping and building block solutions were freshly prepared and kept 
under argon during the automation run. All yields of products obtained by AGA were 
calculated on the basis of resin loading. Resin loading was determined by performing 
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one glycosylation (Module C) with 10 equiv of building block followed by DBU promoted 
Fmoc-cleavage and determination of dibenzofulvene production by measuring its UV 
absorbance. Unless mentioned otherwise, the conditions and modules of AGA are also 
applied to other chapters. 
 Preparation of stock solutions 
 Building block: building block was dissolved in 1 mL of dichloromethane 
(DCM). 
 Activator solution: 1.35 g of recrystallized NIS was dissolved in 40 mL of a 
2:1 mixture of anhydrous DCM and anhydrous dioxane. Then triflic acid (55 μL) 
was added. The solution is kept at 0°C for the duration of the automation run. 
 Fmoc deprotection solution 1: A solution of 20% piperidine in 
dimethylformamide (DMF) (v/v) was prepared. 
 Fmoc deprotection solution 2: A solution of 20% triethylamine in DMF (v/v) 
was prepared. 
 TMSOTf Solution: Trimethylsilyl trifluoromethanesulfonate (TMSOTf) (0.45 
mL) was added to DCM (40 mL). 
 Capping solution: A solution of 10% acetic anhydride (Ac2O) and 2% 
methanesulfunic acid (MsOH) in anhydrous DCM (v/v) was prepared. 
 Modules for automated glycan assembly 
Module A: Resin Preparation for Synthesis (20 min) 
All automated syntheses were performed on 0.0125 mmol scale. Resin was placed in 
the reaction vessel and swollen in DCM for 20 min at room temperature prior to 
synthesis. During this time, all reagent lines needed for the synthesis were washed 
and primed. Before the first glycosylation, the resin was washed with the DMF, 
tetrahydrofuran (THF), and DCM (three times each with 2 mL for 25 s). This step is 
conducted as the first step for every synthesis and test. 
Module B: Acidic Wash with TMSOTf Solution (20 min) 
The resin was swollen in 2 mL DCM and the temperature of the reaction vessel was 
adjusted to -20 °C. Upon reaching the low temperature, TMSOTf solution (1 mL) was 
added drop wise to the reaction vessel. After bubbling for 3 min, the acidic solution 
was drained and the resin was washed with 2 mL DCM for 25 s. 
Action Cycles Solution Amount T (°C) Incubation time 
Cooling - - - -20 (15 min)* 
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-20 3 min 
Wash 1 DCM 2 mL -20 25 s 
*Time required to reach the desired temperature. 
Module C: Thioglycoside Glycosylation (35 min) 
The building block solution (0.08 mmol of BB in 1 mL of DCM per glycosylation) was 
delivered to the reaction vessel. After the set temperature was reached, the reaction 
was started by drop wise addition of the activator solution (1.0 mL, excess). The 
glycosylation conditions are building block dependent (we report the most common set 
of conditions). After completion of the reaction, the solution is drained and the resin 
was washed with DCM, DCM:dioxane (1:2, 3 mL for 20 s) and DCM (two times, each 
with 2 mL for 25 s). The temperature of the reaction vessel is increased to 25 °C for 
the next module. 
Action Cycles Solution Amount T (°C) Incubation time 
Cooling - - - -20 - 














Wash 1 DCM 2 mL 0 5 s 
Wash 1 
DCM : Dioxane 
(1:2) 
2 mL 0 20 s 
Heating - - - 25 - 
Wash 2 DCM 2 mL > 0 25 s 
 
Module D: Capping (30 min) 
The resin was washed with DMF (two times with 2 mL for 25 s) and the temperature 
of the reaction vessel was adjusted to 25 °C. Pyridine solution (2 mL, 10% in DMF) 
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was delivered into the reaction vessel. After 1 min, the reaction solution was drained 
and the resin washed with DCM (three times with 3 mL for 25 s). Capping solution (4 
mL) was delivered into the reaction vessel. After 20 min, the reaction solution was 
drained and the resin washed with DCM (three times with 3 mL for 25 s). 
Action Cycles Solution Amount T (°C) Incubation time 
Heating - - - 25 (5 min)* 
Wash  2 DMF 2 mL 25 25 s 
Deliver 1 
10% Pyridine in 
DMF 
2 mL 25 1 min 
Wash  3 DCM 2 mL 25 25 s 
Deliver 1 Capping Solution 4 mL 25 20 min 
Wash  3 DCM 2 mL 25 25 s 
*Time required to reach the desired temperature. 
Module E: Fmoc Deprotection (9 min) 
The resin was washed with DMF (three times with 2 mL for 25 s) and the temperature 
of the reaction vessel was adjusted to 25 °C. Fmoc deprotection solution (2 mL) was 
delivered into the reaction vessel. After 5 min, the reaction solution was drained and 
the resin washed with DMF (three times with 3 mL for 25 s) and DCM (five times each 
with 2 mL for 25 s). The temperature of the reaction vessel is decreased to -20 °C for 
the next module. 
Module E*: Fmoc Deprotection with TEA (20 min) 
The resin was washed with DMF (three times with 2 mL for 25 s) and the temperature 
of the reaction vessel was adjusted to 25 °C. Fmoc deprotection solution 2 (2 mL) was 
delivered to the reaction vessel. After 5 min, the reaction solution was drained. The 
Action Cycles Solution Amount T (°C) Incubation time 
Wash 3 DMF 2 mL 25 25 sec 
Deliver 1 Fmoc depr. Solution 1 2 mL 25 5 min 
Wash 1 DMF 2 mL   
Cooling - - - -20 - 
Wash 3 DMF 2 mL < 25 25 sec 
Wash 5 DCM 2 mL < 25 25 sec 
60 
 
deprotection process was repeated for three times. The resin was washed with DMF 
(three times with 3 mL for 25 s) and DCM (five times each with 2 mL for 25 s). The 
temperature of the reaction vessel is decreased to -20 °C for the next module. 
Action Cycles Solution Amount T (°C) Incubation time 




2 mL 25 5 min 
Wash 1 DMF 2 mL   
Cooling - - - -20 - 
Wash 3 DMF 2 mL < 25 25 sec 
Wash 5 DCM 2 mL < 25 25 ec 
 Post-synthesizer manipulations 
Module F: On-resin Methanolysis 
The resin was suspended THF (5 mL). 0.5 mL of NaOMe in MeOH (0.5 M) was added 
and the suspension was gently shaken at room temperature. After micro-cleavage 
(Module G1) indicated the complete removal of benzoyl groups (generally around 4 
hours), the resin was repeatedly washed with MeOH (2mL x 3) and DCM (2mL x 3). 
Module G: Cleavage from Solid Support  
The oligosaccharides were cleaved from the solid support using a continuous-flow 
photoreactor as described previously. 
Module G1: Micro-cleavage from Solid Support  
Trace amount of resin (around 20 beads) was dispersed in DCM (0.1 mL) and 
irradiated with a UV lamp (6 watt, 356 nm) for 10 minutes. ACN (10 µL) was then added 
to the resin and the resulting solution analyzed by MALDI. 
Module H: Solution-phase methanolysis  
The protected oligosaccharide was dissolved in MeOH: DCM (1.5 mL, 1:1). NaOMe in 
MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was stirred at 
room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form), filtered and 
concentrated in vacuo. The crude compound was used for hydrogenolysis without 
further purification. 
Module H*: Solution-phase methanolysis for 3-O-methoxycarbonyl sugars 
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The protected oligosaccharide was dissolved in THF (1.5 mL). NaOMe in MeOH (0.5 
M, 3 equiv. per benzoyl ester) was added and the solution was stirred at room 
temperature for 12 h, neutralized with HOAc and concentrated in vacuo. The crude 
compound was used for hydrogenolysis without further purification. These conditions 
also hydrolyze the methyl esters due to the trace amount of water in the reaction 
mixture. 
Module I: Hydrogenolysis 
The crude compound obtained from Module F or H was dissolved in 2 mL of 
EA:tBuOH:H2O (1:0.5:0.5). Palladium on carbon (Pd/C, 10%) was added and the 
reaction was stirred in H2 bomb with 60 psi pressure. Generally, the hydrogenolysis is 
completed within 1 hour. If the reaction does not go to completion after 1 hour, the 
reaction should be monitored every 30 min and stopped right after completion to 
prevent the undesired reduction of the free reducing end. Upon completion, the 
reaction was filtered through celite and washed with DCM, tBuOH and H2O. The 
filtrates were concentrated in vacuo. 
Module I*: Hydrogenolysis at ambient pressure 
The crude compound obtained from Module H* was dissolved in 2 mL of 
EA:tBuOH:H2O (1:0.5:0.5). 100% by weight Pd-C (10%) was added and the reaction 
was stirred under H2–atmosphere for 6 h. The reaction was filtered through celite and 
washed with tBuOH and H2O. The filtrates were concentrated in vacuo. For 3-O-
methoxycarbonyl sugars, the pH value was adjusted to 2-3 by using formic acid before 
HPLC purification. 
Module J: Purification 
Purification was conducted at different stage of the synthesis as reported for the 
individual procedures. The crude products were analyzed using analytical HPLC 
(Agilent 1200 Series spectrometer). The purification was conducted using preparative 
HPLC (Agilent 1200 Series spectrometer) or C18 reverse phase silica gel column 
chromatography. 
 Method A: (YMC-Diol-300 column, 150 x 4.6 mm) flow rate of 1.0 mL / min with 
Hex – 20% EtOAc as eluent [isocratic 20% EtOAc (5 min), linear gradient to 
55% EtOAc (35 min), linear gradient to 100% EtOAc (5 min)]. 
 Method A0: (YMC-Diol-300 column, 150 x 4.6 mm) flow rate of 1.0 mL / min 
with Hex – 10% EtOAc as eluent [isocratic 10% EtOAc (5 min), linear gradient 
to 50% EtOAc (20 min), linear gradient to 100% EtOAc (5 min)]. 
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 Method A50: (YMC-Diol-300 column, 150 x 4.6 mm) flow rate of 1.0 mL / min 
with Hex – 20% EtOAc as eluents [isocratic 20% EtOAc (5 min), linear gradient 
to 40% EtOAc (5 min), linear gradient to 60% EtOAc (30 min), linear gradient 
to 100% EtOAc (5 min)]. 
 Method B: (YMC-Diol-300 column, 150 x 20 mm) flow rate of 15 mL / min with 
Hex – 20% EtOAc as eluents [isocratic 20% EtOAc (5 min), linear gradient to 
55% EtOAc (35 min), linear gradient to 100%. 
 Method B1: (YMC-Diol-300 column, 150 x 20 mm) flow rate of 15 mL/min with 
Heptane/EtOAc as eluent [isocratic 20% EtOAc (5 min), linear gradient to 100% 
EtOAc]. 
 Method B50: (YMC-Diol-300 column, 150 x 20 mm) flow rate of 15 mL / min 
with Hex – 20% EtOAc as eluents [isocratic 20% EtOAc (5 min), linear gradient 
to 50% EtOAc (75 min), linear gradient to 100% EtOAc (10 min)]. 
 Method C: (Synergi Hydro RP18 column, 250 x 4.6 mm) flow rate of 1.0 mL / 
min with H2O (0.1% formic acid) as eluents [isocratic (5 min), linear gradient to 
30% ACN (30 min), linear gradient to 100% ACN (5 min)]. 
 Method D: (Synergi Hydro RP18 column, 250 x 10 mm) flow rate of 4.0 mL / 
min with H2O (0.1% formic acid) as eluents [isocratic (5 min), linear gradient to 
30% ACN (30 min), linear gradient to 100% ACN (5 min)]. 
 Method E: (Hypercarb column, 150 x 10 mm) flow rate of 1.3 mL / min with 
H2O (0.1% formic acid) as eluents [isocratic (5 min), linear gradient to 30% 
ACN (30 min), linear gradient to 100% ACN (5 min)]. 
 Method M: (Manual reverse phase C18 silica gel column chromatography): 
H2O (10 mL), 5% MeOH (10 mL), 7.5% MeOH (10 mL), 10% MeOH (10 mL), 
15% MeOH (10 mL), 20% MeOH (10 mL). 
 Method N: (Manual normal phase silica gel column chromatography): 
hexane:EtOAc = 2:1 to 1:2. 
6.3. Synthesis of building blocks 
 Synthesis of building block BB-6a 
 
Compound S1 was prepared according previously reported procedures.117 
63 
 
Monosaccharide S1 (2.0 g, 3.9 mmol) was dissolved in DCM (20 mL). Pyridine (0.9 
mL, 12 mmol) and (9H-fluoren-9-yl)methyl carbonochloridate (2.0 g, 7.9 mmol) were 
added. The yellow solution was stirred at rt until completion (3 h). The reaction was 
diluted with DCM and washed with 1 M HCl, then saturated aqueous NaHCO3 and 
water. The organic layer was dried over MgSO4, filtered and evaporated. The resulting 
yellow oil was purified by column chromatography (hexane:EtOAc = 4:1) to give BB-
6a as a white solid (2.7 g, 94%). 
Analytical data for ethyl 2-O-benzoyl-3,4-di-O-benzyl-6-O-
fluorenylmethoxycarbonyl-1-thio-β-D-glucopyranoside BB-6a: 1H NMR (400 
MHz, Chloroform-d) δ 8.08 – 7.97 (m, 2H), 7.76 (d, J = 7.5 Hz, 2H), 7.65 – 7.52 (m, 
3H), 7.49 – 7.36 (m, 4H), 7.36 – 7.20 (m, 7H), 7.14 (d, J = 1.9 Hz, 5H), 5.33 (t, J = 9.5 
Hz, 1H), 4.88 (d, J = 10.9 Hz, 1H), 4.77 – 4.66 (m, 2H), 4.62 (d, J = 11.0 Hz, 1H), 4.56 
(d, J = 10.0 Hz, 1H), 4.48 (dt, J = 11.7, 1.5 Hz, 1H), 4.38 (dd, J = 7.8, 2.7 Hz, 2H), 4.33 
– 4.22 (m, 2H), 3.88 (t, J = 8.7 Hz, 1H), 3.75 – 3.61 (m, 2H), 2.69 (dddd, J = 19.8, 12.6, 
7.4, 5.2 Hz, 2H), 1.21 (td, J = 7.5, 1.1 Hz, 3H); 13C NMR (101 MHz, Chloroform-d) δ 
165.21, 154.92, 143.34, 143.26, 141.26, 141.24, 137.54, 137.48, 133.19, 129.82, 
129.75, 128.53, 128.41, 128.29, 128.11, 128.04, 127.98, 127.87, 127.74, 127.17, 
125.19, 125.15, 120.02, 84.31, 83.59, 75.37, 75.18, 72.29, 69.99, 66.56, 46.68, 24.03, 
14.90; m/z (HRMS+) 753.2526 [M + Na]+ (C44H42O8SNa requires 753.2493); [α]D20 
30.93 (c = 1, CHCl3); IR (neat) νmax = 1215, 744, 668 cm-1. 
 Synthesis of building block BB-11 and BB-12 
Synthesis of S3 
 
Monosaccharide S2 (53 g, 204 mmol) was dissolved in anhydrous DMF (1 L). The 
solution was cooled to 0 °C and NaH (60% by weight in mineral oil, 12.2 g, 305 mmol) 
was slowly added portion-wise with vigorous stirring. Evolved H2 was periodically 
vented during NaH addition. After the NaH addition was complete, the reaction was 
stirred for 1 h at 0 °C. MeI (25 mL, 407 mmol) was added drop-wise. After MeI addition 
was complete, the reaction was stirred for 15 min. at 0 °C. The reaction was allowed 
to warm to rt, during which time a white precipitate formed. The reaction was stirred 
for 1.5 h at rt and then cooled back to 0 °C. Saturated aq. NH4Cl was slowly added to 
quench the reaction. When all H2 appeared to have been evolved an additional 50 mL 
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of saturated aq. NH4Cl was added and the reaction was stirred for additional 15 min. 
at 0 °C. The reaction was concentrated to < 200 mL under reduced pressure and DCM 
(1 L) was added. The organic layer was separated and extracted twice with H2O. The 
organics were dried over MgSO4, filtered, and concentrated to give S3 as a light yellow 
oil (56 g, quantitative). 
Analytical data for 1,2:5,6-di-O-isopropylidene-3-O-methyl-α-D-glucofuranose, S3: 
1H NMR (400 MHz, CDCl3) δ 5.85 (d, J = 3.7 Hz, 1H), 4.56 (d, J = 3.7 Hz, 1H), 4.31 – 
4.25 (m, 1H), 4.11 – 4.04 (m, 2H), 3.99 (dd, J = 8.6, 5.4 Hz, 1H), 3.76 (d, J = 3.0 Hz, 
1H), 3.45 (s, 3H), 1.49 (s, 3H), 1.42 (s, 3H), 1.35 (s, 3H), 1.31 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 111.88, 109.16, 105.31, 83.83, 82.03, 81.17, 72.53, 67.37, 58.33, 
27.01, 26.96, 26.37, 25.54; [α]D20 -100.07 (c 1, CHCl3); IR (neat) νmax = 1373, 1072 
cm-1; m/z (HRMS+) 297.1330 [M + Na]+ (C13H22O6Na requires 297.1309). 
Synthesis of S4 
 
Monosaccharide S3 (56 g, 204 mmol) was suspended in H2O (400 mL). Amberlite IR-
120 (H+ form, 75 g) was added. The reaction mixture was heated to 80 °C and stirred 
vigorously for 16 h. The reaction was cooled to rt and the solid material was filtered 
off. The reaction was concentrated under reduced pressure. The residue was 
suspended in ACN and then the solvent was removed under reduced pressure to give 
a pale yellow powder. NaOAc (8.4 g, 102 mmol) was added to the solid sample 
followed by slow qaddition of Ac2O (192 mL, 2.04 mol). The mixture was refluxed for 
45 min, during which time it became orange. The reaction was cooled to room 
temperature, and then quenched with ice. DCM (700 mL) was added and the organic 
layers were washed twice with H2O. The organics were dried over MgSO4, filtered, and 
concentrated to give a crude orange oil. This oil was dissolved in DCM (1.3 L). 
Ethanethiol (38 mL, 510 mmol) was added and the solution was cooled to 0 °C. 
BF3•OEt2 (39 mL, 306 mmol) was slowly added and the reaction was stirred at 0 °C for 
5 h. The pink solution was quenched by slow addition of saturated aq. NaHCO3. 700 
mL DCM were added and the organic layers washed with saturated aq. NaHCO3 and 
H2O. The organics were dried over MgSO4, filtered, and concentrated. The crude 
product was purified by column chromatography (hexane:EtOAc = 2:1) to give S4 as 
a yellow gel (56.7 g, 76%). 
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Analytical data for ethyl 2,4,6-tri-O-acetyl-3-O-methyl-1-thio-β-D-glucopyranoside, 
S4: 1H NMR (400 MHz, CDCl3) δ 5.01 (dd, J = 20.2, 10.0 Hz, 2H), 4.39 (d, J = 10.0 Hz, 
1H), 4.22 – 4.07 (m, 2H), 3.64 – 3.55 (m, 1H), 3.47 (t, J = 9.2 Hz, 1H), 3.41 (s, 3H), 
2.78 – 2.61 (m, 2H), 2.11 (s, 3H), 2.09 (s, 3H), 2.07 (s, 3H), 1.25 (t, J = 7.4 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 170.88, 169.49, 169.47, 83.84, 82.92, 77.48, 77.16, 
76.84, 76.31, 70.83, 69.26, 62.65, 59.32, 24.15, 21.11, 20.95, 20.91, 14.93; [α]D20 -
56.58 (c 1, CHCl3); IR (neat) νmax = 1743, 1218 cm-1; m/z (HRMS+) 387.1093 [M + 
Na]+ (C15H24O8SNa requires 387.1084). 
Synthesis of S5 
 
Monosaccharide S4 (56.7 g, 156 mmol) was dissolved in MeOH (310 mL) and the 
solution was cooled to 0 °C. NaOMe (840 mg, 15.6 mmol) was added. The reaction 
was allowed to warm to rt and stirred for 14 h. The reaction was neutralized with 
Amberlite IR-120 (H+ form) and the solid was filtered off. The solvent was removed 
under reduced pressure to give S5 as a yellow gel (35.7 g, 96%). 
Analytical data for ethyl 3-O-methyl-1-thio-β-D-glucopyranoside, S5: 1H NMR (400 
MHz, CD3OD) δ 4.39 (d, J = 9.8 Hz, 1H), 3.86 (dd, J = 12.0, 2.2 Hz, 1H), 3.69 – 3.61 
(m, 4H), 3.39 – 3.23 (m, 3H), 3.09 (t, J = 8.7 Hz, 1H), 2.84 – 2.65 (m, 2H), 1.30 (t, J = 
7.4 Hz, 3H); 13C NMR (101 MHz, CD3OD) δ 89.42, 86.89, 81.93, 74.17, 71.10, 62.78, 
61.28, 24.81, 15.40; [α]D20 +13.10 (c 1, CHCl3); IR (neat) νmax = 3389, 1035 cm-1; m/z 
(HRMS+) 261.0791 [M + Na]+ (C9H18O5SNa requires 261.0767). 
Synthesis of S6 
 
Monosaccharide S5 (35.7 g, 150 mmol) was dissolved in anhydrous DMF (500 mL). 
p-Toluenesulfonic acid (PTSA) (4.3 g, 22.5 mmol) was added and then benzaldehyde 
dimethyl acetal (45 mL, 300 mmol) was slowly added using a dropping funnel. 
Following benzaldehyde dimethyl acetal addition the reaction was heated to 45°C and 
stirred for 18 h. The reaction was cooled to 0°C and quenched by addition of TEA (7 
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mL). The reaction was concentrated under reduced pressure and the crude product 
was purified by column chromatography (hexane:EtOAc = 1:1) to give S6 as a white 
powder (30.0 g, 61%). 
Analytical data for ethyl 4,6-O-benzylidene-3-O-methyl-1-thio-β-D-
glucopyranoside, S6: 1H NMR (400 MHz, CDCl3) δ7.55 – 7.43 (m, 2H), 7.41 – 7.30 
(m, 3H), 5.56 (s, 1H), 4.47 (d, J = 9.5 Hz, 1H), 4.35 (dd, J = 10.5, 4.9 Hz, 1H), 3.77 (t, 
J = 10.3 Hz, 1H), 3.69 (s, 3H), 3.67 – 3.58 (m, 2H), 3.54 – 3.47 (m, 2H), 3.47 – 3.40 
(m, 1H), 2.80 – 2.72 (m, 2H), 1.32 (t, J = 7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 
137.30, 134.59, 129.88, 129.15, 128.38, 126.15, 101.40, 86.75, 83.66, 81.49, 72.99, 
70.83, 68.77, 61.17, 24.76, 15.39; m/z (HRMS+) 349.1106 [M + Na]+ (C16H22O5SNa 
requires 349.1080). 
Synthesis of S7 
 
Monosaccharide S6 (30.0 g, 92 mmol) was dissolved in anhydrous DCM (310 mL). 
The solution was cooled to 0°C and Bz2O (41.6 g, 184 mmol), 4-Dimethylaminopyridine 
(DMAP) (5.6 g, 46 mmol), and trimethylamine (TEA) (38 mL, 276 mmol) were 
successively added. The reaction was allowed to warm to rt and stirred for 12 h, during 
which time it became yellow and a white precipitate formed. DCM (300 mL) was added 
and the organic layers were washed with saturated aq. NaHCO3 and brine. The 
organics were dried over MgSO4, filtered, and concentrated. The crude product was 
purified by column chromatography (7 hexane: 2 EtOAc) to give S7 as a pale yellow 
solid (33.1 g, 84%). 
Analytical data for ethyl 2-O-benzoyl-4,6-O-benzylidene-3-O-methyl-1-thio-β-D-
glucopyranoside, S7: 1H NMR (400 MHz, CDCl3) δ 8.14 – 8.06 (m, 2H), 7.60 (t, J = 
7.8 Hz, 1H), 7.53 – 7.44 (m, 4H), 7.41 – 7.33 (m, 3H), 5.60 (s, 1H), 5.27 (t, J = 10.2 
Hz, 1H), 4.66 (d, J = 10.1 Hz, 1H), 4.41 (dd, J = 10.5, 4.9 Hz, 1H), 3.82 (t, J = 10.3 Hz, 
1H), 3.79 – 3.61 (m, 2H), 3.59 (dd, J = 9.8, 5.2 Hz, 1H), 3.54 (s, 3H), 2.73 (qd, J = 7.4, 
3.4 Hz, 2H), 1.24 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 165.36, 137.27, 
133.82, 133.36, 130.31, 130.00, 129.95, 129.17, 128.60, 128.58, 128.39, 126.18, 
101.43, 84.47, 82.35, 81.35, 72.18, 70.94, 68.78, 60.90, 24.19, 14.94; [α]D20 +8.07 (c 
1, CHCl3); IR (neat) νmax = 3442, 1071 cm-1; m/z (HRMS+) 431.1529 [M + Na]+ 
(C23H26O6SNa requires 431.1523). 
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Synthesis of BB-11 
 
Monosaccharide S7 (9.7 g, 22.5 mmol) was dissolved in anhydrous dichloromethane 
(DCM) (125 mL). Triethylsilane (TES) (21.6 mL, 135 mmol) was added and the solution 
was cooled to 0°C. Trifluoroacetic acid (TFA) (8.7 mL, 113 mmol) and trifluoroacetic 
anhydride (TFAA) (1.6 mL, 11.3 mmol) were added sequentially. The solution was 
stirred at 0°C for 3 hours. The reaction was diluted with DCM (150 mL) and washed 
with saturated aq. NaHCO3 (2 x 50 mL) and H2O (1 x 50 mL). The organics were dried 
over MgSO4, filtered, and evaporated. The remaining pale yellow oil was dissolved in 
pyridine and the solvent was removed under reduced pressure. The crude compound 
was dissolved in DCM (75 mL). Pyridine (Py) (6.8 mL, 67.6 mmol) was added followed 
by Fmoc-Cl (11.7 g, 45.1 mmol). The yellow solution was stirred at room temperature 
under inert Ar atmosphere until completion (3 h). The reaction was diluted with DCM 
(100 mL) and washed with 1 M HCl (1 x 50 mL), saturated aq. NaHCO3 (1 x 50 mL), 
and H2O (1 x 50 mL). The organics were dried over MgSO4, filtered, and evaporated. 
The crude product was purified by column chromatography (hexane : EtOAc = 4:1) to 
give BB-11 as a pale yellow solid (9.7 g, 66%). 
Analytical data for ethyl 2-O-benzoyl-6-O-benzyl-4-O-fluorenylcarboxymethyl-3-O-
methyl-1-thio-β-D-glucopyranoside, BB-11: 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J 
= 8.0 Hz, 2H), 7.77 (d, J = 7.5 Hz, 2H), 7.63 – 7.55 (m, 3H), 7.47 (t, J = 7.7 Hz, 2H), 
7.41 (t, J = 7.5 Hz, 2H), 7.36 – 7.27 (m, 7H), 5.27 (t, J = 9.6 Hz, 1H), 4.92 (t, J = 9.5 
Hz, 1H), 4.58 (d, J = 10.0 Hz, 1H), 4.55 (s, 2H), 4.47 (dd, J = 10.4, 7.4 Hz, 1H), 4.36 
(dd, J = 10.4, 6.9 Hz, 1H), 4.21 (t, J = 7.1 Hz, 1H), 3.75 (dt, J = 11.9, 3.3 Hz, 1H), 3.73 
– 3.64 (m, 3H), 3.41 (s, 3H), 2.80 – 2.67 (m, 2H), 1.25 (t, J = 7.4 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) δ 165.14, 154.44, 143.40, 143.26, 141.46, 141.42, 138.01, 133.40, 
129.98, 129.84, 128.60, 128.45, 128.03, 127.74, 127.29, 127.27, 125.17, 125.13, 
120.20, 83.82, 83.28, 77.36, 75.00, 73.73, 71.89, 70.10, 69.77, 60.17, 46.88, 24.25, 
15.02; [α]D20 +4.60 (c 1, CHCl3); IR (neat) νmax = 1754, 1729 cm-1; m/z (HRMS+) 
677.2191 [M + Na]+ (C38H38O8NaS requires 677.2180). 




Monosaccharide S7 (19.4 g, 45.1 mmol) was dissolved in anhydrous DCM (78 mL). 
The solution was cooled to 0°C and a 1 M solution of BH3 in THF (0.1 M, 180 mL, 180 
mmol) was added followed by TMSOTf (4.1 mL, 22.5 mmol). The reaction was allowed 
to warm to rt and stirred for 4 h. The reaction was then cooled to 0 °C and quenched 
by addition of saturated aq. NaHCO3. The reaction was then diluted with DCM and the 
aqueous layer was separated. The organic layer was extracted with saturated aq. 
NaHCO3 and H2O. The organics were dried over MgSO4, filtered, and concentrated. 
The crude product was purified by column chromatography (4 hexane: 1 EtOAc) to 
give S8 as a fluffy white solid (16.0 g, 82%). 
Analytical data for ethyl 2-O-benzoyl-4-O-benzyl-3-O-methyl-1-thio-β-D-
glucopyranoside, S8: 1H NMR (400 MHz, CDCl3) δ 8.10 (d, J = 7.1 Hz, 2H), 7.59 (t, 
J = 7.4 Hz, 1H), 7.47 (t, J = 7.7 Hz, 2H), 7.40 – 7.28 (m, 5H), 5.24 – 5.14 (m, 1H), 4.88 
(d, J = 11.0 Hz, 1H), 4.69 (d, J = 11.0 Hz, 1H), 4.58 (d, J = 10.1 Hz, 1H), 3.91 (d, J = 
12.0 Hz, 1H), 3.72 (dd, J = 14.0, 7.8 Hz, 1H), 3.65 – 3.59 (m, 2H), 3.53 (s, 3H), 3.50 – 
3.41 (m, 1H), 2.71 (qd, J = 7.4, 2.4 Hz, 2H), 1.23 (t, J = 7.4 Hz, 3H); 13C NMR (101 
MHz, CDCl3) δ 165.35, 137.99, 133.33, 129.92, 128.60, 128.56, 128.25, 128.07, 86.55, 
83.75, 79.75, 77.25, 75.10, 72.60, 62.15, 60.96, 24.24, 14.98; [α]D20 +152.44 (c 1, 
CHCl3); IR (neat) νmax = 3484, 1725, 1069 cm-1; m/z (HRMS+) 455.1497 [M + Na]+ 
(C23H28O6SNa requires 455.1499). 
Synthesis of S9 
 
Monosaccharide S8 (9.25 g, 21.4 mmol) was dissolved in anhydrous DMF (110 mL). 
The solution was cooled to 0 °C and NaH (60% by weight in mineral oil, 2.14 g, 53.5 
mmol) was slowly added. After the NaH addition was complete, the reaction was stirred 
for 30 min at 0 °C. MeI (4.0 mL, 64.2 mmol) was added drop-wise. The reaction was 
allowed to warm to rt, during which time a white precipitate formed. The reaction was 
stirred for 1 hour at rt and then cooled back to 0 °C. Saturated aq. NH4Cl was slowly 
added to quench and the reaction. The reaction was concentrated to < 30 mL under 
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reduced pressure and DCM (200 mL) was added. The organic layer was separated 
and extracted twice with H2O. The organics were dried over MgSO4, filtered, and 
concentrated to give S9 as a light yellow gel (9.55 g, quantitative). 
Analytical data for ethyl 2-O-benzoyl-4-O-benzyl-3,6-di-O-methyl-1-thio-β-D-
glucopyranoside, S9: 1H NMR (400 MHz, CDCl3) δ 8.09 (d, J = 7.4 Hz, 2H), 7.58 (t, 
J = 6.8 Hz, 1H), 7.47 (t, J = 7.7 Hz, 2H), 7.37 – 7.28 (m, 5H), 5.20 (t, J = 9.4 Hz, 1H), 
4.86 (d, J = 11.1 Hz, 1H), 4.65 (d, J = 11.0 Hz, 1H), 4.50 (d, J = 10.1 Hz, 1H), 3.69 – 
3.53 (m, 5H), 3.51 (s, 3H), 3.39 (s, 3H), 2.76 – 2.65 (m, 2H), 1.20 (t, J = 7.5 Hz, 3H); 
13C NMR (101 MHz, CDCl3) δ 165.42, 138.28, 133.30, 129.99, 128.62, 128.24, 128.03, 
86.74, 83.70, 79.53, 77.48, 75.17, 72.66, 71.51, 60.98, 59.58, 24.11, 14.89; [α]D20 
+11.61 (c 1, CHCl3); IR (neat) νmax = 1728, 1094, 1071 cm-1; m/z (HRMS+) 469.1666 
[M + Na]+ (C24H30O6SNa requires 469.1655). 
Synthesis of BB-12 
 
Monosaccharide S9 (7.36 g, 17.9 mmol) was dissolved in AcOH (40 mL). 3.2 g Pd/C 
(40% of reactant by weight) was added. The mixture was stirred in H2 atmosphere at 
40 psi for 3 days. The crude material was filtered through celite and the filtrate was 
concentrated. The crude product was purified by column chromatography 
(hexane:EtOAc = 3:1 – 1:1) to give a clear gel. The gel was then co-evaporated with 
pyridine and dissolved in 22 mL of DCM. Pyridine (2 mL, 19.8 mmol) was added 
followed by Fmoc-Cl (3.45 g, 13.2 mmol). The yellow solution was stirred at rt until 
completion (3 h). The reaction was diluted with DCM and extracted with 1 M HCl, sat. 
aq. NaHCO3, and H2O. The organics were dried over MgSO4 and concentrated. The 
product was purified by column chromatography (4 hexane: 1 EtOAc) to give BB-12 
as a flaky white solid (3.8 g, 40% over two steps). 
Analytical data for ethyl 2-O-benzoyl-4-O-fluorenylcarboxymethyl-3,6-di-O-
methyl-1-thio-β-D-glucopyranoside, BB-12: 1H NMR (400 MHz, CDCl3) δ 8.07 (dd, 
J = 5.1, 3.3 Hz, 2H), 7.77 (d, J = 7.5 Hz, 2H), 7.64 – 7.56 (m, 3H), 7.47 (t, J = 7.7 Hz, 
2H), 7.41 (t, J = 7.5 Hz, 2H), 7.31 (tdd, J = 7.5, 2.3, 1.2 Hz, 2H), 5.26 (t, J = 9.6 Hz, 
1H), 4.87 (t, J = 9.6 Hz, 1H), 4.58 – 4.43 (m, 3H), 4.28 (t, J = 7.0 Hz, 1H), 3.69 (ddd, J 
= 12.6, 5.8, 3.0 Hz, 2H), 3.58 – 3.52 (m, 2H), 3.40 (s, 3H), 3.35 (s, 3H), 2.78 – 2.66 
(m, 2H), 1.23 (t, J = 7.5 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 165.18, 154.52, 143.32, 
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141.47, 133.45, 130.01, 129.81, 128.63, 128.08, 127.32, 125.17, 120.25, 83.82, 83.23, 
77.48, 74.81, 71.99, 71.84, 70.19, 60.21, 59.74, 46.90, 24.22, 14.87; [α]D20 +12.75 (c 
1, CHCl3); IR (neat) νmax = 1752, 1729, 1247 cm-1; m/z (HRMS+) 601.1870 [M + Na]+ 
(C32H34O8SNa requires 601.1867) 
6.4. Capping test 
 
The preparation of linker 1 and building blocks BB-6b, BB-7, BB-8, BB-9, BB-5, and 
BB-17 was conducted according to previously established procedures.46, 48, 76, 118 
 Modification of capping condition 






A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6a 6.5 equiv (-20°C 5 min, 0°C 20 min) 
E: Fmoc Deprotection  
 
6.4.1.2.  Modules for pilot synthesizer 
 Module “Inject DCM” : 
Close Valve 1(a,c), Valve 2(c); 
Open Valve 1(b), Valve 2(a,b); 
Vacuumize Valve 2(b); 
Close Valve 2(b); 
Open Valve 1(a); 
Inject Valve 1(a); 
Close Valve 1(a). 
 Module “Waste out”: 
Close Valve 1(a,c), Valve 2(c); 
Open Valve 1(b), Valve 2(a,b); 
Vacuumize Valve 2(b); 
Close Valve 2(b); 
Open Valve 2(c); 
Close Valve 2(c). 
 Module “Inject reagent”: 
Close Valve 1(a,c), Valve 2(c); 
Open Valve 1(b), Valve 2(a,b); 
Vacuumize Valve 2(b); 
Close Valve 2(b); 
Change syringe 2(b); 
Open Valve 2(b); 
Inject Valve 2(b); 
Close Valve 2(b). 
 Module “Bubble”: 
Close Valve 1(a), Valve 2(b); 
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Open Valve 1(b,c), Valve 2(a,c); 
6.4.1.3. Capping with TMSOTf-Ac2O 
This is an example showing the capping test procedure, including capping reaction, 
photocleavage, and analysis. The other tests in Table 2-1 were performed following 
the same strategy. 
 
Resin 13 was treated with 0.1% Ac2O and 0.01% TMSOTf in DCM for 5 min (Table 1, 
entry 1, Main Text). Then the solution was drained and the resin was washed with 
DCM for 3 times (2 mL). This procedure was repeated for six times. Cleavage from the 
solid support followed by analytical HPLC (Method A0) gave two major peaks. 
Purification using preparative HPLC afforded the desired compound 14 (Method B, tR 
= 12.1 min) and the 6-acetylated compound 15 (Method B, tR = 14.6 min). 
Analytical HPLC (Method A0, λ = 280 nm) of crude products (14 and 15). 
 
Analytical data for N-benzyloxycarbonyl-5-amino-pentyl 4-O-acetyl-2-O-benzoyl-
3,6-O-benzyl-β-D-glucopyranoside (14): 1H NMR (400 MHz, CDCl3) δ 8.05 – 7.97 
(m, 2H), 7.60 – 7.51 (m, 1H), 7.43 (t, J = 7.7 Hz, 2H), 7.37 – 7.30 (m, 9H), 7.30 – 7.27 
(m, 1H), 7.20 – 7.14 (m, 3H), 7.11 (dd, J = 6.8, 3.0 Hz, 2H), 5.29 (dd, J = 9.5, 7.9 Hz, 
1H), 5.11 (t, J = 9.4 Hz, 1H), 5.07 (s, 2H), 4.62 – 4.48 (m, 6H), 3.93 – 3.79 (m, 2H), 
3.65 (dt, J = 9.5, 4.6 Hz, 1H), 3.59 (dd, J = 4.6, 1.6 Hz, 2H), 3.43 (q, J = 7.2 Hz, 1H), 
2.90 (q, J = 6.7 Hz, 2H), 1.89 (s, 3H), 1.45 (s, 2H), 1.29 (d, J = 7.4 Hz, 2H), 1.18 (q, J 
= 7.6 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 169.76, 165.06, 156.39, 137.91, 137.74, 
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136.79, 133.39, 129.90, 129.85, 128.65, 128.59, 128.52, 128.41, 128.26, 128.21, 
128.03, 127.89, 127.82, 101.26, 79.88, 77.48, 77.36, 77.16, 76.84, 73.80, 73.76, 
73.46, 71.04, 69.86, 69.81, 66.65, 40.92, 29.50, 29.03, 23.21, 21.00; m/z (HRMS+) 
748.3093 [M + Na]+ (C42H47NO10Na requires 748.3098). 





Analytical data for N-benzyloxycarbonyl-5-amino-pentyl 4,6-di-O-acetyl-2-O-
benzoyl-3-O-benzyl-β-D-glucopyranoside (15): 1H NMR (700 MHz, CDCl3) δ 8.01 
(d, J = 7.7 Hz, 2H), 7.56 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 7.36 (d, J = 5.3 
Hz, 4H), 7.32 (d, J = 6.3 Hz, 1H), 7.17 (d, J = 4.9 Hz, 3H), 7.14 – 7.10 (m, 2H), 5.30 (t, 
J = 8.7 Hz, 1H), 5.19 (t, J = 9.6 Hz, 1H), 5.07 (s, 2H), 4.60 (d, J = 11.3 Hz, 2H), 4.58 – 
4.52 (m, 2H), 4.24 (dd, J = 12.3, 5.1 Hz, 1H), 4.18 – 4.13 (m, 1H), 3.86 (q, J = 9.4, 7.9 
Hz, 2H), 3.65 (dd, J = 9.2, 4.5 Hz, 1H), 3.43 (d, J = 8.8 Hz, 1H), 2.93 (q, J = 6.9 Hz, 
2H), 2.09 (d, J = 1.3 Hz, 3H), 1.98 (s, 3H), 1.52 (s, 2H), 1.47 (d, J = 6.3 Hz, 2H), 1.35 
– 1.28 (m, 2H); 13C NMR (176 MHz, CDCl3) δ 171.00, 169.51, 165.04, 156.44, 137.70, 
136.85, 133.44, 129.91, 129.86, 128.66, 128.63, 128.45, 128.25, 128.22, 128.02, 
127.89, 101.39, 79.86, 77.34, 77.16, 76.98, 73.88, 73.47, 72.32, 69.90, 69.86, 66.67, 
62.54, 40.96, 29.53, 29.03, 23.21, 20.97, 20.95; m/z (HRMS+) 700.2728 [M + Na]+ 
(C37H43NO11Na requires 700.2734). 








Resin 13 was treated with 10% Ac2O and 2% MsOH in DCM for 20 min. Then the 
solution was drained and the resin was washed with DCM for three times (2 mL). 
Cleavage from the solid support followed by analytical HPLC (Method A0) gave one 
single peak. Purification using preparative HPLC (Method B) afforded compound 14, 
which indicates the completion of capping after only one cycle of capping. 





6.4.1.5. Capping with MsOH - Stability test 
 
Resin 13 was treated with 10% Ac2O and 2% MsOH in DCM for 20 min. Then the 
solution was drained and the resin was washed with DCM for 3 times (2 mL). This 
procedure was repeated for six times followed by photocleavage. Cleavage from the 
solid support followed by analytical HPLC (Method A0) gave one single peak. 
Purification using preparative HPLC (Method B) afforded compound 14, which 
indicates the stability of 6-Bn even after six cycles of capping. 
Analytical HPLC (Method A0, ELS1 A) of crude products (14). 
 
 Test of stability of Fmoc, Lev and TCA groups  
6.4.2.1. Direct stability test for Fmoc and Lev 





A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-17, 6.5 equiv (-20°C 5 min, 0°C 20 min) 
Capping six times followed by photocleavage 
 
At first, I tried to test the stability of Fmoc group in a direct way. Resin S3 was capped 
for six times followed by photocleavage. However, compound S5 was also obtained. 
As observed in our laboratory, Fmoc group is not stable during the photocleavage 
process, which may be the reason of the partial deprotection of Fmoc group. Based 
on this hypothesis, we tested the stability of Fmoc group again in an indirect way. 
6.4.2.2. Indirect stability test for Fmoc 
Capping was repeated for six times on resin S10 before the deprotection of Fmoc 
group. Cleavage from the solid support followed by analytical HPLC (Method A0, 
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ELS1 A) gave one single peak (See below). Purification using preparative HPLC 
afforded compound S12 (Method B, tR = 24.0 min) with free 3-hydroxyl group and no 
3-acetylated compound S13 or Lev-deprotected product were observed. If the Fmoc 
group was not stable under capping condition and the free hydroxyl group was 
released during the capping process, theoretically this hydroxyl group should have 
been capped by the acetyl group giving the corresponding 3-acetylated compound 
S13.  
 
Capping after the deprotection of Fmoc group on resin S10 was also conducted. 
Cleavage from the solid support followed by purification using preparative HPLC 
afforded 3-acetylated compound S1 (Method B, tR = 19.3 min). This result confirms 
that the hydroxyl group released by the deprotection of Fmoc could be acetylated in 
capping condition. 
Analytical HPLC (Method A0, ELS1 A) of crude products (S13) 
                                                                                                 
Analytical data for N-benzyloxycarbonyl-5-amino-pentyl 2-O-benzoyl-4-O-benzyl-
6-O-levulinyl-β-D-galactopyranoside (S12): 1H NMR (700 MHz, CDCl3) δ 8.04 (d, J 
= 7.8 Hz, 2H), 7.55 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.6 Hz, 2H), 7.40 – 7.33 (m, 7H), 
7.32 – 7.28 (m, 3H), 5.27 – 5.22 (m, 1H), 5.10 (s, 1H), 5.06 (s, 1H), 4.80 (q, J = 11.7 
Hz, 2H), 4.60 (s, 1H), 4.51 (d, J = 7.8 Hz, 1H), 4.36 (dd, J = 11.2, 6.5 Hz, 1H), 4.19 
(dd, J = 11.2, 6.5 Hz, 1H), 3.88 (d, J = 3.5 Hz, 2H), 3.83 (d, J = 9.8 Hz, 1H), 3.73 (t, J 
= 6.5 Hz, 1H), 3.48 (q, J = 7.2 Hz, 1H), 2.96 (q, J = 6.3, 5.8 Hz, 2H), 2.75 (t, J = 6.4 
Hz, 2H), 2.58 (s, 1H), 2.55 (t, J = 6.3 Hz, 2H), 2.19 (s, 3H), 1.51 – 1.43 (m, 2H), 1.35 
(d, J = 6.9 Hz, 2H), 1.27 – 1.22 (m, 2H); 13C NMR (176 MHz, CDCl3) δ 206.58, 172.53, 
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166.98, 156.42, 137.88, 133.48, 129.96, 129.90, 128.75, 128.65, 128.57, 128.35, 
128.25, 128.22, 101.19, 77.34, 77.16, 76.98, 75.82, 74.32, 73.61, 72.34, 69.78, 66.66, 
62.90, 41.01, 38.05, 29.97, 29.62, 29.14, 27.98, 23.31; m/z (HRMS+) 714.2888 [M + 
Na]+ (C38H45NO11Na requires 714.2890). 
Analytical HPLC (Method A0, ELS1 A) of pure compound S12 
 
Analytical data for N-benzyloxycarbonyl-5-amino-pentyl 3-O-acetyl-2-O-benzoyl-
4-O-benzyl-6-O-levulinyl-β-D-galactopyranoside (S13): 1H NMR (700 MHz, CDCl3) 
δ 8.00 (d, J = 7.7 Hz, 2H), 7.55 (t, J = 7.4 Hz, 1H), 7.42 (t, J = 7.7 Hz, 2H), 7.35 (d, J 
= 3.9 Hz, 8H), 7.30 (dq, J = 8.9, 4.5, 3.8 Hz, 2H), 5.61 (dd, J = 10.4, 7.9 Hz, 1H), 5.16 
(dd, J = 10.4, 3.0 Hz, 1H), 5.06 (s, 2H), 4.78 (d, J = 11.7 Hz, 1H), 4.59 (d, J = 11.6 Hz, 
2H), 4.55 (d, J = 7.9 Hz, 1H), 4.31 (dd, J = 11.1, 6.2 Hz, 1H), 4.15 (dd, J = 11.1, 6.6 
Hz, 1H), 3.97 (d, J = 3.0 Hz, 1H), 3.87 (dt, J = 11.3, 5.9 Hz, 1H), 3.78 (t, J = 6.5 Hz, 
1H), 3.47 – 3.41 (m, 1H), 2.93 (q, J = 6.8 Hz, 2H), 2.73 (t, J = 6.5 Hz, 2H), 2.52 (t, J = 
6.4 Hz, 2H), 2.18 (s, 3H), 1.93 (s, 3H), 1.52 (s, 1H), 1.48 – 1.43 (m, 1H), 1.32 (q, J = 
7.3 Hz, 2H), 1.19 (dt, J = 21.7, 6.4 Hz, 2H); 13C NMR (176 MHz, CDCl3) δ 206.55, 
172.44, 170.60, 165.34, 137.65, 136.89, 133.40, 129.84, 128.64, 128.60, 128.50, 
128.25, 128.19, 128.12, 101.62, 77.34, 77.16, 76.98, 75.15, 73.86, 72.32, 70.36, 
69.80, 66.64, 62.63, 40.97, 38.02, 29.97, 29.55, 29.04, 27.92, 23.22, 20.93; m/z 
(HRMS+) 756.2996 [M + Na]+ (C40H47NO12Na requires 756.2997). 







6.4.2.3. Stability test of TCA group 
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A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-9, 6.5 equiv (-20°C 5 min, 0°C 20 min) 
E: Fmoc Deprotection  
Capping six times followed by photocleavage 
 
Cleavage from the solid support followed by analytical HPLC (Method A0) gave one 
single peak. Purification using preparative HPLC afforded compound S15 (Method B, 
tR = 14.5 min), which indicates the stability of TCA group even after 6 cycles of capping. 
 Analytical HPLC (Method A0, ELS1 A) of crude products (S15) 
 
Analytical data for N-benzyloxycarbonyl-5-amino-pentyl 3-acetyl-4,6-di-O-benzyl-
2-deoxy-2-trichloracetamido-β-D-glucopyranoside (S15) 1H NMR (700 MHz, 
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CDCl3) δ 7.37 – 7.33 (m, 8H), 7.30 (tt, J = 11.7, 5.3 Hz, 5H), 7.18 – 7.14 (m, 2H), 6.82 
(d, J = 9.1 Hz, 1H), 5.19 (dd, J = 10.7, 9.0 Hz, 1H), 5.09 (s, 2H), 4.81 (s, 1H), 4.65 (d, 
J = 12.1 Hz, 1H), 4.59 – 4.52 (m, 3H), 4.46 (d, J = 8.1 Hz, 1H), 3.97 (q, J = 9.2 Hz, 
1H), 3.89 (dt, J = 9.7, 6.1 Hz, 1H), 3.77 (t, J = 9.3 Hz, 1H), 3.74 (d, J = 3.1 Hz, 2H), 
3.53 (dt, J = 9.6, 3.2 Hz, 1H), 3.46 – 3.42 (m, 1H), 3.20 – 3.10 (m, J = 6.8 Hz, 2H), 1.94 
(s, 3H), 1.60 (d, J = 7.1 Hz, 1H), 1.48 (q, J = 7.3 Hz, 2H), 1.42 – 1.30 (m, 3H); 13C NMR 
(176 MHz, CDCl3) δ 171.25, 162.06, 156.57, 138.07, 137.80, 136.85, 128.65, 128.63, 
128.58, 128.25, 128.19, 128.10, 128.03, 127.95, 127.93, 101.19, 92.61, 77.34, 77.16, 
76.98, 75.92, 75.34, 74.87, 74.19, 73.75, 69.70, 68.54, 66.71, 56.18, 41.04, 29.68, 
29.08, 23.31, 20.90; m/z (HRMS+) 765.2109 [M + Na]+ (C37H43Cl3N2O9Na requires 
765.2112). 
Analytical HPLC (Method A0, ELS1 A) of pure compound S15 
 
6.5. Synthesis of oligosaccharides 
 AGA synthesis of 1,6-hexaglucose 
6.5.1.1. Synthesis without capping 
 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6a, 2.5 equiv (-20°C 5 min, 0°C 20 min) 






 G: Cleavage from Solid Support  
Cleavage from the solid support was performed. Yield was calculated by 280 nm signal 
of analytical HPLC (14%, see below).  
Analytical HPLC (Method A0, ELS1 A) of crude products (16a and deletion 
sequences) 
 
6.5.1.2. Synthesis with capping 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
         
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6a, 2.5 equiv (-20°C 5 min, 0°C 20 min) 
D: Capping  
E: Fmoc Deprotection  
 G: Cleavage from Solid Support  
 J: Purification Method B 
Cleavage from the solid support followed by purification using preparative HPLC 
afforded compound 16a (Method B, tR = 36.2 min). Yield was calculated by 280 nm 
signal of analytical HPLC (30%). 
Analytical HPLC (Method A0, ELS1 A) of crude products (16a and deletion 
sequences) 
 
Analytical data for 1,6-hexaglucose (16a): 1H NMR (700 MHz, CDCl3) δ 8.24 (d, J = 
7.8 Hz, 2H), 8.22 – 8.15 (m, 6H), 8.08 (t, J = 8.4 Hz, 4H), 7.56 (t, J = 7.5 Hz, 2H), 7.44 
(ddd, J = 31.3, 16.2, 7.9 Hz, 8H), 7.36 – 7.26 (m, 18H), 7.22 (d, J = 7.4 Hz, 2H), 7.17 





– 6.79 (m, 5H), 5.50 (t, J = 8.7 Hz, 1H), 5.43 (p, J = 9.3 Hz, 3H), 5.33 (t, J = 8.7 Hz, 
1H), 5.24 (t, J = 8.7 Hz, 1H), 5.12 – 4.99 (m, 2H), 4.85 (t, J = 9.5 Hz, 2H), 4.78 (t, J = 
10.1 Hz, 3H), 4.75 – 4.71 (m, 2H), 4.71 – 4.61 (m, 11H), 4.53 (d, J = 7.9 Hz, 1H), 4.51 
– 4.44 (m, 3H), 4.39 (ddd, J = 21.8, 10.3, 5.1 Hz, 5H), 4.27 (d, J = 10.0 Hz, 1H), 4.17 
(s, 1H), 4.12 (d, J = 11.6 Hz, 1H), 4.09 – 4.01 (m, 4H), 3.97 (t, J = 9.1 Hz, 1H), 3.91 (t, 
J = 9.0 Hz, 3H), 3.87 (q, J = 8.5 Hz, 4H), 3.80 (q, J = 9.7, 9.3 Hz, 2H), 3.75 (dd, J = 
12.1, 7.3 Hz, 6H), 3.72 – 3.63 (m, 4H), 3.58 (t, J = 11.0 Hz, 3H), 3.39 (dtt, J = 25.8, 
17.0, 7.1 Hz, 6H), 3.30 (t, J = 9.4 Hz, 1H), 2.88 (q, J = 6.7 Hz, 2H), 1.45 (d, J = 7.0 Hz, 
1H), 1.37 (dt, J = 13.3, 7.0 Hz, 1H), 1.33 – 1.27 (m, 2H), 1.22 (t, J = 7.2 Hz, 1H), 1.12 
(d, J = 12.9 Hz, 1H); 13C NMR (176 MHz, CDCl3) δ 165.58, 165.52, 165.27, 165.21, 
164.90, 164.87, 156.52, 138.38, 138.34, 138.31, 138.17, 138.06, 138.01, 137.91, 
137.90, 137.83, 137.74, 137.56, 137.14, 133.45, 133.41, 133.10, 132.89, 132.79, 
130.52, 130.49, 130.44, 130.36, 130.33, 130.25, 130.23, 130.19, 130.11, 129.92, 
129.90, 128.72, 128.70, 128.66, 128.58, 128.58, 128.48, 128.43, 128.40, 128.37, 
128.33, 128.30, 128.25, 128.20, 128.19, 128.16, 128.15, 128.11, 128.05, 128.03, 
128.01, 127.99, 127.96, 127.87, 127.85, 127.80, 127.76, 127.73, 127.69, 127.52, 
127.49, 127.37, 127.35, 102.83, 102.60, 102.07, 101.91, 101.63, 100.80, 84.28, 84.07, 
83.96, 83.48, 82.98, 82.79, 80.18, 79.93, 79.83, 79.77, 79.28, 78.17, 77.34, 77.16, 
76.98, 75.85, 75.60, 75.47, 75.43, 75.40, 75.35, 75.26, 75.22, 75.12, 75.05, 74.98, 
74.67, 74.60, 74.50, 74.21, 74.19, 74.17, 73.62, 73.40, 70.77, 70.37, 69.52, 66.41, 
61.70, 41.11, 29.36, 28.91, 23.27; m/z (HRMS+) 2937.178 [M + Na]+ (C175H175NO39Na 
requires 2937.164). 
Analytical HPLC (Method A0, ELS1 A) of pure compound 16a (8.91 mg in 5.0 mL 
solvent) 
 
6.5.1.3. Determination of yield using analytical HPLC 
Pure compound 16a (8.91 mg) was dissolved in a 1:1 mixture of hexane and ethyl 
acetate (5.0 mL). This solution (30 μL) was injected into analytical HPLC (Method A0) 
and the result used as a standard. The yield was calculated by comparison of the area 
of the product signal (at 280 nm) with the standard. 
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Sample Integral area (280 nm) Yield (%) 
8.91 mg pure compound 16a in 5.0 mL 3276 - 
Crude product of synthesis 6.5.1.1 in 4.0 mL 2338 14 
Crude product of synthesis 6.5.1.2 in 4.0 mL 4978 30 
 AGA synthesis of 1,4-hexaglucose 
 
6.5.2.1. Synthesis without capping 




A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6b, 2.5 equiv (-20°C 5 min, 0°C 20 min) 
E: Fmoc Deprotection  
 G: Cleavage from Solid Support  
Cleavage from the solid support was performed. Yield was calculated by 280 nm signal 
of analytical HPLC (1%).  
Analytical HPLC (Method A0, ELS1 A) of crude products (16b and deletion 
sequences) 
 






 Module Conditions 
 A: Resin Preparation for Synthesis  
 
         
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6b, 2.5 equiv (-20°C 5 min, 0°C 20 min) 
D: Capping  
E: Fmoc Deprotection  
 G: Cleavage from Solid Support  
 J: Purification Method B 
Cleavage from the solid support followed by purification using preparative HPLC 
afforded compound 16b (Method B, tR = 34.8 min). Yield was calculated by 280 nm 
signal of analytical HPLC (15%).  
Analytical HPLC (Method A0, ELS1 A) of crude products (16b and deletion 
sequences) 
 
Analytical data for 1,4-hexaglucose (16b): 1H NMR (700 MHz, CDCl3) δ 7.89 (dd, J = 
17.6, 7.7 Hz, 4H), 7.82 (q, J = 8.6 Hz, 8H), 7.59 (dq, J = 16.0, 7.9 Hz, 4H), 7.54 (t, J = 
7.5 Hz, 1H), 7.48 (t, J = 7.4 Hz, 1H), 7.47 – 7.43 (m, 4H), 7.43 – 7.37 (m, 6H), 7.33 (p, 
J = 7.7 Hz, 10H), 7.27 (d, J = 8.7 Hz, 4H), 7.24 (d, J = 7.5 Hz, 3H), 7.18 – 7.01 (m, 
38H), 6.99 – 6.86 (m, 12H), 5.23 (t, J = 8.8 Hz, 1H), 5.17 (t, J = 8.8 Hz, 1H), 5.13 – 
5.00 (m, 6H), 4.94 – 4.80 (m, 5H), 4.73 (d, J = 11.6 Hz, 1H), 4.67 (d, J = 11.6 Hz, 1H), 
4.63 (d, J = 8.1 Hz, 1H), 4.54 (dtd, J = 28.5, 16.3, 14.1, 9.6 Hz, 8H), 4.45 – 4.33 (m, 
6H), 4.32 – 4.22 (m, 4H), 4.15 (dd, J = 19.8, 12.0 Hz, 2H), 4.08 (t, J = 9.3 Hz, 1H), 4.05 
– 3.87 (m, 7H), 3.79 (t, J = 9.1 Hz, 1H), 3.70 (dd, J = 10.7, 5.5 Hz, 1H), 3.63 – 3.55 (m, 
2H), 3.55 – 3.46 (m, 5H), 3.46 – 3.38 (m, 4H), 3.31 (ddt, J = 36.1, 18.2, 9.1 Hz, 8H), 
3.23 (p, J = 8.1, 7.3 Hz, 1H), 3.10 (d, J = 9.7 Hz, 1H), 3.05 (s, 1H), 2.88 (d, J = 9.9 Hz, 
1H), 2.84 (d, J = 6.0 Hz, 2H), 2.78 (q, J = 10.4, 9.6 Hz, 3H), 1.40 (q, J = 9.1, 7.0 Hz, 
1H), 1.35 – 1.31 (m, 1H), 1.23 – 1.17 (m, 2H), 1.13 – 1.03 (m, 2H); 13C NMR (176 MHz, 
CDCl3) δ 165.18, 165.08, 164.98, 164.95, 156.36, 138.97, 138.93, 138.86, 138.79, 






133.28, 133.13, 133.00, 130.20, 129.94, 129.86, 129.83, 129.81, 129.73, 128.70, 
128.68, 128.66, 128.63, 128.53, 128.43, 128.37, 128.35, 128.34, 128.32, 128.30, 
128.27, 128.25, 128.21, 128.19, 128.16, 128.06, 128.01, 127.99, 127.98, 127.96, 
127.93, 127.91, 127.81, 127.74, 127.21, 127.06, 127.04, 101.27, 100.22, 100.15, 
99.98, 99.98, 99.92, 82.00, 80.24, 80.08, 80.05, 77.34, 77.16, 76.98, 76.27, 76.15, 
76.04, 74.77, 74.70, 74.65, 74.54, 74.48, 74.46, 74.42, 74.35, 74.19, 73.91, 73.72, 
73.62, 73.57, 73.55, 73.49, 73.47, 73.44, 73.23, 73.16, 71.29, 69.48, 67.58, 67.48, 
67.19, 66.59, 40.91, 29.45, 28.93, 23.16; m/z (HRMS+) 2937.173 [M + Na]+ 
(C175H175NO39Na requires 2937.164). 
Analytical HPLC (Method A0, ELS1 A) of pure compound 16b (7.13 mg in 5.0 mL 
solvent)
 
6.5.2.3. Determination of yield using analytical HPLC 
Pure compound 16b (7.13 mg) was dissolved in a 1:1 mixture of hexane and ethyl 
acetate (5.0 mL). This solution (30 µL) was injected into analytical HPLC (Method A0) 
and the result used as a standard. The yield was calculated by comparison of the area 
of the product signal (at 280 nm) with the standard. 
 
Sample Integral area (280 nm) Yield (%) 
7.13 mg pure compound 16b in 5.0 mL 2503 - 
Crude product of synthesis 6.5.2.1 in 4.0 mL 140 1 




 AGA synthesis of Lc4 
 
Module Conditions 
A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-7, 6.5 equiv (-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-8, 6.5 equiv (-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-9, 6.5 equiv (-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-8, 6.5 equiv (-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
G: Cleavage from Solid Support  
J: Purification Method B 
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Cleavage from the solid support followed by purification using preparative HPLC 
(Method B, tR = 32.4 min) afforded compound 17 (17.5 mg, 67%).  
Analytical HPLC (Method A0, ELS1 A) of crude products (17) 
 
Analytical data for Lc4 (17): 1H NMR (400 MHz, CDCl3) δ 8.04 (d, J = 7.8 Hz, 2H), 7.90 
(d, J = 7.8 Hz, 2H), 7.84 (d, J = 7.8 Hz, 4H), 7.48 (dt, J = 16.1, 7.5 Hz, 4H), 7.35 (td, J 
= 13.9, 13.2, 6.8 Hz, 19H), 7.27 – 7.18 (m, 17H), 7.13 (p, J = 7.4 Hz, 12H), 6.63 (d, J 
= 7.6 Hz, 1H), 5.52 (t, J = 9.4 Hz, 1H), 5.36 – 5.26 (m, 2H), 5.22 (t, J = 9.0 Hz, 1H), 
5.05 (s, 2H), 4.90 (d, J = 10.3 Hz, 1H), 4.74 (d, J = 8.3 Hz, 1H), 4.71 – 4.58 (m, 4H), 
4.54 (d, J = 11.9 Hz, 2H), 4.47 (d, J = 8.7 Hz, 1H), 4.36 (ddt, J = 30.2, 19.8, 9.5 Hz, 
8H), 4.21 (d, J = 12.3 Hz, 1H), 4.04 (q, J = 11.6 Hz, 3H), 3.88 (d, J = 4.7 Hz, 2H), 3.81 
– 3.67 (m, 3H), 3.62 (dd, J = 10.7, 4.8 Hz, 2H), 3.52 (dd, J = 13.8, 6.9 Hz, 3H), 3.43 
(d, J = 8.6 Hz, 3H), 3.32 (dd, J = 14.3, 9.4 Hz, 4H), 3.07 (q, J = 8.3 Hz, 1H), 2.86 (tt, J 
= 15.4, 6.4 Hz, 3H), 2.73 (t, J = 8.8 Hz, 1H), 2.40 (d, J = 10.0 Hz, 1H), 1.44 (ddq, J = 
20.8, 14.1, 7.0 Hz, 2H), 1.34 – 1.27 (m, 2H), 1.13 (dt, J = 14.6, 7.1 Hz, 2H); m/z 
(HRMS+) 2092.719 [M + NH4]+ (C120H117Cl3N3O27 requires 2092.725). 
Analytical HPLC (Method A0, ELS1 A) of pure Lc4 (17) 
 
 AGA synthesis of 50-mer polymannoside 




 Module Conditions 
 A: Resin Preparation for Synthesis  
 
        
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-5, 6.5 equiv (-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 G: Cleavage from Solid Support  
 J: Purification Method B50 
Cleavage from the solid support followed by purification using preparative HPLC 
(Method B50, tR = 67.3 min) afforded desired compound 6 (64 mg, 22%).  





Analytical data for 50-mer polymannose (1→6) (6): 1H NMR (700 MHz, CDCl3) δ 8.21 
– 8.17 (m, 100H), 7.54 – 7.48 (m, 125H), 7.25 – 7.06 (m, 530H), 5.87 – 5.84 (m, 50H), 
5.06 (s, 50H), 4.89 (d, J = 11.5 Hz, 50H), 4.80 (d, J = 10.9 Hz, 50H), 4.44 (d, J = 10.9 
Hz, 50H), 4.36 (t, J = 11.2 Hz, 50H), 4.04 (dd, J = 9.3, 3.1 Hz, 50H), 3.99 (t, J = 9.5 
Hz, 50H), 3.75 (d, J = 10.6 Hz, 50H), 3.60 (d, J = 9.7 Hz, 50H), 3.45 (d, J = 11.1 Hz, 
50H), 3.15 – 3.13 (m, 2H), 1.58 – 1.52 (m, 2H), 1.49 (m, 2H), 1.35 – 1.31 (m, 2H); 13C 
NMR (176 MHz, CDCl3) δ 165.54, 138.53, 138.48, 137.51, 133.31, 130.01, 129.86, 
128.65, 128.49, 128.36, 128.34, 128.14, 128.01, 127.68, 127.64, 127.37, 127.30, 
127.24, 127.09, 127.01, 98.55, 78.20, 77.21, 77.02, 76.84, 75.18, 75.00, 73.71, 71.30, 
70.90, 68.39, 65.73, 29.72; m/z (MS+) 22566 [M + Na]+ (C1363H1319NO303Na requires 
22569). 
Analytical HPLC (Method A50, 280 nm) of pure 50-mer polymannoside (6) 
 
 




6.5.4.2. Effect of capping on purification 
 
 
During the synthesis of the synthesis of 6, after the 49th deprotection of the Fmoc 
group, trace amounts of resin were taken out of the reaction vessel. Part of this resin 
was photocleaved to give 49-mer with free hydroxyl group 18. The rest of the resin was 
treated with capping condition to afford capped 49-mer 19. Both crude products were 
analyzed by analytical HPLC (Method A50) and the retention times of 6 and 19 were 
compared. To give a clearer picture of how capping generates better separation 
between desired 50-mer and side-product 49-mer, 6 and 19 were mixed and analyzed 
by analytical HPLC. The peaks of the compounds show baseline separation (See 
below, red line). 
Effect of capping on purification (Method A50, 280 nm)  
 










 AGA synthesis of methylated cellulose hexamers 
Building block BB-10 and BB-16 are commercially available. The synthesis of the 
linkers and other building blocks is the cooperative effort of several scientists (Table 
3-1). The synthetic details are reported in literature92. 
 
The description of general materials, methods and modules for AGA is given in 6.2. 
Following final purification, all deprotected products were lyophilized on a Christ Alpha 
2-4 LD plus freeze dryer prior to characterization. 
6.5.5.1. Synthesis of AAABBB-OH 
 
 Module Conditions 




B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  




B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  





 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis and global deprotection and purification afforded AAABBB-OH 
as white solid (6.3 mg, 49% overall yield). 
Analytical data for AAABBB-OH: 1H NMR (600 MHz, D2O) δ 5.23 (d, J = 3.6 Hz, 0.42 
H, α-H1), 4.67 (d, J = 7.8 Hz, 0.58 H, β-H1), 4.59 – 4.50 (m, 5H), 4.01 (ddt, J = 12.2, 
10.1, 2.2 Hz, 4H), 3.98 – 3.91 (m, 2H), 3.90 – 3.84 (m, 4H), 3.84 – 3.78 (m, 4H), 3.75 
(dd, J = 12.5, 5.9 Hz, 1H), 3.68 (td, J = 8.0, 7.4, 4.1 Hz, 3H), 3.65 (t, J = 4.8 Hz, 2H), 
3.62 (s, 3H), 3.62 (s, 6H), 3.60 – 3.51 (m, 5H), 3.51 – 3.44 (m, 5H), 3.44 – 3.40 (m, 
2H), 3.40 – 3.30 (m, 4H); 13C NMR (151 MHz, D2O) δ 102.48, 102.27, 102.22, 102.18, 
102.17, 95.72 (β-C1), 91.75 (α-C1), 83.51, 83.44, 83.43, 83.39, 80.95, 78.34, 78.32, 
75.91, 75.58, 75.49, 75.47, 75.44, 75.40, 74.99, 74.97, 74.96, 74.77, 74.74, 74.12, 
73.98, 73.29, 73.18, 73.07, 72.87, 72.69, 72.68, 72.64, 70.69, 70.49, 69.37, 60.49, 
59.94, 59.91, 59.87, 59.82, 59.50, 59.11, 59.08, 59.03, 59.00; [α]D20 +14.62 (c 0.3, 
H2O); IR (neat) νmax = 3340, 2927, 1649, 1032 cm-1; m/z (HRMS+) 1055.364 [M + Na]+ 
(C39H68NaO31 requires 1055.364). 
RP-HPLC of AAABBB-OH (ELSD trace, Method C, tR = 17.6 min) 
 






 Module Conditions 









B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis and global deprotection and purification afforded ABAABA-OH 
as white solid (4.9 mg, 39% overall yield). 
Analytical data for ABAABA-OH: 1H NMR (600 MHz, D2O) δ 5.24 (d, J = 3.8 Hz, 0.38 
H, α-H1), 4.67 (d, J = 7.9 Hz, 0.62 H, β-H1), 4.58 – 4.51 (m, 5H), 4.00 (ddt, J = 11.7, 
6.5, 3.4 Hz, 4H), 3.97 – 3.93 (m, 1H), 3.92 (d, J = 1.8 Hz, 1H), 3.89 (d, J = 9.1 Hz, 1H), 
3.87 – 3.81 (m, 6H), 3.79 (td, J = 12.0, 4.8 Hz, 2H), 3.68 (dq, J = 12.4, 3.8 Hz, 4H), 




7H), 3.40 – 3.34 (m, 2H), 3.34 – 3.28 (m, 2H); 13C NMR (151 MHz, D2O) δ 102.32, 
102.28, 102.28, 102.25, 102.19, 95.68 (β-C1), 91.74 (α-C1), 83.21, 83.19, 78.55, 
78.41, 78.32, 78.20, 75.96, 75.60, 75.41, 75.34, 75.01, 74.97, 74.77, 74.73, 74.71, 
74.18, 74.11, 73.94, 73.81, 73.50, 73.26, 72.87, 72.29, 72.24, 71.24, 71.15, 70.03, 
69.41, 60.67, 59.96, 59.93, 59.82, 59.76, 59.16, 59.07, 59.02; [α]D20 +13.27 (c 0.75, 
H2O); IR (neat) νmax = 3360, 2876, 1021 cm-1; m/z (HRMS+) 1041.347 [M + Na]+ 
(C38H66NaO31 requires 1041.348). 
6.5.5.3. Synthesis of ABABAB-OH 
 
 Module Conditions 






B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis and global deprotection and purification afforded ABABAB-OH 
as white solid (3.3 mg, 26% overall yield). 
Analytical data for ABABAB-OH: 1H NMR (400 MHz, D2O) δ 5.14 (d, J = 3.3 Hz, 0.45 




4H), 3.87 (d, J = 6.9 Hz, 1H), 3.84 – 3.76 (m, 5H), 3.76 – 3.66 (m, 5H), 3.63 – 3.56 (m, 
4H), 3.56 – 3.53 (m, 9H), 3.52 (d, J = 5.9 Hz, 5H), 3.46 – 3.39 (m, 3H), 3.39 – 3.32 (m, 
5H), 3.32 – 3.20 (m, 4H); 13C NMR (101 MHz, D2O) δ 102.30, 102.23, 102.19, 102.16, 
102.15, 95.65 (β-C1), 91.69 (α-C1), 83.39, 83.15, 83.10, 80.86, 78.21, 75.92, 75.82, 
75.52, 75.49, 75.35, 75.30, 74.94, 74.72, 74.05, 73.42, 73.24, 73.21, 73.19, 73.08, 
72.27, 72.20, 70.62, 70.47, 69.34, 60.59, 59.87, 59.77, 59.66, 59.47, 59.17, 59.07, 
59.05, 48.72; [α]D20 +10.36 (c 0.2, H2O); IR (neat) νmax = 3348, 2929, 1651, 1031 cm-1; 
m/z (HRMS+) 1055.361 [M + Na]+ (C39H68NaO31 requires 1055.364). 
RP-HPLC of ABABAB-OH (ELSD trace, Method C, tR = 16.9 min) 
 
 
6.5.5.4. Synthesis of ABACAB-OH 
 
Module Conditions 
A: Resin Preparation for Synthesis  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
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D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-12, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
F: On-resin Methanolysis  
G: Cleavage from Solid Support  
I: Hydrogenolysis  
J: Purification Method M 
Automated synthesis and global deprotection and purification afforded ABACAB-OH 
as white solid (9.5 mg, 73% overall yield). 
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Analytical data for ABACAB-OH: 1H NMR (600 MHz, D2O) δ 5.23 (d, J = 3.5 Hz, 0.39 
H, α-H1), 4.67 (d, J = 7.9, Hz, 0.61H, β-H1), 4.58 – 4.51 (m, 4H), 4.46 (d, J = 7.9 Hz, 
1H), 4.01 (ddd, J = 12.8, 5.8, 2.8 Hz, 3H), 3.98 – 3.88 (m, 3H), 3.88 – 3.76 (m, 10H), 
3.73 – 3.67 (m, 2H), 3.67 – 3.64 (m, 4H), 3.64 – 3.61 (m, 9H), 3.60 – 3.54 (m, 3H), 
3.54 – 3.47 (m, 3H), 3.45 (ddd, J = 10.6, 5.1, 2.8 Hz, 4H), 3.42 (s, 3H), 3.40 – 3.35 (m, 
3H), 3.34 – 3.30 (m, 1H); 13C NMR (151 MHz, D2O) δ 102.32, 102.29, 102.23, 102.21, 
102.15, 95.71 (β-C1), 91.75 (α-C1), 83.45, 83.23, 83.01, 80.90, 78.70, 78.66, 78.37, 
75.96, 75.88, 75.60, 75.55, 75.36, 75.31, 75.00, 74.98, 74.80, 74.68, 74.16, 73.50, 
73.45, 73.26, 73.23, 73.15, 73.14, 72.31, 72.11, 70.66, 70.52, 69.91, 69.41, 60.67, 
59.97, 59.95, 59.87, 59.77, 59.43, 59.17, 59.03, 58.31; [α]D20 +14.66 (c 1, H2O); IR 
(neat) νmax = 3361, 2953, 1035 cm-1; m/z (HRMS+) 1069.379 [M + Na]+ (C40H70NaO31 
requires 1069.379). 
RP-HPLC of ABACAB-OH (ELSD trace, Method C, tR = 18.6, 18.7 min) 
 






 Module Conditions 









B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-12, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis and global deprotection and purification afforded ACAACA-OH 
as white solid (5.9 mg, 45% overall yield). 
Analytical data for ACAACA-OH: 1H NMR (600 MHz, D2O) δ 5.24 (d, J = 3.8 Hz, 0.39 
H, α-H1), 4.67 (d, J = 8.0 Hz, 0.61 H, β-H1), 4.55 (dd, J = 15.8, 7.7 Hz, 3H), 4.48 – 
4.41 (m, 2H), 4.02 – 3.96 (m, 2H), 3.95 (dd, J = 6.1, 1.8 Hz, 1H), 3.91 (dd, J = 9.5, 1.9 
Hz, 1H), 3.90 – 3.86 (m, 2H), 3.86 – 3.82 (m, 3H), 3.82 (t, J = 2.1 Hz, 3H), 3.81 – 3.78 
(m, 2H), 3.78 – 3.75 (m, 1H), 3.73 – 3.68 (m, 3H), 3.68 – 3.63 (m, 6H), 3.63 - 3.62 (m, 
6H), 3.61 – 3.54 (m, 2H), 3.53 – 3.50 (m, 1H), 3.50 - 3.48 (m, 1H), 3.48 – 3.47 (m, 1H), 
3.46 – 3.43 (m, 3H), 3.43 – 3.41 (m, 6H), 3.40 – 3.36 (m, 2H), 3.36 – 3.32 (m, 1H), 
3.32 – 3.28 (m, 1H); 13C NMR (151 MHz, D2O) δ 102.36, 102.31, 102.31, 102.27, 




75.64, 75.31, 75.23, 74.81, 74.65, 74.63, 74.22, 74.14, 73.99, 73.76, 73.48, 73.44, 
73.40, 73.16, 72.81, 72.16, 72.11, 71.26, 71.10, 69.93, 69.42, 60.66, 59.97, 59.91, 
59.83, 59.82, 59.12, 59.02, 58.97, 58.30; [α]D20 +14.00 (c 0.8, H2O); IR (neat) νmax = 
3387, 2925, 1650, 1064 cm-1; m/z (HRMS+) 1069.379 [M + Na]+ (C40H70NaO31 requires 
1069.379). 
RP-HPLC of ACAACA-OH (ELSD trace, Method C, tR = 18.8 min) 
 
6.5.5.6. Synthesis of ACACAC-OH 
 
 Module Conditions 







B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-12, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  




D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis and global deprotection and purification afforded ACACAC-OH 
as white solid (4.9 mg, 36% overall yield). 
Analytical data for ACACAC-OH: 1H NMR (600 MHz, D2O) δ 5.21 (d, J = 3.6 Hz, 0.43 
H, α-H1), 4.66 (d, J = 7.9 Hz, 0.57 H, β-H1), 4.55 (d, J = 7.5 Hz, 2H), 4.47 – 4.41 (m, 
3H), 4.06 – 4.02 (m, 1H), 4.00 (dd, J = 12.4, 2.1 Hz, 2H), 3.93 (dd, J = 12.3, 1.5 Hz, 
1H), 3.88 – 3.83 (m, 4H), 3.83 – 3.79 (m, 6H), 3.77 (d, J = 5.2 Hz, 1H), 3.71 (ddd, J = 
9.8, 4.4, 2.5 Hz, 3H), 3.69 – 3.63 (m, 5H), 3.63 – 3.60 (m, 9H), 3.57 (q, J = 6.1, 5.2 Hz, 
2H), 3.53 – 3.43 (m, 6H), 3.43 – 3.41 (m, 6H), 3.41 (d, J = 6.2 Hz, 3H), 3.39 – 3.37 (m, 
1H), 3.37 (s, 3H), 3.35 – 3.30 (m, 1H); 13C NMR (151 MHz, D2O) δ 102.36, 102.34, 
102.25, 102.22, 102.18, 95.78 (β-C1), 91.72 (α-C1), 83.30, 83.06, 83.01, 80.76, 78.68, 
76.02, 75.81, 75.64, 75.41, 75.30, 75.24, 74.73, 74.21, 74.19, 73.62, 73.47, 73.44, 
73.40, 73.10, 73.00, 72.18, 72.11, 70.56, 70.03, 69.94, 69.91, 69.42, 69.17, 60.66, 
59.96, 59.40, 59.13, 59.03, 58.98, 58.30, 58.20, 58.08; [α]D20 +19.86 (c 0.75, H2O); IR 
(neat) νmax = 3395, 2928, 1648, 1066 cm-1; m/z (HRMS+) 1097.409 [M + Na]+ 
(C42H74NaO31 requires 1097.411). 




 AGA synthesis of methylated cellulose 12-mers 
6.5.6.1. Synthesis of AAAAAAAAAAAA-OH 
 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.0 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
 
Automated synthesis, global deprotection, and purification afforded 
AAAAAAAAAAAA-OH as white solid (0.6 mg, 2% overall yield). 
Analytical data for AAAAAAAAAAAA-OH: 1H NMR (700 MHz, D2O) δ 5.24 (d, J = 3.7 
Hz, 0.36 H, α-H1), 4.67 (d, J = 7.9 Hz, 0.64 H, β-H1), 4.57 – 4.51 (m, 11H), 3.99 (d, J 
= 11.9 Hz, 8H), 3.95 – 3.90 (m, 4H), 3.88 (d, J = 11.6 Hz, 2H), 3.84 (dd, J = 12.9, 4.6 
Hz, 8H), 3.81 (d, J = 9.3 Hz, 3H), 3.79 (d, J = 7.6 Hz, 1H), 3.76 – 3.73 (m, 1H), 3.69 
(q, J = 9.5 Hz, 17H), 3.66 – 3.61 (m, 14H), 3.54 – 4.48 (m, 3H), 3.43 (t, J = 9.4 Hz, 
1H), 3.37 (t, J = 8.5 Hz, 8H), 3.31 (dt, J = 22.7, 8.7 Hz, 2H); 13C NMR (176 MHz, D2O) 
δ 102.34, 78.52, 78.48, 78.35, 78.27, 78.27, 74.82, 74.54, 74.01, 73.15, 73.04, 72.94, 
71.32, 60.57, 59.87; solubility not enough for optical rotation measurement; IR (neat) 





RP-HPLC of AAAAAAAAAAAA-OH (ELSD trace, Method C, tR = 16.9 min) 
 
 
6.5.6.2. Synthesis of AAABBBAAABBB-OH 
 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  





 C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis, global deprotection, and purification afforded 
AAABBBAAABBB-OH as white solid (1.8 mg, 7% overall yield). 
Analytical data for AAABBBAAABBB-OH: 1H NMR (600 MHz, D2O) δ 5.24 (d, J = 3.6 
Hz, 0.39 H, α-H1), 4.69 (d, J = 7.8 Hz, 0.61 H, β-H1), 4.63 – 4.51 (m, 11H), 4.05 – 4.00 
(m, 8H), 4.00 – 3.92 (m, 4H), 3.85 (tdd, J = 22.6, 12.8, 4.9 Hz, 17H), 3.77 (dd, J = 12.6, 
5.9 Hz, 2H), 3.73 – 3.65 (m, 13H), 3.65 – 3.62 (m, 18H), 3.59 (td, J = 16.7, 14.9, 5.4 
Hz, 7H), 3.55 – 3.50 (m, 3H), 3.50 – 3.42 (m, 11H), 3.42 – 3.31 (m, 7H); 13C NMR (151 
MHz, D2O) δ 102.49, 102.28, 102.19, 95.72 (β-C1), 91.75 (α-C1), 83.51, 83.45, 83.39, 
83.39, 83.23, 78.35, 78.32, 78.18, 75.91, 75.58, 75.45, 75.43, 75.41, 74.99, 74.77, 
74.75, 74.12, 73.98, 73.93, 73.30, 73.18, 73.07, 72.87, 72.82, 72.77, 72.71, 72.70, 
72.68, 72.65, 72.27, 70.69, 69.38, 60.50, 59.94, 59.90, 59.89, 59.88, 59.82, 59.79, 
59.50, 59.15, 59.12, 59.07, 59.03, 59.00; [α]D20 +10.86 (c 0.2, H2O); IR (neat) νmax = 
3357, 2929, 1647, 1024 cm-1; m/z (HRMS+) 2069.728 [M + Na]+ (C78H134NaO61 
requires 2069.728). 












6.5.6.3. Synthesis of ABAABAAAABBB-OH 
 
 
 Module Conditions 
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
  B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  









B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  






D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
 
Automated synthesis, global deprotection, and purification afforded 
ABAABAAAABBB-OH as white solid (3.9 mg, 15% overall yield). 
Analytical data for ABAABAAAABBB-OH: 1H NMR (600 MHz, D2O) δ 5.24 (d, J = 3.5 
Hz, 0.43 H, α-H1), 4.68 (d, J = 7.8 Hz, 0.57 H, β-H1), 4.60 – 4.52 (m, 11H), 4.01 (d, J 
= 11.5 Hz, 8H), 3.98 – 3.92 (m, 3H), 3.92 – 3.81 (m, 16H), 3.81 – 3.74 (m, 3H), 3.74 – 
3.64 (m, 18H), 3.64 – 3.61 (m, 15H), 3.61 – 3.54 (m, 6H), 3.54 – 3.42 (m, 11H), 3.41 
– 3.35 (m, 6H), 3.35 – 3.31 (m, 1H); 13C NMR (151 MHz, d2o) δ 102.35, 102.33, 102.29, 
102.24, 102.23, 102.20, 102.19, 95.72 (β-C1), 91.76(α-C1), 83.52, 83.46, 83.44, 
83.43, 83.40, 83.23, 83.18, 83.14, 80.96, 78.36, 78.34, 78.21, 78.21, 75.97, 75.92, 
75.91, 75.61, 75.60, 75.48, 75.46, 75.43, 75.42, 75.36, 74.99, 74.76, 74.16, 74.15, 
74.13, 73.95, 73.52, 73.31, 73.27, 73.19, 72.87, 72.70, 72.66, 72.31, 60.69, 59.93, 
59.92, 59.91, 59.89, 59.82, 59.81, 59.79, 59.50, 59.17, 59.12, 59.08, 59.04, 59.00; 
[α]D20 +12.74 (c 0.2, H2O); IR (neat) νmax = 3376, 1019 cm-1; m/z (HRMS+) 2055.714 
[M + Na]+ (C77H132NaO61 requires 2055.712). 
RP-HPLC of ABAABAAAABBB-OH (ELSD trace, Method C, tR = 18.7, 19.3 min) 
 





 Module Conditions 







B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis, global deprotection, and purification afforded 
ABAABAABAABA-OH as white solid (1.8 mg, 7% overall yield). 
Analytical data for ABAABAABAABA-OH: 1H NMR (700 MHz, D2O) δ 5.24 (d, J = 3.7 




11H), 3.96 (dd, J = 11.7, 5.0 Hz, 10H), 3.97 – 3.90 (m, 3H), 3.85 (dq, J = 22.9, 8.5, 6.6 
Hz, 16H), 3.78 (dd, J = 12.6, 4.4 Hz, 1H), 3.67 (tt, J = 10.9, 5.3 Hz, 17H), 3.62 (s, 12H), 
3.60 – 3.55 (m, 5H), 3.53 – 3.41 (m, 11H), 3.37 (q, J = 8.4 Hz, 7H), 3.30 (dt, J = 16.7, 
8.6 Hz, 2H); 13C NMR (176 MHz, D2O) δ 102.40, 102.36, 102.27, 95.76 (β-C1), 91.82 
(α-C1), 83.30, 83.25, 78.50, 78.41, 78.28, 76.04, 75.68, 75.49, 75.42, 75.09, 75.05, 
74.85, 74.81, 74.27, 74.19, 74.03, 73.90, 73.58, 73.34, 72.95, 72.37, 72.32, 71.32, 
71.23, 69.49, 60.75, 60.01, 59.90, 59.84, 59.83, 59.23, 59.14, 59.09; [α]D20 +11.41 (c 
0.2, H2O); IR (neat) νmax = 3360, 2926, 1034 cm-1; m/z (HRMS+) 2041.697 [M + Na]+ 
(C76H130NaO61 requires 2041.696). 
RP-HPLC of ABAABAABAABA-OH (ELSD trace, Method C, tR = 18.8 min) 
 
6.5.6.5. Synthesis of ABACABABACAB-OH 
 
 Module Conditions 




B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 















E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-12, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-11, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-10, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
 F: On-resin Methanolysis  
 G: Cleavage from Solid Support  
 I: Hydrogenolysis  
 J: Purification Method M 
Automated synthesis, global deprotection, and purification afforded 




Analytical data for ABACABABACAB-OH: 1H NMR (600 MHz, D2O) δ 5.23 (d, J = 3.5 
Hz, 0.37 H, α-H1), 4.67 (d, J = 7.9 Hz, 0.63H, β-H1), 4.59 – 4.51 (m, 9H), 4.46 (d, J = 
7.9 Hz, 2H), 4.01 (d, J = 11.9 Hz, 7H), 3.98 – 3.88 (m, 5H), 3.88 – 3.83 (m, 11H), 3.82 
(s, 6H), 3.79 – 3.75 (m, 3H), 3.71 (d, J = 12.7 Hz, 3H), 3.67 (t, J = 8.8 Hz, 10H), 3.64 
– 3.60 (m, 18H), 3.59 (d, J = 11.1 Hz, 7H), 3.54 – 3.43 (m, 13H), 3.42 (s, 6H), 3.39 – 
3.35 (m, 5H), 3.32 (dd, J = 9.4, 7.9 Hz, 2H); 13C NMR (151 MHz, d2o) δ 102.33, 102.30, 
102.27, 102.24, 102.24, 102.21, 102.18, 102.18, 95.72, 83.46, 83.24, 83.19, 83.19, 
83.02, 82.51, 78.37, 78.35, 75.96, 75.61, 75.43, 75.37, 75.31, 74.99, 74.81, 74.69, 
74.17, 73.51, 73.46, 73.27, 73.24, 73.23, 73.21, 73.16, 72.32, 72.26, 72.11, 69.92, 
69.42, 60.00, 59.98, 59.97, 59.78, 59.78, 59.76, 59.44, 59.17, 59.07, 59.03, 58.32; 
[α]D20 +12.15 (c 0.2, H2O); IR (neat) νmax = 3378, 2928, 1066 cm-1; m/z (HRMS+) 
2097.759 [M + Na]+ (C80H138NaO61 requires 2097.759). 
RP-HPLC of ABACABABACAB-OH (ELSD trace, Method C, tR = 21.0, 21.3 min) 
 
 Synthesis of partially protected dimers 
6.5.7.1. Synthesis of 25 




Monosaccharide donor BB-6a (20.0 mg, 0.027 mmol), N-iodosuccinimide (7.4 mg, 
0.0239 mmol) and benzyl alcohol (5.9 mg, 0.055 mmol) were dissolved in anhydrous 
DCM (2 mL). The solution was then stirred with molecular sieve for 1h at room 
temperature under nitrogen atmosphere and then cooled to -15 °C. A 1% solution of 
TfOH in DCM (10 µL) was added and the reaction was stirred for 30 min at -15 °C 
before the removal of cooling bath to raise the temperature to room temperature. After 
TLC indicated the disappearance of BB-6a, piperidine (0.1 mL) was added and the 
yellow solution was stirred at room temperature for additional 30 min. The reaction was 
diluted with DCM and washed with H2O, then saturated aqueous NaCl. The organic 
layer was dried over Na2SO4, filtered and evaporated. The resulting yellow oil was 
purified by column chromatography (hexane:EtOAc = 3:1) to give S16 as white solid 
(13.5 mg, 89%). 
Analytical data for 2-O-benzoyl-1,3,4-tri-O-benzyl-β-D-glucopyranose, S16: 1H 
NMR (400 MHz, CDCl3) δ 8.02 – 7.95 (m, 2H), 7.65 – 7.56 (m, 1H), 7.46 (t, J = 7.6 Hz, 
2H), 7.41 – 7.27 (m, 5H), 7.24 – 7.10 (m, 10H), 5.39 – 5.30 (m, 1H), 4.86 (dd, J = 14.6, 
11.8 Hz, 2H), 4.75 (d, J = 11.2 Hz, 1H), 4.72 – 4.62 (m, 3H), 4.60 (d, J = 8.0 Hz, 1H), 
3.92 (dd, J = 12.1, 2.5 Hz, 1H), 3.86 – 3.71 (m, 3H), 3.44 (ddd, J = 9.6, 4.5, 2.4 Hz, 
1H); 13C NMR (101 MHz, CDCl3) δ 165.24, 137.80, 137.71, 137.02, 133.18, 129.89, 
129.85, 128.57, 128.39, 128.35, 128.30, 128.13, 128.06, 128.04, 127.79, 127.71, 
127.67, 99.69, 82.50, 77.67, 75.40, 75.14, 75.10, 73.70, 70.68, 61.90; m/z (HRMS+) 
577.2203 [M + Na]+ (C34H34O7Na requires 577.2197). 
Synthesis of S17 
 
Monosaccharide acceptor S16 (13.5 mg, 0.0244 mmol), donor BB-6a (21.3 mg, 
0.0292 mmol) and N-iodosuccinimide (6.6 mg, 0.0292 mmol) were dissolved in 
anhydrous DCM (2 mL). The solution was stirred with molecular sieve for 1h at room 
temperature under nitrogen atmosphere and then cooled to -15 °C. A 1% solution of 
TfOH in DCM (10 µL) was added and the reaction was stirred for 30 min at -15 °C 
before the removal of cooling bath to raise the temperature to room temperature. After 
TLC indicated the disappearance of S16, piperidine (0.1 mL) was added and the yellow 
solution was stirred at room temperature for additional 30 min. The reaction was diluted 
with DCM and washed with H2O, then saturated aqueous NaCl. The organic layer was 
dried over Na2SO4, filtered and evaporated. The resulting yellow oil was purified by 
112 
 
column chromatography (hexane:EtOAc = 3:1) to give S17 as white solid (20.1 mg, 
82%). 
Analytical data for S17: 1H NMR (400 MHz, CDCl3) δ 7.97 (ddd, J = 16.2, 8.3, 1.4 Hz, 
4H), 7.65 – 7.56 (m, 1H), 7.47 (dt, J = 16.8, 7.5 Hz, 3H), 7.41 – 7.29 (m, 10H), 7.25 – 
7.01 (m, 17H), 5.36 (dd, J = 9.3, 7.8 Hz, 1H), 5.28 (dd, J = 9.4, 7.9 Hz, 1H), 4.90 (d, J 
= 10.9 Hz, 1H), 4.79 (d, J = 11.1 Hz, 1H), 4.75 – 4.63 (m, 5H), 4.63 – 4.54 (m, 2H), 
4.51 (d, J = 11.1 Hz, 1H), 4.44 – 4.32 (m, 2H), 4.11 (d, J = 10.8 Hz, 1H), 3.98 – 3.84 
(m, 2H), 3.84 – 3.62 (m, 4H), 3.62 – 3.52 (m, 1H), 3.49 (dd, J = 10.1, 5.9 Hz, 2H); 13C 
NMR (101 MHz, CDCl3) δ 165.13, 165.11, 137.82, 137.78, 137.70, 137.67, 136.99, 
133.14, 133.08, 129.86, 129.78, 129.72, 128.58, 128.44, 128.41, 128.30, 128.23, 
128.21, 128.15, 128.06, 128.02, 127.90, 127.87, 127.75, 127.71, 127.64, 127.58, 
101.19, 98.91, 82.64, 82.58, 77.87, 77.67, 75.49, 75.13, 75.12, 74.94, 74.82, 74.71, 
73.64, 73.51, 69.75, 68.55, 61.94; m/z (HRMS+) 1023.387 [M + Na]+ (C61H60O13Na 
requires 1023.393). 
Synthesis of 25 
 
Disaccharide S17 (20.1 mg, 0.020 mmol) was dissolved in MeOH: DCM (1.5 mL,1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form) resin, 
filtered and concentrated in vacuo. The resulting yellow oil was purified by column 
chromatography (hexane: acetone = 3:1) to give 25 as white solid (13.1 mg, 83%). 
Analytical data for 25:  1H NMR (400 MHz, CDCl3) δ 7.43 – 7.27 (m, 25H), 4.95 (ddd, 
J = 14.9, 11.4, 3.5 Hz, 4H), 4.90 – 4.78 (m, 3H), 4.71 – 4.57 (m, 3H), 4.40 (t, J = 6.5 
Hz, 2H), 4.14 (d, J = 11.5 Hz, 1H), 3.87 (d, J = 11.6 Hz, 1H), 3.76 (dt, J = 16.8, 8.4 Hz, 
2H), 3.62 (ddt, J = 15.7, 12.1, 7.5 Hz, 7H), 3.39 (d, J = 5.4 Hz, 1H); 13C NMR (101 MHz, 
CDCl3) δ 138.54, 138.48, 137.97, 137.96, 136.92, 129.95, 128.57, 128.53, 128.51, 
128.48, 128.18, 128.11, 128.10, 128.02, 127.99, 127.96, 127.84, 127.77, 103.56, 
101.75, 84.39, 84.22, 77.62, 77.26, 75.51, 75.29, 75.15, 75.11, 75.09, 74.83, 74.69, 
74.36, 71.36, 68.63, 61.96; m/z (HRMS+) 815.3407 [M + Na]+ (C47H52O11Na requires 
815.3402). 
6.5.7.2. Synthesis of 26 
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Synthesis of S19 
 
Monosaccharide donor S18 is purchased from commercial source.  
S18 (204 mg, 0.274 mmol), N-iodosuccinimide (74 mg, 0.33 mmol) and benzyl alcohol 
(59.3 mg, 0.055 mmol) were dissolved in anhydrous DCM (2 mL). The solution was 
then stirred with molecular sieve for 1h at room temperature under nitrogen 
atmosphere and cooled to -15 °C. A 1% solution of TfOH in DCM (100 µL) was added 
and the reaction was stirred for 30 min at -15 °C before the removal of cooling bath to 
raise the temperature to room temperature. After TLC indicated the disappearance of 
S18, 1 mL piperidine was added and the yellow solution was stirred at room 
temperature for additional 30 min. The reaction was diluted with DCM and washed with 
H2O, then saturated aqueous NaCl. The organic layer was dried over Na2SO4, filtered 
and evaporated. The resulting yellow oil was purified by column chromatography 
(hexane:EtOAc = 3:1) to give S19 as white solid (132 mg, 85%). 
Analytical data for 2,3-di-O-benzoyl-1,4-di-O-benzyl-β-D-glucopyranose, S19:  1H 
NMR (400 MHz, CDCl3) δ 7.89 – 7.80 (m, 4H), 7.44 (q, J = 7.2 Hz, 2H), 7.30 (td, J = 
7.7, 3.9 Hz, 4H), 7.16 – 7.03 (m, 10H), 5.61 (t, J = 9.6 Hz, 1H), 5.34 (dd, J = 9.9, 7.9 
Hz, 1H), 4.80 (d, J = 12.6 Hz, 1H), 4.68 (d, J = 8.0 Hz, 1H), 4.61 (d, J = 12.6 Hz, 1H), 
4.52 (s, 2H), 3.95 – 3.82 (m, 2H), 3.74 (ddd, J = 12.2, 8.4, 3.9 Hz, 1H), 3.49 (dt, J = 
9.7, 3.2 Hz, 1H), 1.85 (dd, J = 8.4, 5.3 Hz, 1H); 13C NMR (101 MHz, CDCl3) δ 165.81, 
165.45, 137.24, 136.87, 133.34, 133.29, 130.00, 129.89, 129.46, 128.52, 128.50, 
128.43, 128.34, 128.13, 128.04, 127.81, 114.22, 99.77, 77.36, 75.61, 75.53, 75.02, 
74.94, 72.09, 71.09, 61.73; m/z (HRMS+) 591.1990 [M + H]+ (C34H32O8Na requires 
591.1989); 




Monosaccharide acceptor S19 (132 mg, 0.232 mmol), donor S18 (207 mg, 0.278 
mmol) and N-iodosuccinimide (62.6 mg, 0.278 mmol) were dissolved in anhydrous 
DCM (2 mL). The solution was then stirred with molecular sieve for 1h at room 
temperature under nitrogen atmosphere and cooled to -15 °C. A 1% solution of TfOH 
in DCM (100 µL) was added and the reaction was stirred for 30 min at -15 °C before 
the removal of cooling bath to raise the temperature to room temperature. After TLC 
indicated the disappearance of S19, piperidine (1 mL) was added and the yellow 
solution was stirred at room temperature for additional 30 min. The reaction was diluted 
with DCM and washed with H2O, then saturated aqueous NaCl. The organic layer was 
dried over Na2SO4, filtered and evaporated. The resulting yellow oil was purified by 
column chromatography (hexane:EtOAc = 3:1) to give S20 as white solid (196 mg, 
82%). 
Analytical data for S20: 1H NMR (400 MHz, CDCl3) δ 7.97 – 7.83 (m, 8H), 7.54 – 7.45 
(m, 3H), 7.37 (tdt, J = 7.5, 5.9, 5.0 Hz, 8H), 7.25 – 7.07 (m, 14H), 7.01 – 6.92 (m, 2H), 
5.75 (td, J = 9.7, 7.9 Hz, 1H), 5.57 (t, J = 9.5 Hz, 1H), 5.47 (dd, J = 9.8, 7.8 Hz, 1H), 
5.35 (ddd, J = 14.6, 9.9, 7.9 Hz, 1H), 4.79 (d, J = 7.8 Hz, 1H), 4.73 (d, J = 12.7 Hz, 
1H), 4.66 – 4.55 (m, 3H), 4.50 (d, J = 12.7 Hz, 1H), 4.34 (s, 2H), 4.19 – 4.09 (m, 1H), 
4.04 – 3.91 (m, 2H), 3.89 – 3.76 (m, 3H), 3.61 (tdd, J = 9.8, 4.5, 2.0 Hz, 2H), 3.52 (s, 
1H); 13C NMR (101 MHz, CDCl3) δ 165.74, 165.59, 165.26, 165.24, 137.15, 137.14, 
136.74, 133.26, 133.23, 133.19, 133.10, 129.88, 129.85, 129.76, 129.38, 129.32, 
129.24, 128.44, 128.43, 128.41, 128.35, 128.33, 128.31, 128.26, 128.03, 127.86, 
127.83, 127.77, 101.22, 99.14, 75.99, 75.59, 75.51, 75.09, 74.92, 74.84, 74.69, 74.60, 
72.13, 71.86, 70.30, 68.41, 61.66; m/z (HRMS+) 1051.345 [M + Na]+ (C61H56O15Na 
requires 1051.351). 
Synthesis of 26 
 
 
Disaccharide S20 (196 mg, 0.191 mmol) was dissolved in MeOH: DCM (15 mL,1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form) resin, 
filtered and concentrated in vacuo. The resulting yellow oil was purified by column 
chromatography (DCM: MeOH = 15:1) to give 26 as white solid (115 mg, 98%). 
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Analytical data for 26: 1H NMR (400 MHz, Methanol-d4) δ 7.46 – 7.26 (m, 15H), 5.02 – 
4.93 (m, 4H), 4.76 – 4.63 (m, 3H), 4.37 (dd, J = 20.3, 7.8 Hz, 2H), 4.17 (dd, J = 11.5, 
1.4 Hz, 1H), 3.81 (ddd, J = 21.8, 11.8, 3.3 Hz, 2H), 3.68 (dd, J = 12.0, 4.9 Hz, 1H), 
3.61 – 3.47 (m, 4H), 3.43 (t, J = 9.3 Hz, 1H), 3.31 – 3.24 (m, 2H); 13C NMR (101 MHz, 
Methanol-d4) δ 138.69, 138.63, 137.69, 127.91, 127.89, 127.76, 127.73, 127.69, 
127.29, 127.26, 103.60, 102.00, 77.91, 77.70, 77.10, 76.96, 75.63, 74.75, 74.35, 
74.29, 73.95, 73.90, 70.56, 68.13, 60.88; m/z (HRMS+) 635.2457 [M + Na]+ 
(C33H40O11Na requires 635.2462). 
6.5.7.3. Synthesis of 27 
Synthesis of S22 
 
S21 is purchased from commercial source. 
Monosaccharide donor S21 (28.9mg, 0.0274 mmol,), N-iodosuccinimide (7.4 mg, 
0.024 mmol) and benzyl alcohol (5.9 mg, 0.055 mmol) were dissolved in anhydrous 
DCM (2 mL). The solution was then stirred with molecular sieve for 1h at room 
temperature under nitrogen atmosphere and cooled to -15 °C. A 1% solution of TfOH 
in DCM (10 µL) was added and the reaction was stirred for 30 min at -15 °C before the 
removal of cooling bath to raise the temperature to room temperature. After TLC 
indicated the disappearance of S21, 0.1 mL piperidine was added and the yellow 
solution was stirred at room temperature for additional 30 min. The reaction was diluted 
with DCM and washed with H2O, then saturated aqueous NaCl. The organic layer was 
dried over Na2SO4, filtered and evaporated. The resulting yellow oil was purified by 
column chromatography (hexane:EtOAc = 3:1) to give S22 as white solid (12.3 mg, 
81%). 
Analytical data for 2-O-benzoyl-1,3,6-tri-O-benzyl-β-D-glucopyranose, S22:  1H 
NMR (400 MHz, CDCl3) δ 7.96 – 7.86 (m, 2H), 7.57 – 7.48 (m, 1H), 7.41 – 7.35 (m, 
2H), 7.32 – 7.21 (m, 5H), 7.18 – 7.02 (m, 10H), 5.32 – 5.21 (m, 1H), 4.78 (d, J = 12.7 
Hz, 1H), 4.67 – 4.50 (m, 5H), 4.47 (d, J = 7.9 Hz, 1H), 3.79 – 3.68 (m, 3H), 3.62 – 3.51 
(m, 1H), 3.44 (dt, J = 9.5, 4.8 Hz, 1H), 2.66 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 
165.21, 137.93, 137.72, 137.04, 133.15, 129.89, 128.52, 128.42, 128.37, 128.27, 
128.09, 128.03, 127.89, 127.81, 127.68, 127.65, 99.39, 82.09, 74.40, 74.08, 73.80, 
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73.33, 72.21, 70.35, 70.11; m/z (HRMS+) 577.2198 [M + Na]+ (C34H34O7Na requires 
577.2197). 
Synthesis of S23 
 
Monosaccharide acceptor S22 (12.3 mg, 0.0222 mmol), donor S21 (21.1 mg, 0.0266 
mmol) and N-iodosuccinimide (6.0 mg, 0.027 mmol) were dissolved in anhydrous DCM 
(2 mL). The solution was then stirred with molecular sieves for 1h at room temperature 
under nitrogen atmosphere and cooled to -15 °C. A 1% solution of TfOH in DCM (10 
µL) was added and the reaction was stirred for 30 min at -15 °C before the removal of 
cooling bath to raise the temperature to room temperature. After TLC indicated the 
disappearance of S22, piperidine (0.1 mL) was added and the yellow solution was 
stirred at room temperature for additional 30 min. The reaction was diluted with DCM 
and washed with H2O, then saturated aqueous NaCl. The organic layer was dried over 
Na2SO4, filtered and evaporated. The resulting yellow oil was purified by column 
chromatography (hexane:EtOAc = 3:1) to give S23 as white solid (18.2 mg, 82%). 
Analytical data for S23: 1H NMR (700 MHz, CDCl3) δ 7.94 (dd, J = 22.2, 7.7 Hz, 4H), 
7.62 (t, J = 7.4 Hz, 1H), 7.58 (q, J = 6.8, 6.2 Hz, 1H), 7.47 (t, J = 7.6 Hz, 2H), 7.37 
(dddd, J = 45.9, 30.2, 13.5, 7.5 Hz, 14H), 7.22 – 7.17 (m, 6H), 7.12 (d, J = 4.5 Hz, 4H), 
7.07 (dt, J = 14.2, 6.9 Hz, 3H), 5.30 (t, J = 8.6 Hz, 1H), 5.22 (t, J = 8.8 Hz, 1H), 4.86 
(d, J = 11.7 Hz, 1H), 4.81 (d, J = 12.7 Hz, 1H), 4.76 (d, J = 11.6 Hz, 1H), 4.74 – 4.68 
(m, 3H), 4.64 (d, J = 11.7 Hz, 1H), 4.53 (d, J = 12.7 Hz, 1H), 4.50 – 4.44 (m, 2H), 4.42 
(d, J = 7.9 Hz, 1H), 4.38 (d, J = 12.2 Hz, 1H), 4.12 (t, J = 9.2 Hz, 1H), 3.82 (t, J = 9.1 
Hz, 1H), 3.72 – 3.62 (m, 3H), 3.57 – 3.51 (m, 3H), 3.40 (dt, J = 10.2, 5.3 Hz, 1H), 3.24 
(dq, J = 9.0, 3.6, 3.0 Hz, 1H), 3.09 (s, 1H); 13C NMR (176 MHz, CDCl3) δ 165.12, 
164.90, 138.55, 138.13, 138.10, 137.50, 137.11, 133.24, 132.90, 130.02, 129.84, 
129.78, 129.68, 128.55, 128.52, 128.49, 128.29, 128.21, 128.19, 128.10, 127.96, 
127.94, 127.88, 127.79, 127.71, 127.61, 127.55, 127.10, 100.26, 99.38, 81.82, 80.28, 
76.49, 74.77, 74.39, 74.35, 73.95, 73.78, 73.64, 73.59, 73.10, 71.08, 70.01, 67.63; m/z 
(HRMS+) 1023.391 [M + Na]+ (C61H60O13Na requires 1023.393). 




Disaccharide S23 (18.2 mg, 0.0182 mmol) was dissolved in MeOH: DCM (1.5 mL,1:1). 
NaOMe in MeOH (0.5 M, 3eq per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h and concentrated in vacuo. The resulting yellow 
oil was purified by column chromatography (hexane: acetone = 3:1) to give 27 as white 
solid (12.5 mg, 87%). 
Analytical data for 27: 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.24 (m, 25H), 5.01 – 4.79 
(m, 5H), 4.73 (d, J = 12.1 Hz, 1H), 4.67 – 4.53 (m, 3H), 4.45 (s, 2H), 4.38 (d, J = 7.0 
Hz, 1H), 4.08 – 3.94 (m, 2H), 3.81 (dd, J = 11.5, 2.2 Hz, 1H), 3.67 – 3.55 (m, 3H), 3.55 
– 3.41 (m, 4H), 3.36 – 3.21 (m, 2H); 13C NMR (101 MHz, CDCl3) δ 138.95, 138.70, 
137.67, 137.53, 137.07, 128.56, 128.53, 128.46, 128.42, 128.33, 128.11, 128.06, 
128.03, 127.93, 127.85, 127.77, 127.70, 127.45, 127.30, 103.11, 101.82, 83.55, 83.40, 
77.26, 74.88, 74.68, 74.60, 74.57, 74.49, 73.70, 73.65, 73.60, 72.03, 71.10, 70.60, 
68.58; m/z (HRMS+) 815.3397 [M + Na]+ (C47H52O11Na requires 815.3402). 
6.5.7.4. Synthesis of 31 
Synthesis of S24 
 
Monosaccharide donor S18 (200 mg, 0.27 mmol), N-iodosuccinimide (74.4 mg, 0.239 
mmol) and MeOH (18 mg, 0.55 mmol) were dissolved in anhydrous DCM (20 mL). The 
solution was then stirred with molecular sieve for 1h at room temperature under 
nitrogen atmosphere and then cooled to -15 °C. A 1% solution of TfOH in DCM (100 
µL) was added and the reaction was stirred for 30 min at -15 °C before the removal of 
cooling bath to raise the temperature to room temperature. After TLC indicated the 
disappearance of S18, piperidine (1 mL) was added and the yellow solution was stirred 
at room temperature for additional 30 min. The reaction was diluted with DCM and 
washed with H2O, then saturated aqueous NaCl. The organic layer was dried over 
Na2SO4, filtered and evaporated. The resulting yellow oil was purified by column 
chromatography (hexane:EtOAc = 2:1) to give S24 as colorless oil (119 mg, 91%). 
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Analytical data for 2,3-di-O-benzoyl-4-O-benzyl-1-methyl-β-D-glucopyranose, S24:  
1H NMR (600 MHz, CDCl3) δ 7.93 (ddt, J = 12.2, 8.3, 1.1 Hz, 4H), 7.52 – 7.46 (m, 2H), 
7.36 (td, J = 7.7, 3.8 Hz, 4H), 7.22 – 7.06 (m, 5H), 5.74 (t, J = 9.6 Hz, 1H), 5.36 – 5.30 
(m, 1H), 4.66 – 4.62 (m, 1H), 4.61 (s, 2H), 4.01 – 3.93 (m, 2H), 3.84 (dd, J = 12.1, 3.8 
Hz, 1H), 3.61 (dt, J = 9.7, 3.1 Hz, 1H), 3.52 (s, 3H); 13C NMR (151 MHz, cdcl3) δ 165.84, 
165.52, 137.30, 133.31, 133.25, 129.96, 129.86, 129.53, 129.52, 128.52, 128.51, 
128.44, 128.34, 128.33, 128.12, 102.21, 75.67, 75.56, 75.11, 74.98, 72.18, 61.68, 
57.43; m/z (HRMS+) 515.1687 [M + Na]+ (C28H28O8Na requires 515.1676). 
Synthesis of S25 
 
Monosaccharide acceptor S24 (90.0 mg, 0.188 mmol), donor BB-12 (131.6 mg, 0.226 
mmol) and N-iodosuccinimide (51.9 mg, 0.226 mmol) were dissolved in anhydrous 
DCM (20 mL). The solution was stirred with molecular sieve for 1h at room temperature 
under nitrogen atmosphere and then cooled to -15 °C. A 1% solution of TfOH in DCM 
(90 µL) was added and the reaction was stirred for 30 min at -15 °C before the removal 
of the cooling bath to raise the temperature to room temperature. After TLC indicated 
the disappearance of S24, piperidine (1 mL) was added and the yellow solution was 
stirred at room temperature for additional 30 min. The reaction was diluted with DCM 
and washed with H2O, then saturated aqueous NaCl. The organic layer was dried over 
Na2SO4, filtered and evaporated. The resulting yellow oil was purified by column 
chromatography (hexane:EtOAc = 1:1.5) to give S25 as white solid (125 mg, 78%). 
Analytical data for 25: 1H NMR (600 MHz, CDCl3) δ 7.92 (ddd, J = 13.7, 8.3, 1.4 Hz, 
4H), 7.71 – 7.65 (m, 2H), 7.48 (ddt, J = 7.4, 5.7, 1.7 Hz, 2H), 7.43 – 7.38 (m, 3H), 7.35 
(ddd, J = 8.2, 4.1, 2.9 Hz, 4H), 7.18 – 7.09 (m, 3H), 7.00 (dd, J = 7.8, 1.7 Hz, 2H), 5.93 
(d, J = 5.2 Hz, 1H), 5.70 – 5.65 (m, 1H), 5.32 (dd, J = 9.8, 7.9 Hz, 1H), 4.59 – 4.54 (m, 
2H), 4.52 – 4.44 (m, 2H), 3.84 (t, J = 9.4 Hz, 1H), 3.77 (dd, J = 10.5, 2.0 Hz, 1H), 3.70 
(td, J = 4.3, 2.8 Hz, 2H), 3.67 – 3.62 (m, 2H), 3.58 (ddd, J = 10.0, 7.5, 4.2 Hz, 2H), 3.51 
(q, J = 1.6 Hz, 1H), 3.50 (s, 3H), 3.49 (s, 3H), 3.39 (s, 3H), 2.75 (s, 1H); 13C NMR (151 
MHz, cdcl3) δ 165.79, 165.53, 165.51, 137.24, 136.11, 133.28, 133.18, 129.96, 129.86, 
129.85, 129.66, 129.60, 129.54, 128.56, 128.52, 128.51, 128.50, 128.44, 128.41, 
128.19, 127.99, 126.39, 120.05, 101.79, 98.28, 81.82, 76.17, 75.80, 75.24, 74.77, 
74.16, 72.89, 72.16, 71.26, 68.82, 62.51, 59.63, 58.46, 56.98; m/z (HRMS+) 809.2792 
[M + Na]+ (C43H46O14Na requires 809.2780). 
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Synthesis of 31 
 
Disaccharide S25 (125 mg, 0.106 mmol) was dissolved in MeOH: DCM (1.5 mL,1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form) resin, 
filtered and concentrated in vacuo. The crude compound was dissolved in 2 mL of 
tBuOH:H2O (1:1). 100% by weight Pd-C (10%) was added and the reaction was stirred 
in H2 bomb with 60 psi pressure for 10 minutes. The reactions were filtered through 
celite, washed with MeOH. The filtrates were concentrated in vacuo. The resulting 
yellow oil was purified by C18 silica column chromatography (H2O: MeOH = 10:1) to 
give 31 as white solid (45.8 mg, 75%). 
Analytical data for 31: 1H NMR (400 MHz, Deuterium Oxide) δ 4.34 (d, J = 7.8 Hz, 1H), 
4.20 (d, J = 8.0 Hz, 1H), 4.02 (dd, J = 11.7, 2.0 Hz, 1H), 3.68 (dd, J = 11.7, 5.8 Hz, 
1H), 3.60 (dd, J = 11.1, 1.9 Hz, 1H), 3.49 – 3.45 (m, 1H), 3.44 (s, 3H), 3.41 (d, J = 1.9 
Hz, 1H), 3.39 (s, 3H), 3.37 (d, J = 1.8 Hz, 1H), 3.35 – 3.25 (m, 3H), 3.23 (s, 3H), 3.19 
(dd, J = 10.4, 2.5 Hz, 1H), 3.15 – 3.05 (m, 2H); 13C NMR (101 MHz, d2o) δ 103.23, 
102.69, 84.92, 75.53, 74.71, 74.22, 72.91, 72.16, 70.76, 69.27, 68.87, 68.61, 59.58, 
58.46, 57.27; m/z (HRMS+) 407.1528 [M + Na]+ (C15H28O11Na requires 407.1524). 
 Synthesis of fully functionalized dimers 
6.5.8.1. Synthesis of 32 
 
Disaccharide 26 (25.0 mg, 0.0408 mmol) and benzyl bromide (52.0 mg, 0.306 mmol) 
were dissolved in DMF (2 mL). NaH (7.3 mg, 0.306 mmol) was added and the solution 
was stirred at room temperature for 12 h. The reaction was then quenched with MeOH 
(0.1 mL), diluted with DCM and washed with H2O and saturated aqueous NaCl. The 
organic layers were dried over Na2SO4, filtered and evaporated. The resulting yellow 
oil was purified by column chromatography (hexane:EtOAc = 4:1) to give 32 as white 
solid (30.5 mg, 70%). 
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Analytical data for 32: 1H NMR (600 MHz, CDCl3) δ 7.35 – 7.19 (m, 38H), 7.16 (d, J = 
6.9 Hz, 2H), 5.01 (d, J = 11.1 Hz, 1H), 4.96 – 4.88 (m, 3H), 4.86 (d, J = 12.0 Hz, 1H), 
4.81 (d, J = 10.8 Hz, 1H), 4.77 (dd, J = 10.9, 6.7 Hz, 4H), 4.70 (d, J = 10.9 Hz, 1H), 
4.61 (d, J = 12.2 Hz, 1H), 4.57 – 4.48 (m, 4H), 4.48 – 4.43 (m, 2H), 4.22 (d, J = 11.3 
Hz, 1H), 3.70 (ddd, J = 21.0, 11.1, 7.4 Hz, 3H), 3.66 – 3.55 (m, 4H), 3.49 (td, J = 8.4, 
3.2 Hz, 2H), 3.44 (t, J = 9.2 Hz, 2H); 13C NMR (151 MHz, cdcl3) δ 138.56, 138.47, 
138.37, 138.17, 138.01, 137.49, 128.40, 128.36, 128.34, 128.32, 128.14, 128.06, 
127.92, 127.86, 127.76, 127.70, 127.63, 127.61, 127.59, 127.57, 103.97, 102.59, 
84.75, 84.70, 82.30, 82.14, 78.31, 77.82, 75.69, 75.67, 75.16, 74.95, 74.93, 74.87, 
74.84, 74.77, 73.51, 71.13, 68.92, 68.62; m/z (HRMS+) 1085.4802 [M + Na]+ 
(C68H70O11Na requires 1085.4810). 
6.5.8.2. Synthesis of 33 
 
Disaccharide 35 (25.0 mg, 0.0731 mmol) and methyl iodide (125 mg, 0.877 mmol) 
were dissolved in of DMF (2 mL). NaH (21 mg, 0.877 mmol) was added and the 
solution was stirred at room temperature for 12 h. The reaction was then quenched by 
MeOH (0.1 mL), diluted with DCM and washed with H2O and saturated aqueous NaCl. 
The organic layers were dried over Na2SO4, filtered and evaporated. The resulting 
yellow oil was purified by column chromatography (hexane: acetone: DCM = 9:3:1) to 
give 33 as white solid (10.5 mg, 31%). 
Analytical data for 33: 1H NMR (600 MHz, CDCl3) δ 4.31 (d, J = 7.8 Hz, 1H), 4.15 (dd, 
J = 10.9, 1.9 Hz, 1H), 4.13 (d, J = 7.7 Hz, 1H), 3.65 – 3.62 (m, 2H), 3.62 (s, 3H), 3.61 
(s, 3H), 3.57 (s, 3H), 3.56 (s, 3H), 3.56 – 3.53 (m, 1H), 3.52 (s, 6H), 3.51 (s, 3H), 3.40 
(s, 3H), 3.36 (ddd, J = 10.0, 6.4, 1.9 Hz, 1H), 3.26 (ddt, J = 7.0, 4.9, 2.2 Hz, 1H), 3.17 
(t, J = 8.9 Hz, 1H), 3.13 (dd, J = 6.8, 2.6 Hz, 2H), 3.06 – 3.00 (m, 2H), 2.97 (dd, J = 
9.1, 7.7 Hz, 1H); 13C NMR (151 MHz, cdcl3) δ 104.17, 103.84, 86.59, 86.40, 83.73, 
83.59, 79.82, 79.33, 74.60, 74.59, 71.36, 68.72, 60.77, 60.74, 60.43, 60.40, 60.35, 
60.30, 59.34, 56.91; m/z (HRMS+) 477.2307 [M + Na]+ (C68H70O11Na requires 
477.2306). 




A suspension of 35 (50.0 mg, 0.146 mmol) in acetic anhydride (2 mL) was heated to 
90°C. NaOAc (201 mg, 2.33 mmol) was added and the solution was stirred at the same 
temperature for 12 h. The reaction was then cooled down to room temperature and 
evaporated. The crude product was suspended in DCM and washed with H2O and 
saturated aqueous NaCl. The organic layer was dried over Na2SO4, filtered and 
evaporated. The resulting yellow oil was purified by column chromatography 
(hexane:EtOAc = 3:1) and recrystallized to give 34 as white solid (45.0 mg, 45%). 
Analytical data for 34: 1H NMR (400 MHz, CDCl3) δ 5.67 (d, J = 8.2 Hz, 1H), 5.19 (dt, 
J = 15.4, 9.5 Hz, 2H), 5.11 – 4.92 (m, 4H), 4.53 (d, J = 7.9 Hz, 1H), 4.24 (dd, J = 12.4, 
4.7 Hz, 1H), 4.10 (dd, J = 12.3, 2.4 Hz, 1H), 3.97 – 3.87 (m, 1H), 3.81 – 3.72 (m, 1H), 
3.65 (dt, J = 9.6, 3.3 Hz, 1H), 3.55 (dd, J = 11.4, 5.8 Hz, 1H), 2.09 (s, 3H), 2.07 (s, 3H), 
2.06 (s, 3H), 2.02 (s, 3H), 2.01 (s, 3H), 2.00 (s, 3H), 1.99 (s, 6H); 13C NMR (151 MHz, 
CDCl3) δ 170.58, 170.17, 170.02, 169.46, 169.34, 169.33, 169.16, 168.75, 100.58, 
91.56, 73.85, 72.81, 72.70, 71.87, 70.86, 70.22, 68.39, 68.30, 67.45, 61.80, 20.73, 
20.68, 20.55, 20.53, 20.51, 20.49; m/z (HRMS+) 701.1893 [M + Na]+ (C68H70O11Na 
requires 701.1899). 
 AGA synthesis of partially deprotected hexamers 
6.5.9.1. Synthesis of 28 
 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
 
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation BB-6a, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  




Cleavage from the solid support as described in Post-synthesizer manipulation 
followed by purification using preparative HPLC afforded compound 16a (27.0 mg, 
74%). 
  
Hexasaccharide 16a (27.0 mg, 9.27 μmol) was dissolved in MeOH: DCM (1.5 mL, 1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h and then filtered. The resulting solid compound 
was dispersed in Milli-Q water and sonicated for 1h. The white suspension was then 
centrifuged at 7000 rcf for 10 min followed by removal of supernatant. The sonication 
and centrifugation was repeated twice. The solid was then dried in vacuo overnight to 
give 28 as white powder (13.5 mg, 63%); m/z (HRMS+) 2312.999 [M + Na]+ 
(C133H151NO33Na requires 2313.006); due to the low solubility of compound 28, no 
distinguishable NMR spectrum was able to be obtained. 
HRMS of 28 
 





 Module Conditions 
 A: Resin Preparation for Synthesis  
 
  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation S18, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 
D: Capping  
E: Fmoc Deprotection  
Cleavage from the solid support as described in Post-synthesizer manipulation 
followed by purification using preparative HPLC afforded S26 (23.0 mg, 61%). 
Analytical data for S26 (1-6): 1H NMR (600 MHz, CDCl3) δ 8.29 – 8.22 (m, 6H), 8.20 
(d, J = 7.7 Hz, 2H), 8.14 – 8.08 (m, 4H), 8.07 (d, J = 7.9 Hz, 2H), 8.03 (d, J = 8.0 Hz, 
1H), 8.01 – 7.92 (m, 6H), 7.90 – 7.86 (m, 2H), 7.53 – 7.43 (m, 4H), 7.42 – 7.20 (m, 
22H), 7.20 – 6.99 (m, 21H), 6.99 – 6.94 (m, 2H), 6.93 – 6.85 (m, 5H), 6.85 – 6.73 (m, 
4H), 6.73 – 6.64 (m, 5H), 6.61 (t, J = 7.4 Hz, 1H), 6.53 (t, J = 7.5 Hz, 2H), 6.50 – 6.44 
(m, 4H), 6.41 (t, J = 7.5 Hz, 2H), 6.02 (t, J = 9.6 Hz, 2H), 5.95 (td, J = 9.6, 7.1 Hz, 2H), 
5.89 – 5.78 (m, 4H), 5.72 – 5.60 (m, 3H), 5.53 – 5.43 (m, 3H), 5.31 (d, J = 8.0 Hz, 1H), 
5.27 (d, J = 8.1 Hz, 1H), 5.11 (t, J = 10.5 Hz, 1H), 5.07 – 4.95 (m, 3H), 4.95 – 4.88 (m, 
1H), 4.78 (br, 1H), 4.69 – 4.60 (m, 4H), 4.42 – 4.22 (m, 11H), 4.22 – 4.12 (m, 4H), 4.09 
– 3.92 (m, 7H), 3.85 – 3.72 (m, 3H), 3.71 – 3.65 (m, 2H), 3.63 (d, J = 9.6 Hz, 1H), 3.59 
– 3.53 (m, 2H), 3.51 (t, J = 9.5 Hz, 1H), 3.28 – 3.24 (m, 1H), 3.21 (dd, J = 13.4, 2.6 Hz, 
1H), 2.93 (dq, J = 12.5, 6.3 Hz, 2H), 1.68 – 1.59 (m, 2H), 1.47 – 1.35 (m, 2H), 1.34 – 





Hexasaccharide S26 (23.0 mg, 7.67 μmol) was dissolved in MeOH: DCM (1.5 mL, 1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form) resin, 
filtered and concentrated in vacuo. The resulting yellow oil was purified by column 
chromatography (DCM: MeOH = 10:1) to give 29 as white solid (10.2 mg, 76%). 
Analytical data for 29: 1H NMR (600 MHz, Methanol-d4) δ 8.01 – 7.96 (m, 2H), 7.55 – 
7.51 (m, 1H), 7.42 (t, J = 7.7 Hz, 2H), 7.37 (t, J = 6.6 Hz, 4H), 7.35 – 7.26 (m, 20H), 
7.23 (qt, J = 7.2, 4.2 Hz, 6H), 6.88 (dd, J = 6.9, 4.5 Hz, 1H), 5.04 (s, 2H), 4.92 (d, J = 
4.6 Hz, 1H), 4.91 – 4.86 (m, 5H), 4.66 (dd, J = 11.1, 6.7 Hz, 2H), 4.60 – 4.54 (m, 4H), 
4.34 – 4.30 (m, 2H), 4.29 – 4.26 (m, 1H), 4.22 (d, J = 7.8 Hz, 1H), 4.18 (d, J = 7.9 Hz, 
1H), 4.09 (ddd, J = 11.9, 7.5, 2.1 Hz, 2H), 4.04 – 3.94 (m, 3H), 3.86 (dt, J = 9.7, 6.7 
Hz, 1H), 3.77 – 3.70 (m, 4H), 3.70 – 3.58 (m, 5H), 3.57 – 3.47 (m, 8H), 3.37 (pd, J = 
9.2, 5.6 Hz, 7H), 3.28 – 3.20 (m, 4H), 3.16 (ddd, J = 10.1, 4.8, 2.2 Hz, 1H), 3.10 (q, J 
= 6.7 Hz, 2H), 1.60 (q, J = 7.7, 7.3 Hz, 2H), 1.49 (q, J = 7.3 Hz, 2H), 1.39 (s, 2H), 1.27 
(s, 2H), 0.87 (dt, J = 18.7, 6.4 Hz, 2H); 13C NMR (151 MHz, cd3od) δ 157.46, 138.66, 
138.64, 138.62, 131.97, 129.18, 128.03, 127.96, 127.95, 127.92, 127.92, 127.88, 
127.85, 127.81, 127.71, 127.66, 127.63, 127.50, 127.37, 127.30, 127.29, 127.25, 
127.23, 127.20, 103.81, 103.61, 103.58, 103.52, 103.45, 102.72, 78.44, 78.41, 78.29, 
78.07, 77.71, 77.14, 77.09, 77.04, 76.94, 75.57, 74.54, 74.42, 74.38, 74.30, 74.26, 
74.13, 74.03, 73.92, 73.84, 73.80, 69.44, 69.05, 68.44, 65.90, 60.88, 48.13, 47.99, 
47.84, 47.70, 47.56, 47.42, 47.28, 47.14, 40.38, 29.17, 28.97, 22.88; m/z (HRMS+) 
1172.721 [M + Na]+ (C91H111NNaO33Na requires 1772.724). 
6.5.9.3. Synthesis of 30 
 
 Module Conditions 
 A: Resin Preparation for Synthesis  
 
  
B: Acidic Wash with TMSOTf Solution  
C: Thioglycoside Glycosylation S21, 6.5 equiv.(-20°C 5 min, 0°C 5 min) 




E: Fmoc Deprotection  
Post-synthesizer manipulation followed by purification using preparative HPLC 
afforded compound 16b (17.0 mg, 47%).  
 
 
Hexasaccharide 16b (17.0 mg, 5.83 μmol) was dissolved in MeOH: DCM (1.5 mL, 1:1). 
NaOMe in MeOH (0.5 M, 3 equiv. per benzoyl ester) was added and the solution was 
stirred at room temperature for 12 h, neutralized with Amberlite IR-120 (H+ form) resin, 
filtered and concentrated in vacuo. The resulting yellow oil was purified by column 
chromatography (hexane: acetone = 3:1) to give 30 as white oil (10.2 mg, 76%). 
Analytical data for 30: 1H NMR (400 MHz, CDCl3) δ 7.39 – 7.18 (m, 65H), 5.10 (s, 1H), 
4.94 – 4.85 (m, 6H), 4.85 – 4.64 (m, 6H), 4.62 – 4.32 (m, 14H), 4.25 (d, J = 7.4 Hz, 
1H), 4.01 – 3.83 (m, 6H), 3.78 (d, J = 10.9 Hz, 1H), 3.69 – 3.48 (m, 11H), 3.42 (ddd, J 
= 21.0, 12.1, 3.4 Hz, 10H), 3.36 – 3.06 (m, 13H), 1.66 (q, J = 6.7 Hz, 4H), 1.59 – 1.52 
(m, 4H), 1.43 (t, J = 7.8 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 156.44, 139.21, 139.19, 
139.14, 139.11, 139.00, 138.75, 137.74, 137.44, 137.26, 137.21, 136.56, 128.54, 
128.48, 128.41, 128.38, 128.36, 128.29, 128.27, 128.20, 128.15, 128.04, 127.91, 
127.88, 127.75, 127.69, 127.38, 127.28, 127.22, 127.09, 126.84, 126.67, 126.57, 
126.53, 103.83, 103.79, 103.69, 103.57, 103.35, 102.90, 83.52, 83.47, 83.38, 75.77, 
75.51, 75.17, 74.57, 74.38, 74.22, 73.64, 73.60, 73.55, 71.65, 70.44, 69.76, 68.58, 
66.64, 40.85, 29.74, 29.58, 29.03, 23.17; m/z (HRMS+) 2328.977 [M + K]+ 




6.6. Solubility, XRD measurements, and MD simulation of cellulose 
analogues 
 Solubility measurements 
The lyophilized oligomer was weighed in a glass vial and water was injected in 
portions. After each portion, the mixture was bubbled with N2 through a syringe for 30 
seconds. Upon complete disappearance of insoluble matter, the range of solubility was 
calculated. The water addition was stopped when the solubility was calculated to be 
less than 1 mg/mL. 
 






A6 1.0 mg 1000 - <1 
A3B3 1.0 mg - 20 >50 
(ABA)2 1.0 mg - 20 >50 
(AB)3 1.0 mg - 20 >50 
ABACAB 1.0 mg - 20 >50 
(ACA)2 1.0 mg - 20 >50 
(AC)3 1.0 mg - 20 >50 
(AFA)2 1.1 mg - 20 >50 
(FA)3 1.0 mg - 20 >50 
(ADA)2 1.0 mg - 20 >50 
(DA)3 1.0 mg - 20 >50 
(AEA)2 1.0 mg - 20 >50 
(AE)3 1.0 mg - 20 >50 
N6 2.6 mg 150 200 13-17 
(ANA)2 1.0 mg - 20 >50 
A12 0.6 mg 600 - <1 
A3B3A3B3 1.0 mg - 20 >50 
(ABA)2A3B3 1.0 mg - 20 >50 
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(ABA)4 1.0 mg - 20 >50 
(ABACAB)2 1.0 mg - 20 >50 





 XRD Analysis 
 








 Molecular Dynamics Simulations (selected, by Theodore Tyrikos‐Ergas) 
 






Figure 6-4. Ramachandran plots of dodecamers (selected). A noticeable deviation 
of the methylated analogues conformations from the main population of A12 was 
observed. An irregular substitution pattern appears to be important to drastically 
change the cellulose conformation (e.g. (ABA)2A3B3). A regular substitution pattern 
such as (ABA)4 maintains more cellulose character, while improving water solubility. 
A more detailed analysis of the dihedral angles can be found in reported literature. 
6.7. Self-assembly of oligosaccharides and characterizations 
 Oligosaccharide self-assembly 
6.7.1.1. Dialysis method 
The oligosaccharide was dissolved in DMAc (1mL) and sonicated for 10 minutes. The 
mixture was diluted with 1 mL of ultrapure water and sonicated for additional 10 
minutes. The final solutions with concentration of 0.01, 0.1 and 2 mg mL−1 were 
prepared by extensive dialysis (3 days) at room temperature with 500 Da and 1 kDa 










27-D 27 0.1 
132 
 
28-D 28 0.01* 
29-D 29 0.1 
30-D 30 0.01* 




6.7.1.2. Solvent-switch method 
Stock solutions of the oligosaccharide (5, 10 and 100 mg mL−1) in HFIP, isopropyl 
alcohol, acetone and DMAc were prepared. Ultrapure water was added at room 
temperature to give a final concentration of 0.1, 2 and 20 mg mL−1.  







HFIP 2 2.0 





26-S-HFIP-20% HFIP 20 




26-S-DMAc DMAc 2 
2.0 
27-S-HFIP 27 HFIP 2 
28-S-DMAc 28 DMAc 2 
29-S-HFIP 29 HFIP 2 





6.7.1.3. Film-forming method 
The oligosaccharide was dissolved in a proper solvent (10 mg mL−1) and dried on the 



































 Characterization of self-assembling samples 
 
 
Figure 6-5. AFM (left) and TEM (right) images of 26-S-HFIP. 
 
 
Figure 6-6. SEM images of 26-S-HFIP for time 0 (left) and after one month upon 







Figure 6-7. SEM (left, scale bar: 2 µm) and TEM (right, scale bar: 200 nm) images 
of 25-S-HFIP. 
 
Figure 6-8. SEM images and photographs (inset) of 26-S-Ace-20% with 2 mg 





Figure 6-9. Real-time merged bright-field (scale of gray) and fluorescence 
(magenta) images of self-assembly process for 26-S-HFIP with excitation 
wavelength at 405 nm and detection range 410-676 nm (scale bar: 20 µm). 
Compound 26 was dissolved in HFIP with a 100 mg mL−1 concentration. After addition 
of ultrapure water (final concentration of 2 mg mL−1), the solution was transferred to a 








Figure 6-10. Confocal microscopy images of 26 prepared with different solvent 
with the film forming method F (top, scale bar: 100 μm) and the solvent-switch 
method S (bottom, scale bar: 10 μm) in four different channels (blue(ex/em): 




Figure 6-11. Confocal microscopy images of the five oligosaccharides prepared 
by film forming method F in four different channels (blue(ex/em): 405/451 nm, 






Figure 6-12. Confocal microscopy images of the five oligosaccharides prepared 
by solvent-switch method S in four different channels (blue(ex/em): 405/451 nm, 









Figure 6-13. Excitation spectra for 26-F-HFIP at emission wavelengths of 410, 
420, 430, 440, 450, 460, 470, 480, 490, 500, 510, 520, 530, 540 and 550 nm. 
 
 
Figure 6-14. Absorption (grey) and excitation (scale of blue) spectra for 26-F-
HFIP. Excitation spectra were recorded for emission wavelengths of 460, 500, 





Figure 6-15. Fluorescence emission images of 26-F-HFIP collected at different 
spectral windows with excitation wavelength at 405 nm. 
 
Figure 6-16. Emission spectra of (A) 26-F-HFIP, (B) 31-F-HFIP, (C) 32-F-HFIP, and 
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Appendix 1: NMR spectra 
1H NMR of BB-6a (400 MHz, CDCl3)  
 









1H NMR of S3 (400 MHz, CDCl3) 
 





1H NMR of S4 (400 MHz, CDCl3)  
 
 





1H NMR of S5 (400 MHz, Methanol-d4) 
 
 




1H NMR of S6 (400 MHz, CDCl3)  
 
 




1H NMR of S7 (400 MHz, CDCl3) 
 
 




















1H NMR of S8 (400 MHz, CDCl3)  
 
 




1H NMR of S9 (400 MHz, CDCl3)  
 
 




1H NMR of BB-12 (400 MHz, CDCl3)  
 

















1H NMR of 15 (400 MHz, CDCl3) 
 
 





1H NMR of S12 (400 MHz, CDCl3) 
 
 




1H NMR of S13 (400 MHz, CDCl3) 
 
 






1H NMR of S15 (400 MHz, CDCl3) 
 
 





1H NMR of 16a (700 MHz, CDCl3)  
 
 




1H NMR of 16b (700 MHz, CDCl3) 
 
 





1H NMR of 17 (400 MHz, CDCl3) 
 
 





13C NMR of 6 (176 MHz, CDCl3)  
 




1H NMR of AAAAAA-OH (600 MHz, D2O) 
 
 





HSQC NMR of AAAAAA-OH (D2O) 
 
 














1H NMR of ABAABA-OH (600 MHz, D2O) 
 
 




HSQC NMR of ABAABA-OH (D2O)  
 
 























HSQC NMR of ABACAB-OH (D2O)  
 
 




13C NMR of ACAACA-OH (151 MHz, D2O)  
 
 




1H NMR of ACACAC-OH (600 MHz, D2O) 
 
 





HSQC NMR of ACACAC-OH (D2O)  
 




13C NMR of AAAAAAAAAAAA-OH (176 MHz, D2O)  
 
 






1H NMR of AAABBBAAABBB-OH (600 MHz, D2O) 
 
 







HSQC NMR of AAABBBAAABBB-OH (D2O)  
 




13C NMR of ABAABAAAABBB-OH (151 MHz, D2O)  
 
 




1H NMR of ABAABAABAABA-OH (700 MHz, D2O) 
 
 




HSQC NMR of ABAABAABAABA-OH (D2O)  
 
 





13C NMR of ABACABABACAB-OH (151 MHz, D2O)  
 
 




1H NMR of S16 (400 MHz, CDCl3) 
 
 





HSQC NMR of S16 (CDCl3)  
 
 





13C NMR of S17 (101 MHz, CDCl3)  
 
 




1H NMR of 25 (400 MHz, CDCl3)  
 
 





HSQC NMR of 25 (CDCl3)  
 
 




13C NMR of S19 (101 MHz, CDCl3)  
 




1H NMR of S20 (400 MHz, CDCl3)  
 
 





HSQC NMR of S20 (CDCl3)  
 
 




13C NMR of 26 (101 MHz, Methanol-d4)  
 




1H NMR of S22 (400 MHz, CDCl3)  
 
 




HSQC NMR of S22 (CDCl3)  
 
 




13C NMR of S23 (101 MHz, CDCl3)  
 
 





1H NMR of 27 (400 MHz, CDCl3)  
 
 





HSQC NMR of 27 (CDCl3)  
 




13C NMR of 29 (101 MHz, Methanol-d4)  
 
 




1H NMR of 30 (400 MHz, CDCl3)  
 





HSQC NMR of 30 (CDCl3)  
 
 




13C NMR of S24 (101 MHz, CDCl3) 
 





1H NMR of S25 (400 MHz, CDCl3)  
 
 




HSQC NMR of S25 (CDCl3)  
 
 




13C NMR of 31 (101 MHz, D2O)  
 
 




1H NMR of 32 (400 MHz, CDCl3)  
 
 





HSQC NMR of 32 (CDCl3) 
 




13C NMR of 33 (101 MHz, CDCl3)  
 
 




1H NMR of 34 (400 MHz, CDCl3) 
 
 





HSQC NMR of 34 (CDCl3)  
 
 
 
